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GENERAL INTRODUCTION
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i. anatomy oF the human Cornea
The cornea is a transparent, avascular tissue and serves as a crystal clear “window” of 
the eye that allows the entry of light. The size of an adult human cornea is 11 to 12 
mm horizontally and 9 to 10 mm vertically. Central corneal thickness is about 0.5 mm, 
increasing slightly toward the periphery, where it is about 0.7 mm.1, 2 The cornea consists 
of three different cellular layers and two interfaces in between, from anterior to poste-
rior: epithelium, Bowman’s layer, stroma, Descemet’s membrane, and the endothelium 
(Figure 1). Recently, a novel acellular pre-Descemet’s layer has been reported (Dua’s 
layer).3 
Optimal corneal optics requires a smooth surface with healthy tear film and epitheli-
um. The corneal transparency is mainly dependent on the stroma and endothelium. The 
stroma forms the largest portion, about 90%, of the thickness of the cornea. The stroma 
is covered at the anterior side by epithelium, and the interface between epithelium and 
stroma is the Bowman’s layer. The Bowman’s layer does not regenerate after damage, 
and the function of this layer remains uncertain. The stroma consists of an uniform ar-
rangement of collagen fibers, which is essential for corneal transparency.2 The posterior 
side of the stroma is covered by Descemet’s membrane and endothelium. Descemet’s 
membrane becomes thicker throughout life; it is 3 µm at birth and increases to 10 µm 
in adulthood.4 Corneal endothelium is a single layer and covers the posterior surface 
Figure 1. anatomy of the human Cornea
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of Descemet’s membrane. Normal endothelium consists primarily of hexagonal cells, 
and after loss or damage to the endothelium, the hexogonality value decreases and 
variability of cell area increases. Endothelial cell density is about 3500 to 4000 cells/mm2 
at birth and decreases with a physiologic rate of 0.6% per year to 2500 to 3000 cells/mm2 
in older age.5, 6 Further, an intact corneal endothelium is important for maintenance of 
stromal transparency, since the endothelium regulates corneal hydration. Endothelial 
function becomes impaired when cell numbers decline to 300-600 cells/mm.2, 7
ii. Corneal transPlantation
2.1 history of corneal transplantation 
In 1824 it was Franz Riesinger who was the first to suggest replacing human opaque cor-
nea with transparent animal cornea, and used the term “keratoplasty”.8 Unfortunately, 
none of the corneas remained clear. After several decades of experiment and devel-
opment, finally the first successful human penetrating corneal transplantation was 
performed by Dr. Eduard Zirm in 1906.9 He had suggested a few important points for a 
successful keratoplasty: use of young and healthy human corneas, use of the von Hippel 
trephine, anesthesia, protection of the graft, and use of overlay sutures.10 
Since this first successful report of penetrating corneal transplantation (Figure 2A), 
various clinical and laboratory research had been performed to develop new trephine 
models, suturing techniques, and surgical instruments.11 The introduction of topical 
Figure 2. Different types of Cornea transplantation 
A = Penetrating Keratoplasty, B = Anterior Lamellar Keratoplasty, C = Deep Anterior Lamellar Keratoplasty , D = Descemet’s 
Stripping Automated Endothelial Keratoplasty, E = Descemet’s Membrane Endothelial Keratoplasty
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antibiotics and corticosteroids had a profound impact on the success rate of corneal 
graft survival. Worldwide, human corneas are the most commonly transplanted tissue, 
and corneal transplantations are the most successful type of tissue transplantation.
During the last decade, different types of lamellar corneal transplantation surgery have 
been described (such as anterior lamellar keratoplasty and endothelial keratoplasty), 
which selectively replace only the diseased layers of the cornea (Figure 2). These lamellar 
techniques have replaced a great part of the standard penetrating techniques. In 2012, 
46102 corneal transplantations were performed in the United States.12 The number of 
penetrating keratoplasty (PK) had decreased from 42063 in 2005 to 21422 in 2012, and 
the number of endothelial keratoplasties increased from 1398 in 2005 to 23049 in 2012, 
which was the most performed type of lamellar keratoplasty in 2012. Anterior lamellar 
keratoplasty showed a slight increase of 641 in 2005 to 883 in 2012, but it remains lower 
in comparison with PK. In the Netherlands, the reported number of corneal transplanta-
tions in 2012 increased from 1290 to1401 (9%).13 
iii. Penetrating keratoPlasty 
3.1 indications for penetrating keratoplasty
Until the last century, full thickness PK was the gold standard treatment for various 
corneal diseases. In PK, the recipient full-thickness corneal tissue is replaced with full-
thickness donor corneal tissue. The goals of PK were visual rehabilitation, tectonic sup-
port, reduction of pain, prevention of infection and cosmetic restoration. The leading 
indications were keratoconus, pseudophakic bullous keratopathy, Fuchs’ endothelial 
dystrophy and regrafts. Other less common indications were post-infectious scarring, 
diverse corneal dystrophies, perforating corneal injury or chemical burns.12, 14-20 PK has 
been shown to be a successful treatment for restoration of vision in eyes with corneal 
disease. In general, PK results in a clear corneal graft with a graft survival rate of 90% at 
1 year follow-up and up to 72% after 5 years follow-up.14, 21 Few PK studies have reported 
up to 10-years follow-up, and the 10-year graft survival rate has been reported to be 50% 
to over 90%.22-27 
3.2 Clinical outcomes and complications of penetrating keratoplasty
Over the last century, several technological improvements have substantially reduced 
the incidence of early postoperative complications, but adverse effects including high 
irregular astigmatism, suture-related events, wound healing problems, allograft rejec-
tion, graft failure and raised intraocular pressure still remain challenging.14, 21, 28
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Astigmatism
By the late 1800’s, von Hippel designed a circular mechanical trephine to remove the 
donor and recipient corneas. His principle is still widely used today. In PK, the recipi-
ent cornea is trephined in the vertical direction and the donor cornea is sutured into 
the recipient bed. Depending on the strength, length or depth, sutures may result in 
high and/or irregular postoperative astigmatism, and limit postoperative useful vision 
for patients. A variety of suturing techniques, such as interrupted sutures, a running 
suture, a combined interrupted and running sutures, and double running sutures have 
been described. However, no single suturing technique has proven superior in order to 
control final suture-out astigmatism.29-31 
Other factors that may also influence postoperative PK astigmatism include graft 
size,32, 33 donor-recipient disparity,29 oval or eccentric trephination,34, 35 and timing of 
suture removal or adjustment.36 Larger corneal grafts tend to be related with lower 
astigmatism and higher rejection rates. In contrast, a smaller corneal graft results in a 
lower rejection rate and a higher degree of topographic irregularity.33 
Post-PK astigmatism greater than 3.0 diopters has been reported in more than 40% 
of eyes, leading to anisometropia and image distortion, and are not correctable with 
spectacles.21, 37, 38 Both postoperative selective suture removal and suture adjustment 
can be used to reduce astigmatism, but astigmatism after suture removal is very vari-
able. Other treatment options for postoperative irregular astigmatism and ametropia 
are rigid gas permeable contact lenses, arcuate corneal relaxing incisions,39 corneal laser 
refractive surgery,40 and implantation of toric intraocular lenses.41
Suture-related problems 
Sutures are needed to keep the donor cornea in place, and different suture-related 
complications have been reported. Breaking or loosening of a suture may result in pain, 
excess mucus production, filamentary keratitis, corneal ulceration, sterile infiltrates, and 
wound dehiscence.42 Loose sutures increase the risk of inflammation and allograft rejec-
tion,43 and therefore, broken or loose sutures should be removed immediately. 
Wound dehiscence
Wound dehiscence may appear after suture removal or traumatic accident.44 Different 
graft configurations have been described to achieve a stronger corneal wound. In 1951, 
Francheschetti described the first mushroom configuration graft,45 and later Busin 
popularized the inverted mushroom configuration (later coined top-hat configuration) 
by using a mechanical trephination technique.46 The idea was to combine the advan-
tages of a clear optical center of the donor graft and the increased wound healing of 
a lamellar graft in the periphery. However, the manual trephination technique has not 
gained widespread use, mainly because of the surgical difficulties involved with the 
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manual dissection. Seitz et al. were the first to report the feasibility of an industrial fem-
tosecond laser to create an inverse mushroom shape in polymethylmethacrylate blocks 
and porcine corneas.47 After the introduction of femtosecond laser it became possible 
to create different trephination profiles. Using femtosecond laser technology, precise 
corneal incisions with customized graft edges and lamellar planes for both donor and 
recipient corneas, such as top-hat, mushroom, zigzag and Christmas tree configurations 
can be constructed. It has been suggested that these trephination profiles offer a better 
donor-recipient fit and increase donor-host junction surface contact, resulting in faster 
wound healing with a stronger wound, earlier suture removal, and lower postoperative 
astigmatism.48-52 However, there are no randomized clinical trial studies demonstrating 
a superior clinical outcome in comparison to PK. 
Allograft rejection
Corneal transplantation is the oldest and most successful human tissue transplantation 
with a high percentage of graft survival (up to 90% at 1 year).14, 21 It has been observed 
that donor corneas were rejected less frequently than other transplanted tissue. This led 
to the concept that the cornea is an immune privileged tissue with a reduced incidence 
in immune corneal allograft rejection.53 However, corneal allograft rejection is one of the 
most important causes of corneas graft failure.23, 54, 55 
The three layers of the cornea (epithelium, stroma, and endothelium) may show 
allograft rejection either individually or simultaneously. Epithelial rejection has been 
reported at a rate of 10% of patients with rejection and it is usually seen in the early 
postoperative period (1-13 months).56 It appears as an elevated, linear epithelial ridge 
from the periphery towards the center of the graft. Distinct subepithelial infiltrates in 
the central of the cornea may manifest as corneal graft rejection. Stromal rejection is 
uncommon and it may visible as stromal infiltrates and neovascularisation. The charac-
teristic signs of endothelial rejection are a linear line from the peripheral cornea towards 
the center (Khodadoust line) or randomly fine endothelial keratic precipitates on the 
endothelial surface.57 The most important and serious allograft rejection is endothelial 
rejection, because the endothelial cells can be damaged and are not able to restore. It is 
very important to recognize the early signs of allograft rejection and to start aggressive 
therapy, because most of the allograft rejection can be reserved. 
Graft failure 
The important factors of corneal graft failure are endothelial rejection and late endo-
thelial failure, which represent more than 50% of graft failures.23, 55 The late endothelial 
failure was defined as a gradual decrease in graft transparency without evident cause, 
unresponsive to corticosteroid therapy, and not related to a recent episode of graft 
rejection. Endothelial cell density is known to decrease over time with a physiologic 
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rate of 0.6% per year after age 18,5 and endothelial cell loss after PK is faster than the 
physiologic rate.23 The reported endothelial cell loss with a follow-up of 1 year, 5 years, 
10 years and 15 years are 34%, 59%, 67% and 71%, respectively.55 Furthermore, another 
important risk factor for graft failure is glaucoma, since elevated intraocular pressure 
may result in endothelial cell damage.58, 59
iv. anterior lamellar keratoPlasty
4.1 history and indications of anterior lamellar keratoplasty 
The concept for anterior lamellar keratoplasty was first described in 1840 by Franz 
Mühlbauer.60 Whereas in PK all five layers of the cornea are transplanted, in anterior 
lamellar keratoplasty the recipient corneal stroma is partially or totally removed to pre-
serve Descemet’s membrane and the endothelium, and the corneal stroma is replaced 
with a lamellar donor cornea button. In the 1970s, there was an increased interest in 
anterior lamellar keratoplasty, but due to the technical difficulty of the procedure and 
the reduced postoperative acuity, PK remained the standard procedure.61 Over the past 
10 years, several innovative surgical techniques have been described which allow lamel-
lar dissection of recipient and donor cornea. This procedure has been described as deep 
lamellar keratoplasty (DLK) and deep anterior lamellar keratoplasty (DALK), but the 
term DLK has widely used as “diffuse lamellar keratitis” after laser in situ keratomileusis 
surgery, so DLK is no longer used in anterior lamellar keratoplasty.62, 63 
The surgical challenge of anterior lamellar keratoplasty is separating the anterior 
stromal layers from Descemet’s membrane and endothelium. Various techniques have 
been described to achieve baring of Descemet’s membrane, including intrastromal air 
injection,64 hydrodelamination,63 viscoelastic dissection using an air-to-endothelium 
interface,65 blunt spatula delamination,66 femtosecond laser-assisted,67, 68 and the most 
widely used technique is the “big-bubble” of Anwar and Teichmann.66 Recently, anterior 
segment optical coherence tomography-guided big-bubble technique has also been 
described.69, 70
Indications for DALK are corneal pathologies without involvement of the endothe-
lium, such as keratoconus, corneal scarring related to infectious keratitis, and stromal 
corneal dystrophies.71 
4.2 advantages of anterior lamellar keratoplasty 
DALK has several advantages over PK. The main advantage of DALK is preservation of 
the recipient’s own endothelium, while replacing epithelium and corneal stroma. This 
eliminates the risk of endothelial allograft rejection, which is the major cause of graft 
failure in PK surgery.55 Furthermore, long-term endothelial cell loss is lower and the pre-
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dicted graft survival is higher after DALK than after PK.72 Other proposed advantages of 
DALK include shorter postoperative steroid therapy, reduced risk of intraocular infection 
due to a “closed eye” procedure, better wound stability, and earlier suture removal.73-75
4.3 Clinical outcomes of anterior lamellar keratoplasty 
The two main outcome parameters of corneal grafting are visual outcome and graft 
survival. A significantly better best-corrected visual acuity (BCVA) after DALK has been 
reported,76 but the majority of comparative studies show no significant difference in the 
postoperative best spectacle-corrected visual acuity (BSCVA) between DALK and PK.62, 
73, 77-83 Only some studies show a significant better BSCVA after PK compared to DALK.74, 
84 Visual outcomes of DALK may be limited compared with PK if baring of Descemet’s 
membrane is incomplete or interface haze occurs. It has been suggested that the main 
parameter for good visual outcome after DALK is the thickness of residual recipient 
stromal bed.84, 85 An eye with DALK with a residual stromal bed of less than 20 µm has 
been shown to give similar visual results as an eye after PK. Deep dissection up to the 
level of Descemet’s membrane is thought to lead to better visual outcomes because of 
the absence of stromal scarring at the level of the graft-host stromal interface.63
There is no significant difference in postoperative astigmatism and spherical equiva-
lent for DALK versus PK in several published studies.75, 83 Other outcomes than standard 
visual outcomes, such as glare testing, contrast sensitivity, intraocular straylight, and 
wavefront analysis have been reported by several studies.62, 73, 80, 84, 86-89 
Graft survival is generally determined in the majority of cases by endothelial rejection 
or late failure. As mentioned above, the advantage of DALK is preservation of the own 
endothelium, which eliminates the risk of endothelial allograft rejection. Randomized 
and non-randomized clinical trials have compared postoperative endothelial cell loss 
between DALK and PK, and showed a significantly higher endothelial cell loss after PK.72, 
75, 83 Studies have also shown a trend in which most of endothelial cell loss occurs in the 
first 6 months after a DALK procedure.75 Borderie et al were the first who used a joint 
regression model to predict long-term graft survival of DALK versus PK, and showed a 
higher median predicted graft survival in the DALK group.72 This means that a young 
patient undergoing DALK should not require regrafting in the long term. On the other 
hand, regrafting is likely to be necessary in the long term for a young patient undergo-
ing PK. 
Immune-mediated endothelium rejection cannot occur after DALK, but epithelial 
rejection and stromal rejection may still occur following DALK.90 This can result in sig-
nificant corneal scarring with decreased graft clarity and decreased visual outcome. 
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4.4 Complications unique to anterior lamellar keratoplasty 
The main complication of DALK procedure is intraoperative perforation of the Descemet’s 
membrane, which occurs in approximately 4% to 39%.75 Large perforations (macroper-
forations) require convertion to a PK procedure intraoperatively (2.0 to 18%).75, 83 Small 
perforations (microperforations) can usually be managed with air or gas injection into 
the anterior chamber. The occurrence of a double anterior chamber postoperatively 
is generally related to a perforation of Descemet’s membrane. Although spontaneous 
attachment of Descemet’s membrane might occur, usually air injection in the anterior 
chamber is required. Other uncommon interface related complications after DALK are 
debris, hemorrhage, vascularization, infection, and epithelial ingrowth.75
v. enDothelial keratoPlasty
5.1 history and indications of endothelial keratoplasty 
The concept of selective tissue replacement for the posterior cornea has been described 
for many decades. The first successful endothelial keratoplasty was reported by Charles 
Tillet in 1956.91 Although Tillet’s endothelial keratoplasty was successful, no further cases 
were reported for decades. In 1998, Melles et al described a revised technique of insert-
ing a donor tissue through a limbal incision, and injection of an air bubble in the anterior 
chamber to initiate self-adherence of the donor tissue without the need for sutures.92 
This technique was first described by Melles as posterior lamellar keratoplasty (PLK). In 
2000, Terry et al modified this technique, and called it deep lamellar endothelial kerato-
plasty (DLEK).93 Despite the improvement in the two techniques, PLK and DLEK were not 
widely practiced due to the technical challenges. In both techniques, it requires manual 
lamellar dissection for both the posterior recipient cornea and the preparation of the 
donor lenticule. Continued development of newer techniques, such as stripping of the 
Descemet’s membrane from the recipient, “Descemetorrhexis”, resulted in a smoother 
recipient interface.94 This procedure has been popularized as Descemets’s stripping 
endothelial keratoplasty (DSEK).95 The use of an automated microkeratome has replaced 
the difficult hand-dissection donor cornea preparation and this provides a smooth deep 
lamellar cut in the donor cornea.96 This procedure was described as Descemet’s stripping 
automated endothelial keratoplasty (DSAEK) by Gorovoy.96 Afterwards, preparation of 
the donor cornea for endothelial keratoplasty with femtosecond laser has also been 
described.97 Recently, transplantation of only Descemet’s membrane with endothelium 
has been named Descemet’s membrane endothelial keratoplasty (DMEK) by Melles,98 
and Descemet’s membrane automated endothelial keratoplasty (DMAEK) by McCauley 
et al.99 
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Indications for endothelial keratoplasty are corneas with endothelial cell dysfunction 
and a healthy anterior recipient cornea. Currently in the United States, endothelial 
dystrophy (e.g. Fuchs endothelial dystrophy) and pseudophakic bullous keratopathy are 
the two most important indications for endothelial keratoplasty.12 Other less common 
indications are posterior polymorphous dystrophy, iridocorneal endothelial syndrome, 
endothelial decompensation due to trauma, glaucoma devices, chronic iritis, or failed 
PK.100, 101 
According to the Eye bank of America Association 2012 statistical report, DSEK/DSAEK 
(23049 cases) is at present the most performed procedure of endothelial keratoplasty in 
the United States, and DMEK has been increased from 344 cases in 2011 to 748 cases in 
2012.12
5.2 advantages of endothelial keratoplasty
The major advantage of all currently used endothelial keratoplasty procedures are 
that no sutures are required to keep the donor tissue in place, thereby preventing the 
occurrence of suture- or incision-induced high and irregular astigmatism, resulting 
in faster visual rehabilitation, more predictable postoperative corneal power, better 
wound stability, minimal suture-related complications.102 It is a closed eye surgery 
which also reduces the risk of preoperative expulsive hemorrhage. Further, the reported 
Kaplan-Meier cumulative probability of immunologic rejection at 1 year  follow-up was 
1%, 8% and 14% for DMEK, DSEK and PK, respectively.103 The immunologic rejection rate 
is significantly reduced in thinner graft, but the rejection rate between Ultrathin-DSAEK 
and DMEK at 1 year is comparable.104
5.3 Clinical outcomes of endothelial keratoplasty
Endothelial keratoplasty has reported faster visual rehabilitation in comparison with 
PK. Despite the advantages of endothelial keratoplasty, visual acuity of the first large 
report of DLEK is limited to 20/46 due to the graft-host interface.105 After introduction of 
Descemetorhexis and microkeratome, the interface smoothness improved significantly, 
and this resulted in a substantial improvement in quality of vision and rapidity of visual 
recovery. Numerous studies have reported better visual recovery after DMEK in compari-
son with DSAEK. Six months after DSAEK, 69-92% of eyes have a BCVA of  ≥ 20/40 and 11-
20% can obtain ≥ 20/20.106-109 In studies after DMEK, the percentage of eyes with BCVA 
≥ 20/40 and ≥ 20/20 are 88-95% and 36-50% at 6 months follow-up, respectively.110-112 
 Another advantage of endothelial keratoplasty over PK is the amount of postopera-
tive astigmatism. PK frequently results in unpredictable topography and high irregular 
astigmatism; this has changed considerably with endothelial keratoplasty. The average 
surgically induced astigmatism in a several large series of DSAEK was less than 0.25 diop-
ters.106, 107, 109 Further, due to the minimal change in corneal topography, the anterior cor-
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nea curvature remained moderately unchanged, thereby causing only minimal change 
in spherical equivalent. Several endothelial keratoplasty procedures have reported a 
mild hyperopic shift.102, 105, 109 This results from the change in posterior curvature, since 
the donor lenticule is thinner in the center and thicker at the edges. Hyperopic shift has 
also been reported after DMEK, but this may result from corneal deturgescence instead 
of posterior corneal curvature change.113, 114 Therefore, when performing cataract surgery 
in combination with endothelial keratoplasty or cataract surgery prior to endothelial 
keratoplasty, the power of the intraocular lens must be targeted at mild myopia of -1.0 
to -1.25 diopters. 
The main concern of both endothelial keratoplasty and PK is to maintain a high endo-
thelial cell density, as it is a crucial factor for long-term graft survival. Mean endothelial 
cell loss after DSAEK ranges widely, from 13% to 50% at 6 months, 42% to 44% at 3 years, 
and 54% at 5 years.73, 115-120 121, 122 After DMEK, the endothelial cell loss has been reported 
between 15 % and 41 % at 6 months, and between 39% and 55% at 5 years.111-113, 123-125  
5.4 Complications unique to endothelial keratoplasty
The most frequent complication of endothelial keratoplasty is dislocation of donor tissue. 
Dislocation rates are between 0% and 82%, with an average of 15%.126 Various technical 
modifications have evolved in order to reduce the incidence of donor dislocation, such 
as surface sweeping to remove interface fluid, longer postoperative supine positioning, 
3 to 4 corneal stab incisions into the interface to release small amounts of interface fluid, 
and gentle scraping of the stripped surface of the peripheral recipient bed to expose the 
peripheral stromal fibrils and promote donor edge adhesion.127, 128 Primary graft failure 
after DSEK has been reported to be higher than after PK, although this higher rate may 
be associated with the surgical learning curve in endothelial keratoplasty.126, 129 Pupillary 
block is a rare complication that can develop after endothelial keratoplasty when an 
excessively large air bubble has been left in the anterior chamber.96, 130 Finally, interface 
deposits and epithelial ingrowth have also been reported.131, 132 
aim anD outline oF the thesis
The aim of this thesis is to compare the outcome of classical PK to anterior and posterior 
lamellar keratoplasty in randomized clinical studies and to evaluate the role of the fem-
tosecond laser in performing lamellar transplantation surgery.
Chapter 2 and 3 evaluate the histologic changes in corneal structure and corneal endo-
thelial viability after femtosecond laser preparation of posterior lamellar discs. 
Chapter 4 describes the first case of femtosecond laser-assisted Descemet’s stripping 
endothelial keratoplasty.
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Chapter 5 presents the preliminary visual results of patients after femtosecond laser-
assisted Descemet’s stripping endothelial keratoplasty.
Chapter 6 discusses the visual outcomes, endothelial cell loss and complications of 
femtosecond laser-assisted Descemet’s stripping endothelial keratoplasty versus pen-
etrating keratoplasty in a randomized multicenter clinical trial. 
Chapter 7 compares the straylight and contrast sensitivity after femtosecond laser-
assisted Descemet’s stripping endothelial keratoplasty versus penetrating keratoplasty 
in a randomized multicenter clinical trial.
Chapter 8 evaluates the cost-effectiveness of penetrating keratoplasty, femtosecond 
laser-assisted Descemet stripping endothelial keratoplasty, and Descemet stripping 
automated endothelial keratoplasty.
Chapter 9 evaluates the 1-year visual outcomes and endothelial cell density of a case 
series of patients with femtosecond laser-assisted inverted mushroom keratoplasty. 
Chapter 10 and 11 both discuss the results of endothelial cell loss, visual outcomes 
and quality of vision after deep anterior lamellar keratoplasty versus penetrating kerato-
plasty in a randomized multicenter clinical trial. 
Chapter 12 evaluates the cost-effectiveness of deep anterior lamellar keratoplasty 
versus penetrating keratoplasty in a randomized multicenter clinical trial.
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aBstraCt
Purpose: To evaluate the histologic changes in corneal structure after femtosecond 
laser preparation of posterior lamellar discs, more specifically, the smoothness of the 
stromal bed and the accuracy of the predicted depth of the horizontal lamellar cut.
materials and methods: Nineteen human donor eyes unsuitable for transplantation 
were used. Femtosecond laser was used to prepare a horizontal lamellar cut in donor 
corneas at a depth of 400 µm. Transmission electron microscopy images were used 
to evaluate the changes in the corneal structure and to measure the damage zone. 
Scanning electron microscopy images were used to determine the relative depth of the 
horizontal lamellar cut, and the stromal bed was examined to determine the smooth-
ness of the surface.
results: Transmission electron microscopy images showed a mean damage zone of 6.8 
± 3.1 µm, which consisted of irregularly oriented collagen fibrils and electron-dense 
granular material. The collagen lamellae, both anteriorly and posteriorly of the dam-
aged zone, showed a regular parallel configuration. The relative depth of the horizontal 
lamellar cut as percentage of the total corneal thickness in the center and periphery 
were 70.4 ± 4.5% and 55.6 ± 5.9%. Scanning electron microscopy images of the stromal 
bed showed a relatively smooth surface. 
Conclusion: The femtosecond laser is effective to prepare a deep horizontal lamellar cut 
in a standardized method. The stromal bed is smooth and without extensive adjacent 
tissue damage. The posterior lamellar disc is thinner in the center and thicker at the 
edges, which may produce a mild hyperopic shift after femtosecond laser-assisted 
Descemet’s stripping endothelial keratoplasty.
37
HISTOLOGIC EVALUATION OF HUMAN PLDs FOR FS-DSEK
2
introDuCtion
Corneal endothelial disease has traditionally been treated with penetrating kerato-
plasty, but in recent years posterior lamellar keratoplasty or deep lamellar endothelial 
keratoplasty (DLEK) surgical techniques have become increasingly popular. These surgi-
cal techniques are designed to replace the diseased corneal endothelial layer without 
manipulation of the healthy anterior part of the recipient cornea in pseudophakic or 
aphakic bullous keratopathy and in Fuchs endothelial dystrophy.1,2 
Posterior lamellar keratoplasty and DLEK were not widely practiced due to the techni-
cal challenges, but this has been changed after introduction of Descemet’s stripping 
endothelial keratoplasty (DSEK) and Descemet’s stripping automated endothelial kera-
toplasty (DSAEK).3-7 DSAEK allows to remove the dysfunctional corneal endothelium in 
the recipient eye in a standardized fashion and to prepare the posterior lamellar disc 
(PLD) in a standardized method by using an artificial anterior chamber system with a 
mechanical microkeratome.
We performed a study to examine the feasibility of a femtosecond laser to prepare 
a PLD in human donor corneas for a DSEK procedure.We evaluated the changes in the 
corneal structure, the accuracy of the predicted depth of a horizontal lamellar cut in 
swollen corneas of whole eyes, and the smoothness of the stromal bed. 
materials & methoDs
Donor tissue
Nineteen human donor eyes unsuitable for transplantation because of corneal scar-
ring (n = 18) and pterygium (n = 1), were obtained from the Cornea Bank Amsterdam 
(Netherlands Institute for Neuroscience, Amsterdam, The Netherlands) and transported 
to the University Hospital Maastricht (Maastricht, The Netherlands) in a moist chamber 
at 4°C. 
Femtosecond laser surgical procedure
The eyes were immobilized using an eye holder with a suction ring (D.O.R.C. International, 
Zuidland, The Netherlands). Slit-lamp microscopy and corneal thickness measurements 
(Orbtek Orbscan II, version 3.10.31, Bausch & Lomb, Munich, Germany) were performed 
before the femtosecond laser procedure (AMO-Intralase Corp., Irvine, CA). The epithe-
lium was removed with a cellulose spear and a surgical beaver blade. The pressure was 
measured using a Barraquer tonometer (Bausch and Lomb, Munich, Germany). The 
intraocular pressure was maintained between a range of 40 mmHg and 60 mmHg. A 
deep horizontal lamellar cut in the cornea was prepared using a 30-kHz femtosecond 
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laser. The cornea was applanated with a flat interface lens. The horizontal lamellar cut 
was set at a depth of 400 µm with a diameter of 9.5 mm and the mean energy level 
was 1.07 µJ (range 0.70 - 1.40 µJ) using a raster pattern. After the femtosecond laser 
procedure the whole donor eyes were decontaminated and stored in organ culture for 
two weeks in the Cornea Bank Amsterdam. After organ culture storage, 6 corneoscleral 
buttons with a horizontal lamellar cut (without dissection of the PLD) were fixed in 2.5% 
glutaraldehyde in 0.1 M phosphate buffer or 4% formalin for histologic and electron 
microscopic examination. Additionally, 13 corneoscleral buttons with a horizontal la-
mellar cut were punched from the endothelial side with an 8.0-mm trephine (Medical 
Workshop, Groningen, the Netherlands). The PLD was separated from the anterior 
stroma by injection of sterile balanced salt solution in the horizontal lamellar interface to 
create an intralamellar dissection plane. After dissection of the PLD all specimens were 
fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer or 4% formalin for histologic and 
electron microscopic examination.
histology and electron microscopy
For transmission electron microscopy (TEM), the corneas were postfixed in 1% osmium 
tetroxide, en bloc stained with 2% uranyl acetate, serially dehydrated in graded ethanols 
followed by a 1:1 mixture of 100% ethanol and propylene oxide overnight. They were 
transferred into pure LX-112 resin (Ladd Research Industries, Vt) and after several hours 
were oriented in silicone molds with fresh resin and cured at 50ºC for 2 days. Resin blocks 
were trimmed, 1.5-µm-thick sections were cut and stained with 1% toluidine blue to 
determine the area of interest for thin sectioning and for light microscopy. Ultrathin sec-
tions (80 nm) were cut with a Diatome diamond knife on a Leica Ultracut ultramicrotome 
and picked up on uncoated 300 mesh grids. Sections were stained with uranyl acetate 
and lead citrate and viewed in a Jeol 100CS-II TEM at 60 kv. Images were captured on 
Kodak EM film #4489 and developed in Kodak D-19. 
TEM images of non-dissected corneoscleral buttons were used to evaluate the corneal 
structure, anteriorly and posteriorly of the horizontal lamellar cut, and to measure the 
extent of corneal stromal damage induced by the femtosecond laser. The measurements 
were performed using the ImageJ 1.35s software (available at http://rsb.info.nih.gov/ij; 
developed by Wayne Rasband, National Institute of Health, Bethesda, MD). 
For scanning electron microscopy (SEM), the corneas were dehydrated, critical point 
dried, mounted on specimen tubs, and coated with gold. SEM images of corneoscleral 
buttons were used to measure the relative depth of the horizontal lamellar cut. The 
corneoscleral buttons were hemi-dissected in a anterior-posterior direction from 
epithelium to endothelium. SEM images were made facing the corneal stromal surface 
in the epithelial-endothelial direction. Analysis of the relative depth of the horizontal 
lamellar cut in the cornea was performed using the ImageJ 1.35s software.
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The anterior lamellar discs and the PLDs of the dissected corneoscleral buttons were 
processed to evaluate the smoothness of the stromal side of the discs. The surface of 
the anterior lamellar discs and posterior lamellar discs were examined with SEM (Philips 
XL 30 Scanning Electron Microscopy, Eindhoven, Netherlands) at 10 kV. SEM images 
were subjectively graded by 3 masked independent observers. The smoothness of the 
stromal bed of the discs were graded as follows: 1 = very smooth, 2 = smooth, 3 = rough; 
and 4 = very rough. 
statistical analysis
The difference of smoothness between the anterior lamellar disc and the PLD was com-
pared by the Wilcoxon matched-pair test. A P-value of ≤0.05 was considered statistically 
significant. All data analysis was performed using the SPSS statistical software package 
(SPSS for Windows version 12.0, SPSS Inc., Chicago, IL).
results
Corneal stroma collagen and keratocytes
On light microscopy, there was a smooth, straight horizontal lamellar cut in the cornea 
(Fig. 1). TEM images in the same area showed a mean damage zone of 6.8 ± 3.1 µm (range, 
2.2 -14.3 µm), which consisted of irregularly oriented collagen fibrils, and electron dense 
Figure 1. Light microscopic, cross-sectional histology (toluidine blue) of the corneoscleral rim with a horizontal lameller 
cut. The toluidine blue sections of the corneoscleral rim showed a horizontal lamellar cut (arrows) in a human cornea using 
the femtosecond laser. The large arrowhead showed the end of the horizontal lamellar cut at the corneal periphery. Scale 
bar, 100 µm.
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granular material (Fig. 2A). The collagen lamellae, both anteriorly and posteriorly of the 
damaged zone, showed a regular parallel lamellar configuration (Fig. 2B, 2C). Thermal 
alteration of adjacent tissue was not detected with light microscopy and TEM. The 
keratocytes found just adjacent to the damage zone, both anteriorly and posteriorly, 
contained numerous vacuoles and looked similar to keratocytes after corneal storage 
with 5% Dextran T500 (Pharmacia, Amsterdam, The Netherlands) supplement. 
Depth of the horizontal lamellar cut
The mean central corneal thickness and peripheral corneal thickness (4 mm from the 
center) before the femtosecond laser procedure was 820.0 ± 51.2 µm and 951.5 ± 51.5 
µm, respectively. On light microscopy and SEM, the mean relative depth of the horizon-
tal lamellar cut as percentage of the total corneal thickness in the center and periphery 
were 66.4% ± 4.3% versus 57.6% ± 3.0 % (Fig. 3), and 70.4%  ± 4.5% versus 55.6% ± 5.9%, 
respectively (Fig. 4). 
Figure 2. Transmission electron micrographs of the cornea after horizontal lamellar cut using the 30-kHz femtosecond 
laser. Transmission electron micrograph showed a mean damage area of 6.8 ± 3.1 µm (A, between arrows). The collagen 
lamellae above (B) and below (C) the horizontal lamellar cut  showed a regular parallel-oriented configuration and. After 2 
weeks organ culture storage with Dextran, numerous vacuoles were detected in the keratocytes (B and C, arrows)
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quality of the stromal bed 
After 2 weeks in organ culture storage, the cornea was trephined and all PLDs were 
separated by blunt dissection. The histology of the anterior lamellar disc and the PLD 
demonstrated a relatively smooth surface. Figure 5 shows the SEM images of the four 
gradings of smoothness. The mean smoothness score of SEM for the stromal bed of the 
anterior lamellar disc and PLD was 1.5 ± 0.4 and 2.8 ± 0.9, respectively (P = 0.027; Fig. 6). 
Figure 3. Light microscopic, cross-sectional histology of the cornea in the center and in the peripheral (toluidine blue). The 
toluidine blue sections showed that the horizontal lamellar cut was located at 66.4% of the total corneal thickness in the 
center (A, between arrows), and 57.6% of the total corneal thickness in the peripheral (B, between arrows).
Figure 4. Scanning electron micrographs of human cornea showing the horizontal lamellar cut. Scanning electron micro-
graphs showed in the cornea a horizontal lamellar cut produced with the 30-kHz femtosecond laser. In the center of the 
cornea, the mean relative depth of the horizontal lamellar cut is located at 70.4% of the total corneal thickness (A, between 
arrows), and in the periphery it is located at 55.6% of the total corneal thickness (B, between arrows).
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DisCussion
The introduction of more standardized techniques like DSEK and DSAEK have led to 
renewed interest in endothelial keratoplasty for replacement of the diseased corneal 
endothelial layer and to a dramatic increase in the percentage of donor tissue used for 
endothelial keratoplasty.4,8,9 Several in vivo and in vitro studies have described different 
techniques to prepare a PLD from whole donor eyes or corneoscleral buttons using 
mechanical microkeratomes or femtosecond lasers.5,7,10-14
Currently, there are three femtosecond lasers available for corneal surgical applications: 
Intralase (AMO-Intralase Corp.), Femtec (20/10 Perfect Vision, Heidelberg, Germany), 
Figure 5. The four gradings of the stromal smoothness. SEM images showed a very smooth stromal bed (A), smooth stro-
mal bed (B), rough stromal bed (C), and very rough stromal bed (D). Scale bar, 500 µm.
Figure 6. Scanning electron micrographs of the stromal bed after dissection. Two representative SEM images for the aver-
age smoothness of the anterior lamellar disc (1.3 score in the this case; A) and the PLD (2.7 score in this case; B) are shown. 
Scale bar, 500 µm.
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and Ziemer Ophthalmic Systems AG (FEMTO LDV, Port, Switzerland). Experimental and 
clinical applications of femtosecond lasers include laser in situ keratomileusis (LASIK) 
flap creation,15,16 tunnel incision for corneal rings,17,18 wedge-shaped resection in cor-
rection of high residual astigmatism,19 lamellar and full-thickness keratoplasty tech-
niques7,10,12,14,20-22  and shaped full-thickness keratoplasty with different donor-recipient 
patterns.23-27 Recently, the feasiblity of the femtosecond laser for preparing PLDs for 
DSEK was described.14
The challenge for all lamellar keratoplasty procedures including endothelial kerato-
plasty is to achieve a high level of postoperative quality of vision. It is suggested that the 
lack of stromal smoothness of the PLDs is a major factor in the pathogenesis of interface 
opacification that may be responsible for some loss of the potential best-corrected visual 
acuity.28 Although the stromal bed of the recipient cornea after Descemet’s stripping is 
very smooth, the stromal bed of the PLD prepared by either manual dissection or by an 
automated microkeratome is not as smooth as the bed of the recipient.29 Several studies 
have shown that a femtosecond laser and automated microkeratome are effective in 
preparing a PLD, but the smoothness of the stromal bed of a deep horizontal lamellar 
cut appears to be inferior to the smoothness of the stromal bed of a superficial LASIK 
flap cut by a femtosecond laser.7,10-13 
Recently, the smoothness of the corneal cuts made by a femtosecond laser have been 
related to the type of laser and laser pattern used, the frequency and energy of the 
laser and the type of applanation lens, being flat or curved. When using the FEMTEC 
femtosecond laser, a smooth stromal bed with minor remaining tissue bridges of PLDs 
may be visible10 and after full-thickness trephination with this laser electron microscopy 
reveals more tissue bridges in thicker edematous corneas than in thinner corneas.21 
PLDs prepared by the Intralase femtosecond laser showed an excellent side-cut quality 
and a smooth lamellar bed.12 However, when using a spiral laser pattern SEM showed a 
stromal bed with very mild concentric circular ridges and a stucco-like texture. Sarayba 
et al30 further evaluated the quality of the stromal bed using a spiral or raster pattern 
and demonstrated that a raster pattern provides a smoother stromal bed than a spiral 
pattern. It has been suggested that the circular concentric circular ridges will disappear 
by the application of a curved interface12 and that lower energy levels may result in a 
smoother stromal bed. Indeed, for superficial LASIK flaps it has been shown that a 30-
kHz femtosecond laser with tighter spot/line separation and lower energy level creates 
a smoother stromal bed in comparison with a 15-kHz femtosecond laser and a mechani-
cal microkeratome.31 For the moment it is not clear what the effect of higher frequency 
femtosecond lasers up to 60 kHz on the smoothness of the stromal bed may be when 
making deeper stromal lamellar cuts for PLDs. The effect of the hydrated corneas (mean 
corneal thickness 820 µm before the horizontal lamellar cut) on the smoothness of the 
cut is not clear. One could speculate that posterior interface cuts tend to be more irregu-
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lar because of a looser stromal fibrillar arrangement and density and more laser scatter 
from going through more tissue. However, in an environment of extensive hydration as 
in these fresh donor eyes, the number of fibrils cut by the laser per square millimeter is 
lower. It is unclear if this might result in less roughness at the interface as compared with 
cutting in a normally hydrated posterior corneal stroma. 
In the present study, we have used a raster pattern instead of a spiral pattern, and 
concentric circular ridges were not seen in the SEM photographs. We found that the 
smoothness of the stromal bed of the PLD appears to be comparable to the results 
published by Terry et al.11 However, the stromal bed of the anterior lamellar disc appears 
significantly smoother as compared to the stromal bed of the PLD of the same donor. At 
present we have no explanantion for this finding. Trephination side cuts were not made 
by the femtosecond laser because the maximum cutting depth of the femtosecond laser 
was 400 µm at the time of the study, and we could not exclude that epithelial cells can 
migrate into the trephination side cuts during the 2 weeks of organ culture. In addition, 
we believe that the dissection of the PLD form the anterior part will be more traumatic 
for the endothelial cells when we need to manually dissect along the trephination side 
cuts. Further experiments are needed to study these hypotheses.
Recent reports showed that predictability of flap thickness after a superficial LASIK 
flap was significantly better when using a femtosecond laser [standard deviation 
(SD) of 14 µm] as compared to the Carriazo-Barraquer (Moria, Inc., Antony, France) or 
Hansatome microkeratome (Baush & Lomb, Inc.) (SD of 26 and 29 µm, respectively).16,32 
In vitro studies in cloudy and edematous corneas showed a mean SD between 9 and 61 
µm from the intended thickness for PLDs prepared by a femtosecond laser.12,30 When 
using a mechanical microkeratome with a 350-µm microkeratome head, the SD of the 
anterior lamellar disc was within ± 75 µm.33 Behrens et al34 showed that the accuracy of 
the intended thickness of the anterior lamellar discs decreased, when the head thick-
ness of the automated microkeratome increased. When the intra chamber pressure was 
increased the mean SD of the thickness of the anterior lamellar discs decreased.35
In our study the PLD was not dissected immediately after the femtosecond laser 
procedure, so we could only measure the relative thickness of the posterior lamellar disc 
after the histologic fixation procedures. Both light microscopy and SEM revealed that 
the horizontal lamellar cut was deeper in the center than in the periphery. This means 
that the Intralase femtosecond laser will provide a meniscus-shaped PLD that is thinner 
in the center and thicker at the edges. A meniscus-shaped PLD can produce a mild hy-
peropic shift, as has been shown in a previous study.36 With the current laser technology, 
the depth of the horizontal lamellar cut is calculated from the anterior surface of the 
donor cornea. When it is possible to calculate the depth of the horizontal lamellar cut 
from the endothelial side of the cornea, the PLD will have a more planar shape, which 
may avoid the hyperopic shift. 
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Obviously, during the fixation procedure for electron microscopy the corneas were 
dehydrated, which could result in a shift of the level of the horizontal lamellar cut, that 
is, the ratio of stroma anteriorly versus posteriorly of the lamellar cut as compared with 
total corneal thickness. We cannot exclude that these factors could lead to an inaccuracy 
of the measurements of the depth of the horizontal lamellar cut. In our study an area of 
loose debris of the collagen fibrils of the order of 6.8 ± 3.1 µm was detected with TEM. 
The collagen lamellae above and below the damaged area had a normal ultrastructure. 
This indicates that the femtosecond laser produced a small area of disruption of col-
lagen fibrils without adjacent thermal damage. However, other in vitro studies showed 
no thermal damage in the adjacent tissue when performing corneal trephination with 
the femtosecond laser.10,21 Keratocyte activation in a LASIK flap prepared with the 
microkeratome or femtosecond laser and after photorefractive keratectomy has been 
detected.37-40 After DLEK, activated keratocytes have been found just adjacent to the 
interface line.41 In vivo, a correlation between keratocyte activation and clinical corneal 
haze has been detected using confocal microscopy.39,40,42 Hindman et al43 have used 
a scatterometer and found a higher scattering index in a DLEK group, which indicates 
an increased subclinical corneal haze that may limit best-corrected visual acuity after 
DLEK. It has been suggested that lower energy and smaller step size when using a raster 
pattern will minimize keratocyte activation and the inadvertent sequelae like interface 
opacification.44 
In the present study the femtosecond laser is effective in creating a deep horizontal 
lamellar cut in a swollen cornea from a whole donor eye. Corneas with corneal scar-
ring and healthy endothelial cells can now be predissected and used for endothelial 
keratoplasty, which may lead to more donor corneas available for grafting. We have 
found that preparing of the PLD with a femtosecond laser does not result in a significant 
amount of endothelial cell loss.14 The advantage of this procedure is that corneas with a 
femtosecond laser prepared horizontal lamellar can be stored in organ culture for up to 
2 weeks before corneal transplantation. This allows time for serological screening of the 
donor, microbiological testing and human leucocyte antigen-typing of the tissue, and 
for quality assessment of the endothelial cel layer.45 In addition, precutting the tissue 
with a femtosecond laser could have cost-effective advantages. In contrary, when the 
PLD is cut in the surgical theatre by a microkeratome, no information is available on the 
endothelial status after the preparation. 
In summary, femtosecond laser-assisted preparing of PLDs results in a standardized 
method of preparing PLD with a smooth surface and without extensive adjacent tissue 
damage. In a previous report we have shown that femtosecond laser-assisted DSEK in a 
patient with pseudophakic bullous keratoplasty is feasible.46 A multicenter randomized 
clinical study is in progress to compare the visual results and endothelial cell density 
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of femtosecond laser-assisted DSEK with the results of the conventional penetrating 
keratoplasty.
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aBstraCt
Purpose: To evaluate the feasibility of the femtosecond (FS) laser in preparation of 
posterior lamellar discs (PLDs) and to study the effect on endothelial cell (EC) viability 
for Descemet-stripping endothelial keratoplasty.
methods: Fourteen human donor bulbi unsuitable for transplantation were used. A 
horizontal lamellar cut was prepared in the donor cornea with an FS laser by using a 
raster and/or a spiral spot pattern. The control group consisted of the paired cornea 
of the same donor. EC density was evaluated before and after preservation in organ 
culture. The PLD was stripped from the anterior part by using either a forceps or a blunt 
dissection technique. The damage to the endothelium was evaluated.
results: EC loss after organ storage was not statistically significant between the FS cor-
nea group and the control group in the 15- (7.7% ± 6.9% and 8.9% ±  8.1%, respectively; 
P = 0.78) and 30-kHz (4.3% ± 4.0% and 3.7% ± 3.6%, respectively; P = 0.75) group. There 
was no significant effect of laser frequency (15 vs. 30 kHz) on EC loss (7.7% vs. 4.3%, P = 
0.25). Dissection by using a forceps stripping technique resulted in higher EC loss than 
that with a blunt dissection technique (13.0% vs. 6.5%, P = 0.03).
Conclusions: EC loss after FS laser lamellar cutting is not dependent on the frequency 
(ie, energy level) of the laser. A blunt dissection technique of PLDs resulted in acceptable 
EC loss and supports the clinical use of the FS laser for the preparation of PLDs.
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introDuCtion
Posterior lamellar keratoplasty (PLK), also named deep lamellar endothelial keratoplasty 
(DLEK), has become an increasingly popular corneal transplantation technique in recent 
years. PLK and DLEK are manual techniques and have been introduced for the selective 
transplantation of only the diseased posterior corneal layer in pseudophakic or aphakic 
bullous keratopathy and in Fuchs endothelial dystrophy.1-3 Unfortunately, because of the 
technical challenges, PLK and DLEK have not been widely adapted yet among corneal 
transplant surgeons. The preoperative preparation of the posterior lamellar discs (PLDs) 
from a donor eye, consisting of posterior stroma with the Descemet membrane and 
endothelium,is time consuming, technically difficult, and not standardized. Therefore, 
penetrating keratoplasty (PK) is still the most frequently performed procedure for endo-
thelial disease worldwide.
To eliminate the difficult dissection of the pocket in the recipient cornea and to create 
a smoother surface of the recipient cornea, stripping of the Descemet membrane was 
introduced. This so-called Descemet-stripping endothelial keratoplasty (DSEK) tech-
nique leaves the structure of the posterior cornea intact.4 The most recent innovation in 
DSEK is the use of an automated microkeratome to facilitate an easier preparation of the 
donor PLDs.5-7 Alternatively, the PLD can be prepared by using a femtosecond (FS) laser 
on a whole donor eye or on an artificial anterior chamber. In The Netherlands and most 
other European countries, organ culture is the preferred method of storage for corneal 
donor buttons.8 The FS laser–prepared corneoscleral buttons may be stored in organ 
culture for several weeks before transplantation. A good quality of the donor corneal 
endothelium after FS laser dissection is an important prerequisite for the success of 
selective endothelial transplantation techniques. 
We performed a study to evaluate the feasibility of the FS laser in preparation of PLDs. 
The effects of variations in laser frequency and the effect of organ culture on the endo-
thelial cell (EC) viability of FS laser–prepared PLDs were determined.
materials & methoDs
Donor bulbi
Fourteen human donor bulbi, not suitable for transplantation because of corneal scar-
ring (N = 13) and pterygium(N = 1), were obtained from the Cornea Bank Amsterdam, 
Netherlands Institute for Neuroscience, Amsterdam, The Netherlands. These corneas 
were unsuitable for transplantation but had EC counts >2200 cells/mm2. Consent had 
been obtained from the donors for research use. Donor age averaged 67.3 ± 7.3 years; 11 
donors were men and 3 were women. The bulbi were stored at 4ºC in a moist chamber 
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and subsequently transported to the University Hospital Maastricht, Maastricht, The 
Netherlands.
Fs laser surgical procedure
Before the FS laser procedure, slit-lamp microscopy and Orbscan topography (Orbtek 
Orbscan II, version 3.10.31; Bausch & Lomb, Munich, Germany) were used. An eye holder 
with a suction ring (D.O.R.C. International, Zuidland, The Netherlands) was used to im-
mobilize the whole donor eye. The intraocular pressure was checked with a handheld 
Barraquer tonometer (Bausch and Lomb) and maintained between a range of 40 and 
60 mm Hg. 
We used an FS laser (Intralase Corp., Irvine, CA) to prepare a deep horizontal lamel-
lar cut in the deepithelialized cornea. The cornea was flattened with an applanating 
interface lens. The horizontal lamellar cut was set at a corneal depth of 400 µm with a 
diameter of 9.5 mm (Fig. 1). In the first 8 donor bulbi, the horizontal lamellar cuts were 
obtained with a firing rate of 15 kHz and with an energy level of 2.6 µJ. In the following 
6 donor bulbi, the firing rate was 30 kHz, and the mean energy level was 1.07 µJ (range, 
0.70–1.40 µJ). 
We started with a raster or a combination of a raster and spiral pattern by using a 
15-kHz laser. After the 30-kHz treatment mode laser became available, a raster pattern 
was used. The study group was divided into 2 separate frequency groups: 15 (N = 8) and 
30 kHz (N = 6). In the 15-kHz group, the donor age was 70.6 ± 5.2 years versus 62.8 ± 7.6 
Figure 1. Schematic overview of the horizontal lamellar cut using the FS laser. The cornea was flattened with an applanat-
ing interface lens, and a horizontal lamellar cut was set at a depth of 400 µm.
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years in the 30-kHz group (P = 0.03). There was no significant difference in postmortem 
time between the 15-kHz group and the 30-kHz group (2.8 ± 0.2 and 2.7 ± 0.6 days, 
respectively; P = 0.602).
Donor cornea preparation and ec density
After the FS laser surgical procedure, the whole donor eye was decontaminated, was 
stored at 4ºC in a moist chamber, and subsequently was transported to the Cornea Bank 
Amsterdam, where a corneoscleral button was prepared. In the Cornea Bank Amsterdam, 
the EC density was evaluated before and after 7.3 ± 5.3 days of storage in organ culture 
(before dissection of the PLD from the anterior part) by light microscopy after staining 
with 0.3% trypan blue in 0.9% NaCl (Pharmacy Academic Medical Center, Amsterdam, 
The Netherlands) for 1 minute. The intercellular spaces were visualized by provoked 
swelling with 1.8% sucrose.9 Fixed frame counting technique was used to calculate cell 
density according to the Gundersen method.10 The paired cornea of the same donor, 
suitable for transplantation and untreated, was used as a control in this in vitro study.
After storage in organ culture, the corneoscleral button with a deep horizontal lamel-
lar cut was transported to our clinic. The cornea was punched with an 8.0-mm trephine 
(Medical Workshop, Groningen, The Netherlands), after which the PLD was removed 
from the corneal button by using 2 different techniques. The PLD was either stripped 
from the anterior part of the corneal button by using a forceps (forceps stripping group), 
or injection of sterile balanced salt solution was used to create an interlamellar space 
whereupon blunt dissection was performed (blunt dissection group).
The ECs of the PLD were stained with 0.12% trypan blue in phosphate-buffered 
saline (Pharmacy Academic Medical Center) for 1 minute, after which the cornea was 
rinsed with phosphate-buffered saline. The ECs were subsequently stained with 0.2% 
alizarin red for 3 minutes and rinsed with phosphate-buffered saline.11 EC images of the 
central and peripheral areas of the PLD were obtained by using light microscopy (Leica 
DM5000 B; Leica Microsystems, Cambridge, UK). The area of EC damage of 5 subsequent 
photographs was calculated by using Leica image software (Leica Qwin version 3; Leica 
Microsystems).
statistical analysis
Group differences were assessed by using the Wilcoxon matched-pairs test and the 
Mann–Whitney U test. Values are reported as mean ± SD and 95% confidence intervals 
(CIs). P ≤ 0.05 was considered statistically significant. All data analysis was performed 
by using the SPSS statistical software package (SPSS for Windows version 12.0; SPSS, 
Chicago, IL).
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results
effect of frequency of the fs laser procedure on ec loss
There was a slight significant difference between EC density before and after organ 
culture storage in the FS cornea 15-kHz and FS cornea 30-kHz group (P = 0.03 and P = 
0.05, respectively; Table 1) and in the paired cornea group. After organ culture storage, 
there was no significant difference between EC loss in the FS cornea group versus the 
paired cornea group in the 15- (7.7% ± 6.9%; 95% CI, 1.9–13.5, and 8.9% ± 8.1%; 95% CI, 
2.2–15.7, respectively; P = 0.78) and 30-kHz (4.3% ± 4.0%; 95% CI, 0.2–8.5, and 3.7% ± 
3.6%, 95% CI, -0.2 to 7.5, respectively; P = 0.75) group. The percentage of EC loss after 
organ culture storage between the FS cornea 15-kHz (Fig. 2) and the FS cornea 30-kHz 
taBle 1.  Effect of Laser Frequency on EC Density After Organ Culture
khz Cornea eC Density
Before storage
(95% Ci) (cells /mm²)
eC Density 
after storage
(95% Ci)(cells /mm²)
P *† eC loss
(95% Ci)(%) ‡
P * §
15 FS  (N = 8) 2498.0 ± 282.2
 (2262.1 - 2733.9)
2302.0 ± 274.8 
(2072.3 - 2531.7)
0.03 7.7 ± 6.9 
(1.9 - 13.5)
0.78
Paired (N = 8) 2570.8 ± 172.7
(2426.3 - 2715.2)
2339.6 ± 246.8
(2133.3 - 2546.0)
0.04 8.9 ± 8.1
(2.2 - 15.7)
30 FS (N = 6) 2859.7 ± 267.0
(2579.4 - 3139.9)
2738.7 ± 311.6
(2411.7 - 3065.7)
0.05 4.3 ± 4.0
(0.2 - 8.5)
0.75
Paired (N = 6) 2919.0 ± 155.4
(2755.9 - 3082.1)
2811.0 ± 151.9
(2651.6 - 2970.4)
0.05 3.7 ± 3.6
(-0.2 to 7.5)
Data are expressed as the mean ± SD.
* Wilcoxon paired test. 
†Differences in means between ECD before storage and ECD after storage.
‡ Mean endothelial cell loss after storage in organ culture (%).
§Difference in endothelial cell loss between the FS cornea and the paired cornea after corneal storage.
Figure 2. Light microscopy of the ECs of the donor cornea after preparation of a 9.5-mm horizontal lamellar cut at a depth 
of 400 µm with a laser frequency of 15 kHz. Endothelium of the donor cornea was stained with trypan blue and swelled 
with sucrose before (A) and 4 days after (B) organ culture preservation (before separation of the PLD from the anterior 
part). Average EC loss after organ culture preservation was 7.7% ± 6.9% (N = 8). Scale bar, 100 µm.
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(Fig. 3) group was not significant (7.7% ± 6.9% and 4.3% ± 4.0%, respectively; P = 0.25). 
The percentage difference of EC loss between the FS cornea 15-kHz and the FS cornea 
30-kHz group was 3.4% (95% CI, -3.5 to 10.3).
effect of dissection techniques on ec loss
In the forceps stripping group, the mean EC loss after organ culture storage was 8.1% ± 
4.5% (95% CI, 2.5–13.4); after organ culture storage and dissection, EC loss was 13.0% ± 
5.3% (95% CI, 6.5–19.6; P = 0.08). In the blunt dissection group, the percentage of EC loss 
after the organ culture storage was 6.1% ± 6.8% (95% CI, -2.4 to 14.6); after organ culture 
storage and dissection, the percentage of EC loss was 6.5% ± 3.2% (95% CI, 2.5–10.5; 
P = 0.686). The percentages of EC loss after organ culture storage and dissection for the 
forceps stripping group and blunt dissection group were 13.0% ± 5.3% and 6.5% ± 3.2%, 
respectively (P =  0.03; Table 2; Fig. 4).
Figure 3. Light microscopy of the ECs of the donor cornea after preparation of a 9.5-mm horizontal lamellar cut at a depth 
of 400 µm with a laser frequency of 30 kHz. Endothelium of the donor cornea was stained with trypan blue and swelled 
with sucrose before (A) and 7 days after (B) organ culture preservation (before separation of the PLD from the anterior 
part). Average EC loss after organ culture preservation was 4.3% ± 4.0% (N = 6). Scale bar, 100 µm.
taBle 2. Effect of Dissection on ECD after Organ Culture
variable
Dissection groups
Difference †
(95% Ci)
Forceps stripping 
of the
Fs cornea
(95% Ci) (n = 5)
Blunt Dissection 
of the
Fs cornea
(95% Ci) (n = 5)
P *
Energy level (µJ) 2.6 1.38 ± 0.7 - 0.02
EC loss after organ culture storage (%) 8.1 ± 4.5
(2.5 - 13.4)
6.1 ± 6.8
(-2.4 to 14.6)
2.0 (-6.6 to 10.4) 0.46
EC loss after organ culture storage 
and dissection (%)
13.0 ± 5.3
(6.5 - 19.6)
6.5 ± 3.2
(2.5 - 10.5)
6.5 (0.1 -12.9) 0.03
Data are expressed as the mean ± SD.
* Mann-Whitney test.
† The percent difference between the forceps stripping group and the blunt dissection group. 
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DisCussion
The purpose of this study was to evaluate the feasibility of the FS laser in preparation of 
PLDs, by studying the effects of organ culture and variations in laser frequency and on 
EC viability. An important factor in determining the success of corneal transplantations 
is the quality of the EC layer of the corneal donor button. Clinical studies evaluating en-
dothelial density after PK have shown that there is ongoing EC loss postoperatively, with 
a postoperative loss of 17% after 2 months and 71% after 15 years.12 After DLEK that used 
a large corneoscleral incision (9.0 mm), there was a cumulative EC loss of 20%–27.1%, 
27.9%, and 61% after 1, 2, and 3 years, respectively.13,14 DLEK with a small corneoscleral 
incision (5.0 mm) showed EC loss between 15.4% and 25.0% after 6-month follow-up.15,16
Our in vitro study showed minimal EC loss in the FS cornea group after organ culture 
compared with the paired untreated cornea of the same donor. Unfortunately, the direct 
effect of the FS laser could not be determined, because it was impossible to measure EC 
density in the swollen corneas right before and immediately after the FS laser procedure.
Figure 4. Light microscopy of endothelium of the PLD after combined staining of trypan blue and alizarin red. Trypan blue 
stained the nuclei of damaged ECs (arrowheads), and alizarin red stained the intercellular junctions and the underlying 
Descemet membrane (arrows). A and B, Endothelium after organ culture preservation and forceps stripping showed an 
average EC loss of 13.0% ± 5.3% (N = 5). C and D, Endothelium after organ culture and blunt dissection showed an average 
EC loss of 6.5% ± 3.2% (N = 5).
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The EC loss after lamellar cutting with the 30-kHz laser was 4.3% versus 7.7% after 
cutting with the 15-kHz laser. The 15-kHz laser group has a 3.4% higher EC loss than 
the 30-kHz laser group, but the difference between the 2 groups was not significant. 
Previous studies have evaluated the mean EC loss before and after organ culture storage 
by using a similar preservation technique as in our study.17-19 The organ culture-stored 
corneas showed a mean EC loss of 5.0%–11.0%, which is comparable to the results of 
our study. We could not exclude that differences existed in viability of the EC between 
the 2 groups that were  independent of the effects of laser treatment or organ culture. 
The trypan blue light microscopy technique applied in the Cornea Bank Amsterdam 
allows for EC density measurements only and not for evaluating other parameters of 
viability that include polymegethism and pleomorphism. In addition, the EC loss in the 
untreated eyes of the 15-kHz group was 5.2% higher than in the untreated eyes of the 
30-kHz group. Factors that could explain this difference were donor age and postmor-
tem time. Donor age was significantly lower in the 30- versus 15-kHz group, but there 
was no difference in postmortem time between groups.
We found a relatively low EC loss after organ culture preservation and separation of 
the PLD from the anterior part of the cornea by the blunt dissection method (6.5%) 
compared with before separation of the PLD (6.1%). Manual preparation of PLDs induces 
an average EC loss of 1.0%–8.5%.20,21 When we used a microkeratome and an artificial 
anterior-chamber system for the preparation of PLDs, an EC loss of 6.7% was induced.22 
EC loss after FS laser preparation with applanation from the endothelial side by using 
hydroxypropylmethyl-cellulose as a protective coupling fluid is reported to be 6.0%. In 
this study, endothelial cell damage caused by separation of the PLD from the anterior 
cornea was not reported.23 EC loss after preparation of 150- to 200-µm-thick PLDs with 
the FS laser has been shown to be 4% and did not appear to be related to the level of 
pulse energy used.24 EC losses after preparation of the PLD with an artificial anterior-
chamber system and microkeratome or FS laser after 2-day storage in Optisol GS at 4ºC 
were 3.4% and 1.6%, respectively.25
One major advantage of the preparation of the donor tissue by using the FS laser is 
that the procedure can be performed in an automated and standardized fashion, which 
reduces the level of technical difficulty in relation to the manual dissection of a PLD. The 
corneoscleral button with a horizontal lamellar cut can be stored in organ culture up to 
3 weeks, thereby allowing time for serologic screening of the donor and microbiologic 
testing and human leukocyte antigen typing of the tissue.
In summary, EC loss after FS laser lamellar cutting is not dependent on the frequency 
(ie, energy level) of the laser. A blunt dissection technique for preparation of the PLD 
seems less traumatic to the corneal endothelium than a forceps stripping technique. 
The dissection of a PLD from the anterior cornea by using a blunt dissection technique 
does not result in a significant additional cell loss. This finding supports the clinical use 
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of the FS laser for the preparation of PLDs for DSEK. A multicenter randomized clinical 
study is in progress to compare the postoperative EC viability and visual results of FS 
laser-assisted DSEK with the results of conventional PK.
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aBstraCt
To our knowledge, we describe the first patient with pseudophakic bullous keratoplasty 
treated with femtosecond-laser–assisted endothelial keratoplasty. A 5.5 mm corneo-
scleral tunnel incision was made; after Descemet’s membrane was stripped, an 8.0 mm 
posterior lamellar corneal disk prepared with a femtosecond laser was inserted into 
the anterior chamber against the recipient cornea without the use of corneal sutures. 
Four months postoperatively, the posterior corneal disk was clear and the induced 
astigmatism was 2.1 diopters, demonstrating a functional corneal endothelial layer. The 
femtosecond laser offers a new surgical approach for minimally invasive endothelial 
keratoplasty in corneal endothelial disorders. 
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CASE REPORTS: FEMTOSECOND DSEK
4
introDuCtion
Full-thickness penetrating keratoplasty (PKP) has been the preferred corneal trans-
plantation technique since the first description of successful corneal transplantation 
by Zirm in 1906.1 In PKP, the recipient cornea is trephined in the vertical direction and 
the donor cornea is sutured into the wound bed using a variety of suture techniques. 
Although PKP generally results in clear corneal grafts with a graft survival of up to 72% 
after 5 years,2,3 the procedure is frequently complicated by refractive imperfections and 
wound-healing problems.4,5 Postoperative high, irregular astigmatism and ametropia 
may result in a significant number of patients who cannot be optically rehabilitated with 
glasses. Treatment modalities for post-keratoplasty astigmatism and ametropia are rigid 
gas-permeable contact lens wear, corneal laser refractive surgery, and implantation of 
toric intraocular lenses.6,7 Wound healing after PKP is often unstable and may lead to 
infection, vascularization, and wound dehiscence, with risks for long-term graft survival.
In recent years, posterior lamellar keratoplasty (PLK), also called deep lamellar en-
dothelial keratoplasty (DLEK), has been described for selective transplantation of the 
diseased posterior corneal layer in pseudophakic or aphakic bullous keratopathy and 
Fuchs’ endothelial dystrophy.8–10 Since surface corneal incisions and sutures are not used 
in this technique, the corneal shape is preserved, with minimum surgically induced astig-
matism and ametropia. However, the perioperative preparation of the posterior corneal 
disk from a donor eye, consisting of posterior stroma with Descemet’s membrane and 
endothelium, is time-consuming, technically difficult, and not standardized. Because of 
these technical challenges, PLK is not widely used by corneal transplant surgeons. 
We describe a new method of preparing the posterior corneal disk in a standardized 
and automated fashion using a femtosecond laser, thereby introducing laser technology 
in corneal endothelial transplant surgery.
Case report
An 82-year-old man with pseudophakic bullous keratopathy and preexisting macu-
lopathy in the left eye was examined. Investigational review board approval for this 
study was obtained from the University Hospital Maastricht, and informed consent was 
obtained from the patient. 
The preoperative best corrected visual acuity (BCVA) was counting fingers at 1 m. 
The topographically simulated keratometry values measured with the Pentacam device 
(Oculus, Inc.) were 43.6 D @ 9.1 and 37.3 D @ 99.1. The preoperative central corneal thick-
ness was 887 µm.
A femtosecond laser (IntraLase Corp.) was used to prepare a deep horizontal lamel-
lar interface in the cornea of the donor eye. The postmortem time (ie, period between 
death of the donor and preparation of the donor posterior corneal disk) was 21 hours, 
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and the central corneal thickness of the donor cornea was 856 µm. The energy level of 
the laser for preparation of the horizontal lamellar cut at an intended depth of 400 µm 
was 1.4 µJ. The firing rate was 30 kHz and the spot size, 2.4 µm. A raster spot pattern was 
used; the diameter of the lamellar cut was 9.5 mm.
The donor eye was placed in an eye holder with a suction ring (DORC International) to 
immobilize it, and the epithelium was gently removed with a cellulose spear and a surgi-
cal Beaver knife. After femtosecond laser treatment, the entire donor eye was cleaned 
with sterile sodium chloride 0.9% and thoroughly washed with sterile povidone–iodine 
solution 0.5% (for 2 minutes), sterile sodium thiosulfate solution 0.1% (for 1 minute), and 
sterile phosphate-buffered saline (for 1 minute) (Cornea Bank of the N.O.R.I.). After de-
contamination, the donor eye was stored at 4ºC in a moist chamber. The donor eye was 
transferred to the Cornea Bank Amsterdam according to the existing protocol for trans-
port of donor tissue in The Netherlands. A corneoscleral rim was prepared and stored in 
organ culture medium using the Cornea Bank of Amsterdam’s certified protocol.
One week after organ culture preservation, an 8.0 mm corneal button was trephined. 
The posterior corneal disk was separated from the anterior cornea and inserted through 
a 5.5 mm corneoscleral incision into the anterior chamber after a 7.0 mm circle of 
Descemet’s membrane and endothelium was stripped from the recipient cornea. An 
air bubble was injected into the anterior chamber and pressed against the posterior 
corneal disk for 20 minutes, after which most of the air bubble was removed. Two drops 
of tropicamide minims 0.5% were instilled to avoid a pupillary block. The goal was to 
achieve a pupil diameter that was slightly larger than the diameter of the air bubble. 
No corneal sutures were used for the graft. The corneoscleral incision was closed with a 
10-0 nylon suture.
The patient was instructed to remain in a horizontal position during the next 24 hours 
to maximize the pressure of the air bubble against the posterior corneal disk. (The cor-
neal disk adheres by the endothelial pump mechanism that creates a negative stromal 
pressure and deturgesces the overlying recipient stroma.) The postoperative treatment 
consisted of prednisolone acetate 0.5% 6 times daily and chloramphenicol 0.4% 3 times 
daily.
On the first day, a small cleft of aqueous between the recipient cornea and posterior 
corneal disk was seen. An air bubble was introduced to fill the anterior chamber and 
in the recipient cornea, 3, 1.0 mm full-thickness incisions were made 3.5 mm from the 
corneal apex to facilitate drainage of the interlamellar aqueous. One the day after this 
secondary procedure, the posterior corneal disk was adequately adhered to the recipi-
ent cornea. 
From 1 week to 2 months postoperatively, the corneal thickness decreased from 794 
µm to 593 µm (Figure 1) and the residual stromal edema resolved (Figures 2 and 3). 
Two months after transplantation, the BCVA was 20/60 with a refraction of +1.5 -2.50 
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Figure 1. Central corneal thickness after femtosecond DSEK. Central corneal thickness in the left eye measured by 
Scheimpflug technology (Pentacam) decreased from 794 µm 1 week postoperatively (left) to 593 µm at 2 months (right).
Figure 2. Slitlamp photography of the left eye 1 week after femtosecond DSEK. The margins (arrowhead) of the centrally 
adhered posterior corneal disk are seen. Some residual stromal edema is visible in the posterior corneal disk (arrow), and 
central corneal thickness is 794 µm.
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Figure 3. Slitlamp photography of the left eye 2 months after femtosecond DSEK. The stromal edema in the  posterior 
corneal disk has diminished (arrows), and central corneal thickness decreased to 593 µm.
Figure 4. Corneal topography map of the left eye 2 months after femtosecond DSEK. Note the regular topography of the 
femtosecond DSEK eye with keratometry values of 43.4 D @ 1.3 and 39.4 D @ 91.3. The surgically induced astigmatism by 
femtosecond DSEK was 2.1 D.
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x 105. The postoperative keratometry values were 43.4 D @ 1.3 and 39.4 D @ 91.3, with 
surgically induced astigmatism of 2.1 D (Figure 4). Four months postoperatively, the 
BCVA increased to 20/50 with a refraction of +1.00 -2.25 x 105. The keratometry values 
measured with the EyeMap device (Alcon) were 43.7 D @ 10 and 39.4 D @ 100.
DisCussion
Posterior lamellar keratoplasty was introduced for selective transplantation of the 
diseased posterior corneal layer in pseudophakic or aphakic bullous keratopathy and 
Fuchs’ endothelial dystrophy.8–10 In the original PLK procedure, a large 9.0 mm corneo-
scleral incision was made and a deep lamellar pocket in the recipient cornea dissected 
manually. 
To eliminate the difficult dissection of the pocket in the recipient cornea and to create 
a smoother surface on the recipient cornea, stripping of Descemet’s membrane was 
introduced.11 This so-called Descemet’s stripping with endothelial keratoplasty (DSEK) 
technique leaves the structure of the posterior cornea intact and is also less traumatic to 
the structures in the anterior chamber than DLEK. 
The most recent innovation in DSEK is the use of an automated microkeratome to fa-
cilitate preparation of the donor posterior corneal disk. After a microkeratome-assisted 
lamellar cut, the 300 or 350 µm anterior part of the donor cornea is removed and the 
posterior part is punched with an 8.0 mm trephine. 
The advantages of all currently used lamellar endothelial keratoplasty procedures (eg, 
PLK, DLEK, DSEK) are that no sutures are needed to keep the donor tissue in place, which 
prevents the occurrence of suture- or incision induced high, irregular astigmatism, the 
most frequent complication after PKP.9,12–15 Visual acuity and corneal topographic data 
after DLEK remain stable up to 2 years postoperatively.15 Endothelial cell loss after these 
procedures has been shown to be comparable to that after full-thickness PKP.15,16 A dis-
advantage of the lamellar techniques compared with full-thickness PKP is that interface 
opacification at the 2 lamellar surfaces may result in a reduction of the potential BCVA.17
In recent years, the femtosecond laser has been used as a microkeratome in laser in 
situ keratomileusis (LASIK) for cutting a corneal flap at a depth of 100 to 160 µm. In this 
refractive surgery technique, excellent visual results without optical interface problems 
have been noted after a superficial lamellar interface has been created.18,19 Consequently, 
the feasibility of using femtosecond laser technology to prepare a smooth and deep 
lamellar interface was evaluated in multiple in vitro studies. 
To improve and standardize the technique for harvesting the posterior corneal disk, 
Seitz et al.20 demonstrate the feasibility of a femtosecond laser (Femtec, 20/10 Perfect 
Vision) for nonmechanical endothelial keratoplasty in an in vitro study with human 
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donor corneas. Electron microscopy displayed smooth cut surfaces and normal adjacent 
collagen fibers without evidence of thermal damage. Another study of human cadaver 
eyes21 reports that a femtosecond laser can create deep lamellar dissection smoothness 
comparable to that of manual dissections in recipient and donor tissues. In a further 
study of human eyes and corneoscleral buttons,22 scanning electron microscopy showed 
a slightly more stucco-like texture of the interface of deep cuts than in the cuts made by 
standard anterior surface femtosecond LASIK. Endothelial cell loss after preparation of 
150 to 200 µm thick posterior stromal disks with the femtosecond laser was about 4% 
and did not appear to be caused by laser pulse energy.23 
A significant advantage of the use of the femtosecond laser in DSEK is that the laser 
preparation of the donor tissue can be performed in an automated and standardized 
fashion, which reduces the technical difficulties involved in manual dissection of a 
posterior corneal disk. Unlike a microkeratome posterior corneal disk, which is prepared 
at the time of transplantation, the femtosecond-laser–prepared lamellar interface of the 
disk can be performed up to 3 weeks before the corneal transplantation. Meanwhile, 
the corneoscleral button with intact corneal architecture can be stored in organ culture, 
allowing time for serological screening of the donor and microbiological testing and 
HLA-typing of the tissue.24 Preparing the posterior corneal disk in advance also prevents 
intraoperative situations in which the intended endothelial keratoplasty procedure has 
to be converted to PKP because of complications during the manual or microkeratome 
preparation of the donor disk.
The promising future of the application of femtosecond laser technology to corneal 
endothelial transplant surgery is shown in the present case report in which rapid visual 
recovery to an expected postoperative visual acuity of 20/50 occurred 4 months after 
surgery without significant alteration of the shape of the corneal surface. We believe 
femtosecond DSEK has a potential for facilitating endothelial keratoplasty in amore 
standardized, automated fashion, with equivalent results in terms of visual rehabilita-
tion, than manual or microkeratome-assisted endothelial keratoplasty. A multicenter 
randomized clinical study is in progress to compare the postoperative endothelial cell 
viability and visual results of femtosecond DSEK and conventional PKP. 
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aBstraCt
objective: To evaluate the preliminary visual results of femtosecond laser–assisted 
Descemet stripping endothelial keratoplasty (FS-DSEK).
methods: We prospectively analyzed results of 20 consecutive patients with Fuchs 
endothelial dystrophy or aphakic/pseudophakic bullous keratopathy who underwent 
FS-DSEK. Best spectacle-corrected visual acuity (BSCVA), refraction, corneal topography, 
and endothelial cell density were measured preoperatively and 3 and 6 months after 
FS-DSEK. Corneal thickness was measured using an optical coherence tomography 
technique.
results: The average BSCVA of 11 eyes with normal visual potential significantly im-
proved from 20/110 ± 4 lines to 20/57 ± 1 line at 6 months (P < .007). At 6 months, 
the mean (SD) hyperopic shift was 2.24 (2.3) diopters (D). Preoperative and 6 months 
postoperative refractive astigmatism were −0.75 (0.9) D and −1.58 (1.1) D (P = .01), 
but the topographic astigmatism did not change postoperatively (P = .95). Mean (SD) 
endothelial cell density at 6 months was 1368 (425) cells/mm2. There was a persistent 
deswelling of the graft up to 3 months postoperatively. Complications included graft 
dislocations requiring repositioning (20%), pupillary block glaucoma (5%), epithelial 
ingrowth (5%), and primary graft failure (5%). 
Conclusions: Femtosecond laser–assisted Descemet stripping endothelial keratoplasty 
was effective in treating endothelial failure with minimal induced refractive astigmatism, 
limited improvement of BSCVA, and induction of a hyperopic shift. Endothelial cell count 
and dislocation rate were significant, which may be related to the surgical technique.
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introDuCtion
Several endothelial keratoplasty (EK) procedures, such as posterior lamellar keratoplas-
ty,1 posterior lamellar keratoplasty using the femtosecond laser,2 deep lamellar endo-
thelial keratoplasty,3 Descemet stripping endothelial keratoplasty,4 Descemet stripping 
automated endothelial keratoplasty (DSAEK),5 femtosecond laser–assisted Descemet 
stripping endothelial keratoplasty (FS-DSEK),6 and Descemet membrane endothelial 
keratoplasty,7 allow for selective replacement of the diseased endothelial layer, retain-
ing the healthy recipient anterior corneal stroma. Endothelial keratoplasty techniques 
result in a rapid visual rehabilitation and minimal change in corneal astigmatism.8,9 The 
purpose of this study was to evaluate the clinical outcomes of the first 20 patients after 
FS-DSEK, where the FS laser is used to prepare the posterior lamellar disc (PLD).
methoDs
Twenty eyes of 20 consecutive patients with Fuchs endothelial dystrophy (n = 11) or 
aphakic/pseudophakic bullous keratopathy (n = 9) were included in a prospective study. 
Institutional review board approval and informed consent was obtained. 
Preoperatively, the medical history was recorded and all patients underwent an 
ophthalmologic examination. Manifest refraction was obtained by using Snellen acu-
ity charts, and corneal topography (EyeMap EH-290; Alcon, Fort Worth, Texas) was 
performed. Best spectacle-corrected visual acuity (BSCVA) was determined using the 
Early Treatment of Diabetic Retinopathy Study letter charts and converted to Snellen 
equivalents.10,11 Endothelial cell density (ECD) of the donor tissue was obtained from 
the Cornea Bank Amsterdam. Best spectacle-corrected visual acuity, manifest refrac-
tion, corneal topography, and ECD (Noncon Robo SP 8000; Konan, Hyogo, Japan) were 
performed at 3 and 6 months postoperatively. 
At 1 week and 1, 3, and 6 months postoperatively, the thickness of the PLD and the 
thickness of the recipient corneas were measured using an optical coherence tomog-
raphy technique (Visante; Carl-Zeiss Meditec, Dublin, California). One high resolution 
corneal quad scan was taken. Four cross-sectional images were taken at 0° to 180°, 45° 
to 225°, 90° to 270°, and 135° to 315°. Measurements of each image were taken at the 
vertex of the cornea (0.0 mm) and at 3.5 mm on each side of the vertex (−3.5 mm and 
+3.5 mm). The 4 central measurements and 8 peripheral measurements were averaged 
to a single value to determine the thickness of the recipient cornea and the PLD.
CHAPTER 5
80
Donor tissue 
The PLD was prepared with the 30-kHz femtosecond laser (AMO, Uppsala, Sweden and 
Intralase Corp, Irvine, California). The intended depth of the horizontal lamellar cut was 
400 μm, and the diameter was 9.5 mm using a raster spot pattern with an energy level 
of 1.4 μJ.6
surgical technique
General anesthesia was used in all patients. A 5.0-mm corneoscleral incision and 2 limbal 
paracenteses were made. The Descemet membrane was scored with a Price-Sinskey 
hook (Moria,Anthony, France), and a circle of 7.5 mm of Descemet membrane and en-
dothelium was stripped from the posterior stroma. A 15° blade was used to make 3 or 4 
transcorneal incisions in the midperipheral recipient cornea to drain fluid between the 
recipient cornea and PLD.4
A 8.0-mm donor corneal disc was trephined from the corneoscleral button, and the 
PLD was removed from the anterior cornea. The endothelial surface was coated with a 
small layer of viscoelastic material (Healon; AMO). The PLD was gently folded into a taco 
configuration, and the folded PLD was grasped and inserted using a Goosey forceps 
(Moria).  The corneoscleral incision was closed with two 10-0 nylon sutures. An air bubble 
was injected to unfold the PLD and press the PLD against the recipient cornea. After 20 
minutes, the bubble was partly removed and 2 drops of 0.5% tropicamide minims were 
instilled to avoid a papillary block. After pupillary block occurred in 2 patients, a periph-
eral iridectomy was routinely performed. The patients were instructed to lie supine for 
the next 24 hours to maximize the pressure of the remaining air bubble against the PLD. 
The post-operative treatment consisted of 0.5% prednisolone acetate 6 times daily and 
0.4% chloramphenicol 3 times daily in a tapering dose.
Data analysis 
Comparisons of preoperative measurements and postoperative measurements were 
performed using a paired t test for normally distributed data and Wilcoxon signed-rank 
test for nonnormally distributed data. Values are reported as mean (SD). A P value of <.05 
was considered statistically significant. Statistical analysis was performed with SPSS 
(version 12.0; SPSS Inc, Chicago, Illinois).
results
Twenty eyes of 20 patients underwent FS-DSEK (Figure 1).The mean (SD) age at surgery 
was 70.4 (8.4) years with a mean (SD) follow-up of 27.0 (4.4) weeks. Eight patients re-
quired FS-DSEK for pseudophakic bullous keratopathy, and 1 patient required FS-DSEK 
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for aphakic bullous keratopathy. The remaining 11 patients had Fuchs endothelial 
dystrophy and cataract. Two patients underwent a combined phacoemulsification and 
FS-DSEK procedure. The intraocular lens power was chosen for a postoperative spherical 
equivalent of −0.50 diopter (D).
The preoperative and postoperative details of all patients are shown in Table 1. One 
patient (patient 1) died prior to his 6-month examination. Before surgery and at 6 
months, the average BSCVA of the 20 eyes was 20/150 ± 4 lines and 20/94 ± 3 lines (P = 
.03), respectively. After excluding the eyes with pre-existing retinal problems, amblyopia, 
and primary graft failure, the average BSCVA of 11 eyes with normal visual potential im-
proved from 20/110 ± 4 lines preoperatively to 20/57 ± 1.0 line (range, 20/38-20/100) at 
6 months, and 50% had an improved BSCVA of more than 2 lines at 6 months (Figure 2). 
The preoperative BSCVA of the patient with a graft failure was 20/87, and at 3 and 6 
months, the BSCVA was finger counting. 
The mean (SD) preoperative spherical equivalent and refractive astigmatism were 
−0.89 (2.7) D and −0.75 (0.9) D, compared with 1.30 (1.9) D (P = .002) (Table 2) and −1.58 
(1.1) D (P = .01) 6 months postoperatively. The mean (SD) hyperopic shift was 2.23 (2.3) 
D at 6 months postoperatively. The mean (SD) topographic cylinder was 2.28 (1.7) D 
preoperatively and 1.85 (1.1) D 6 months postoperatively (P = .95).
Two patients had a surgical peripheral iridectomy during FS-DSEK because of a peri-
operative pupillary block. Postoperatively, 4 of the 20 patients experienced dislocation 
of the PLD. These patients underwent repositioning of the PLD with an air bubble 
between 1 day and 1 week postoperatively. One of the 4 patients underwent a second 
repositioning of the PLD, and in 2 additional patients, interface fluid was drained. One 
patient experienced pupillary block glaucoma on the first postoperative day, which 
was relieved by removing a small amount of air from the anterior chamber. At 1 month 
postoperatively, epithelial ingrowth was seen in 1 patient (patient 16) (Figure 3), with no 
progression up to 6 months’ follow-up. One patient had an iatrogenic graft failure, and 
Figure 1. Slitlamp photograph after femtosecond laser–assisted Descemet-stripping endothelial keratoplasty. The cornea 
is clear, and the graft is well positioned (A and B).
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Figure 2. Preoperative and postoperative mean best spectacle-corrected visual acuity (BSCVA), expressed as logarithm of 
the minimum angle of resolution (LogMAR), and Snellen equivalent for the overall group (line A) and excluding all visual-
limiting pathology (line B).
Figure 3. Slitlamp photograph after femtosecond laser–assisted Descemet stripping endothelial keratoplasty. Epithelium 
in the interface through the transcorneal incision is visible (A and B).
taBle 3. Preoperative, 3-months, and 6-months eCD 
   n
eCD (cells/mm²),
mean (sD) [range]
% Cell loss,
mean (range)
eyes without dislocation  
Preoperative 16 2645 (121) [2400-2800] NA
3 mo 15 1325 (379) [807-1683] 49 (35-70)
6 mo 15 1368 (425) [761-2108] 48 (25-72)
eyes with dislocation and repositioning
Preoperative 4 2611 (176) [2300-2900] NA
3 mo 4 753 (280) [546-1183] 71 (53-80)
6 mo 3 740 (372) [468-1489] 71 (43-82)
ECD, endothelial cell density; NA, not applicable.
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Figure 4. Optical coherence tomography image after femtosecond laser–assisted Descemet stripping endothelial kerato-
plasty. The corneal thickness at the vertex and 3.5 mm on each side of the vertex in the 45° to 225° meridian.
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Figure 5. The corneal thickness of the recipient and the posterior lamellar disc at the vertex. At 3 months postoperatively, 
the thickness of the recipient cornea and posterior lamellar disc had decreased 16.3% and 16.0%, respectively (P =.03), and 
remained stable at 6 months.
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Figure 6. The corneal thickness of the recipient and the posterior lamellar disc at the periphery (3.5 mm of the vertex). At 3 
months postoperatively, the thickness of the recipient cornea and posterior lamellar disc had decreased 20.3% and 29.6%, 
respectively (P = .03), and remained stable at 6 months.
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after re–FS-DSEK, BSCVA was 20/70. All grafts remained adherent and were clear during 
the last follow-up visit.
At 6 months postoperatively, the mean (SD) ECD with and without dislocation of the 
PLD were 740 (372) cells/mm2 (71% cell loss) and 1368 (425) cells/mm2 (48% cell loss), 
respectively (Table 3). 
At 3 months postoperatively, the recipient corneal thickness in the center and pe-
riphery had decreased a mean (SD) of 16.3% (8.5%) (P = .03) and 20.3% (9.0%) (P = .03), 
respectively (Figures 4, 5, and 6). The thickness of the PLD in the center and periphery 
decreased a mean (SD) of 16.0% (8.5%) (P = .03) and 29.6% (10.9%) (P = .03), respectively. 
The PLD thinned significantly faster at the periphery than at the center (P = .03).
Comment
In a previous in vitro study, we showed that an FS laser is feasible to prepare a PLD for 
EK,12 and in December 2005, we performed the first FS-DSEK.6 In the present study, we 
report the first 20 patients with a follow-up of 6 months after FS-DSEK.
In this first series of FS-DSEK, the average BSCVA improved from 20/110 to 20/57 at 
6 months’ follow-up, and 50% of our series with normal vision potential showed an 
improve-ment of 2 lines or more. After small-incision DSEK, 55% of the patients had 
an average BSCVA of 20/40.13,14 In a large retrospective series of DSAEK patients with 6 
months’ follow-up, 69% of the patients had a BSCVA of 20/40 or better.14 In other DSAEK 
series, an average BSCVA between 20/45 and 20/34 was reported at 3 and 6 months, 
respectively.5,9,15,16 The average BSCVA in our series appears to be lower as compared 
with recent DSAEK series. A possible explanation for this finding is the quality of the 
interface at the stromal side of the PLD as prepared by the FS laser. It has been shown 
that the smoothness of the stromal bed of a PLD prepared with a 15-kHz FS laser is 
comparable with a manually prepared PLD.17 However, Jones et al18 found that a 30-kHz 
FS laser, using energy levels up to 7.4 μJ, produced a rougher stromal surface than a 
manual microkeratome. Some authors suggest that the FS laser may cause concentric 
ridges at the interface disc because of the flat applanation when making the lamellar 
cut.19 Another explanation for the lower than expected BSCVA could be an increase in 
interface haze after FS-DSEK because of activationof keratocytes, which results in more 
scatter.20,21
Our study showed a mean (SD) hyperopic shift of 2.24 (2.3) D at 6 months post-
operatively, which was higher in comparison with other studies.15,16 Previous studies of 
small-incision DSEK or DSAEK have reported a mild hyperopic shift, but other studies 
did not find a change in spherical equivalent.9,13,14,16,22 The shape of the PLD may account 
for the mild hyperopic shift after small-incision DSEK or DSAEK. The PLDs prepared with 
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the microkeratome or the FS laser are thinner in the center and thicker at the edges, as 
has been shown by our optical coherence tomography results, where the periphery was 
53.9% thicker than the center at 6 months. The intraocular lens selection in our series 
was targeted to account for emmetropia. The hyperopic shift induced by the PLD should 
be neutralized by targeting for −1.00 D to −1.25 D of myopia when combining cataract 
procedures with DSEK.23
Descemet stripping endothelial keratoplasty or DSAEK results in more predictable 
postoperative corneal curvature than penetrating keratoplasty.5,15,16 In our study, the 
change of the topographic astigmatism was not significant, which was comparable with 
other studies.9,16 In contrast to previous DSEK or DSAEK studies,14-16,22 which have gener-
ally shown no increase in mean refractive astigmatism, our study showed a mild increase 
in refractive astigmatism, which may be explained by the changes of the posterior cor-
neal curvature. The optical coherence tomography images showed that the thickness of 
the recipient cornea and the PLD decreased in the first 3 months and remained stable 
at 6 months. Further, the thickness of the PLD decreased faster in the periphery than in 
the center, which may influence the posterior corneal curvature and the refraction.23 
Consequently, centering the PLD on the visual axis may be important to avoid inducing 
astigmatism. 
In the past few years, the surgical techniques for EK have evolved impressively.24,25 The 
major goal of EK is to replace endothelial cells (ECs), as the ECD is an important factor for 
long-term graft survival. Small incision deep lamellar endothelial keratoplasty showed 
an EC loss between 15.4% and 34.0% after 6 months,8,26,27 and the EC loss after small-
incision DSEK was between 36% and 61% at 12 months.13,28,29 The EC loss after DSAEK 
was between 34% and 50% with various follow-up.5,15,29 In our series, the EC loss of eyes 
without dislocation was 48% at 6 months, which was comparable with the results of 
small-incision DSEK and DSAEK. Several steps (folding of the PLD, compression of ECs by 
forceps during insertion, unfolding, long-standing contact with air bubble) during the 
EK may induce EC loss.30,31 In the present multicenter study, FS-DSEK was a new surgical 
technique for the participating surgeons and the learning curve may have influenced 
the EC loss.
The most frequently reported complication of small incision DSEK and DSAEK was 
PLD dislocation. The dislocation rate after small-incision DSEK was between 0.7% and 
50.0%, and after DSAEK, it was between 4.0% and 34.6%, which was comparable with 
our study.4,5,9,14,16,32
Pupillary block has been reported in between 3.8% and 9.5% after DSAEK and occurred 
peroperatively in 2 of our patients.9,16 We suggest that a surgical iridectomy is preferable 
at the time of DSEK to prevent this complication. One patient in our series had epithelial 
ingrowth presumably through the transcorneal incision. Epithelium in the interface 9 
months after DSEK has been described by Culbertson, 33 but it was not reported where 
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the epithelium originated from. In previous studies, the primary graft failure ranged 
from 1.0% to 11.5%, and in our series, 1 graft (5%) failed because of extensive donor 
manipulation.5,9,13,16,32
In summary, FS-DSEK was effective in treating endothelial failure, with minimal change 
in refractive astigmatism and a mild hyperopic shift in refraction. Although BSCVA im-
proved significantly, we believe that interface issues may result in a lower than expected 
visual acuity. The EC loss after EK is a concern for long-term graft survival, but this may 
be related to the steep learning curve of the surgeons. A randomized multicenter study 
is in progress to compare the visual outcomes and ECD of FS-DSEK with the results of 
penetrating keratoplasty.
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aBstraCt
Background: To evaluate the efficacy and safety of femtosecond laser-assisted endo-
thelial keratoplasty (FLEK) versus penetrating keratoplasty (PK) in patients with corneal 
endothelial disease.
methods: A randomized multicenter clinical trial of 80 eyes of 80 patients with corneal 
endothelial disease were randomized to FLEK or PK. Clinical outcomes (astigmatism and 
visual acuity) and incidence of postoperative complications were compared between 
the two groups.
results: At 12 months, the percentage of eyes with a refractive astigmatism less than 
or equal to 3 diopters was higher in the FLEK group in comparison with the PK group 
(86.2% vs. 51.3%, P = 0.004). The mean postoperative best corrected visual acuity was 
20/70 ± 2 lines in the FLEK group and 20/44 ± 2 lines in the PK group (P < 0.001), but the 
gain in the best corrected visual acuity between the two groups was not significantly 
different. The endothelial cell loss in the FLEK and PK group was 65 ± 12% and 23 ± 15% 
(P < 0.001). The most common postoperative complication in the FLEK group was graft 
dislocation (27.8%). Wound healing related problems occurred in six eyes (15%) in the 
PK group and in none of the FLEK eyes.
Conclusions: FLEK effectively reduces postoperative astigmatism and results in an ab-
sence of wound healing related problems in patients with endothelial disease. However, 
visual acuity is lower as compared with conventional PK, and the high level of endothe-
lial cell loss warrants a modification of the insertion technique of the endothelial graft.
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introDuCtion
Penetrating keratoplasty (PK) has been the standard treatment of corneal endothelial 
disease, and the study has demonstrated that it is a safe and an effective treatment (1). 
However, dis-advantages of PK are slow visual recovery, high irregular astigmatism, 
suture-related events, long-term need for topical steroids, postoperative intraocular 
pressure rise, allograft rejection, and graft failure (2, 3). 
In recent years, so-called endothelial keratoplasty (EK) techniques are developed for 
treatment of endothelial disease. These procedures only replace the diseased endothe-
lium, and the healthy anterior stromal tissue can be maintained. Advantages of EK are a 
rapid visual recovery and fewer wound healing problems (4–6). Techniques for EK have 
gradually evolved from posterior lamellar keratoplasty (7) and deep lamellar EK (DLEK; 
5) to Descemet-stripping EK (DSEK; 6), Descemet-stripping automated EK (DSAEK; 4), 
femtosecond laser-assisted Descemet-stripping EK (8), and Descemet membrane EK 
(9). Major technological improvements were the introduction of the descemetorhexis 
technique (10) and the use of the microkeratome and femtosecond laser for preparing 
the endothelial graft (4, 8, 11–16). Reports from the Eye Bank Association of America 
report a significant increase in demand for donor corneas needed for EK procedures 
(13.3% in 2006 vs. 28.2% in 2007; 17). 
Recently, we showed that a femtosecond laser can be used for the preparation of the 
endothelial graft (8, 12, 18). In a country such as The Netherlands, one femtosecond 
laser based at a cornea bank could be sufficient to produce all tissue for EK procedures. 
Further-more, the corneoscleral button prepared by the femtosecond laser can be 
stored in organ culture up to 3 weeks, allowing time for serologic and microbiological 
screening, tissue typing, and quality control of the donor (19, 20). 
The Dutch Lamellar Corneal Transplantation Study has been designed to compare vi-
sual outcome, amount of endothelial cell loss, complication profile, patient satisfaction, 
and cost-effectiveness in femtosecond laser-assisted EK (FLEK) versus PK. In this article, 
we will focus on the safety and efficacy of FLEK, especially its ability to achieve a level of 
astigmatism at 12 months postoperatively that is compatible with an adequate visual 
rehabilitation after corneal transplantation.
Patients anD methoDs
This randomized multicenter trial was conducted at five ophthalmic centers in the 
Netherlands. The institutional review boards of all participating centers have approved 
the study. Informed consent was obtained from all patients. The patients were recruited 
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between April 2005 and April 2007. The trial was registered at the Netherlands trial 
register (http://www.trialregister.nl, no. ISRCTN02191620).
Inclusion criteria were patients with Fuchs’ endothelial dystrophy, pseudophakic bul-
lous keratopathy, or posterior polymorphous dystrophy, aminimum patient age of 18 
years, and best spectacle-corrected visual acuity (BSCVA) lower than 20/50. Exclusion 
criteria were patients with mental retardation, previous PK, and human leukocyte anti-
gen typed keratoplasty.
The medical history was recorded, and all the patients underwent a comprehensive 
ophthalmic examination. Preoperative data included patient age, gender, refractive er-
ror, intraocular pressure, preoperative lens status, and ocular comorbidities. Endothelial 
cell density of the donor tissue was obtained from the Cornea Bank Amsterdam, as 
described previously (19).
surgical procedures
In both the FLEK and PK groups, patients with cataract underwent primary cataract 
extraction with posterior chamber intraocular lens implantation before the corneal 
transplantation technique or in combination with FLEK or PK. In the FLEK group, patients 
who were phakic without visually significant cataract also underwent primary cataract 
extraction and intraocular lens implantation, to avoid iatrogenic crystalline lens touch 
during the FLEK procedure. All surgical procedures were performed under general 
anesthesia.
Flek
In the FLEK group, the donor endothelial graft was prepared with the 30-kHz femtosec-
ond laser (AMO-Intralase, Irvine, CA) as previously described (Fig. 1) (8). In the recipient, 
a 5.0-mm corneoscleral incision and two limbal paracenteses were made. The Descemet 
membrane was scored with a Price-Sinskey hook (Moria, Anthony, France), and a circle of 
7.5-mm Descemet membrane and endothelium was stripped from the posterior stroma. 
A 15-degree blade was used to make four transcorneal incisions in the midperipheral 
recipient cornea to drain fluid between the recipient cornea and endothelial graft (6). 
An 8.0-mm donor corneal disc was trephined from the corneoscleral button, and the 
endothelial graft was removed from the anterior cornea. The endothelial surface of 
the endothelial graft was coated with a small layer of viscoelastic material (Healon, 
AMO, Uppsala, Sweden), gently folded into a taco-configuration, and inserted using a 
Goosey forceps (Moria, Anthony, France). The corneoscleral incision was closed with 
four 10-0 nylon sutures. An air bubble was injected to unfold the endothelial graft and 
press the endothelial graft against the recipient cornea. After 20 min, the bubble was 
partly removed, and two drops of tropicamide minims 0.5% (Chauvin Benelux, Brussel, 
Belgium) were instilled to avoid a pupillary block. However, after two cases of pupillary 
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block had occurred, a peripheral iridectomy was routinely performed. Patients were 
instructed to lie in supine position during 24 hr, to maximize the pressure of the remain-
ing air bubble against the endothelial graft. Postoperatively, all patients received topical 
dexamethasone 0.1% drops (Ratiopharm, Zaandam, The Netherlands) 6 times daily and 
chloramphenicol 0.5% drops (Ratiopharm, Zaandam, The Netherlands) three times daily 
in a tapering dose.
Penetrating keratoplasty 
In the PK group, the recipient cornea was trephined using a 7.75- or 8.0-mm Hessburg-
Barron vacuum trephine, and the donor cornea was trephined with an 8.0- or 8.25-mm 
disposable trephine. In all cases, a combined suturing technique of a running 11-0 nylon 
suture with eight interrupted 10-0 nylon sutures was used. Selective suture removal was 
based on topographic astigmatism pattern. Postoperatively, all patients received topical 
dexamethasone 0.1% drops (Ratiopharm, Zaandam, The Netherlands) six times daily 
and chloramphenicol 0.5% drops (Ratiopharm, Zaandam, The Netherlands) three times 
daily in a tapering dose.
Figure 1. (A) The donor cornea is applanated with an applanation cone. (B) A horizontal lamellar cut at a depth of 400 µm 
has been made with the femtosecond laser. (C) After the femtosecond laser procedure, the donor eye has been sent to the 
Cornea Bank in Amsterdam, and a corneascleral rim has been prepared, and it is stored in organ culture for 2 weeks. (D) 
During the surgery, the donor scleral rim has been trephined, and the endothelial graft is dissected from the anterior part 
of the donor cornea. The endothelial graft is used for transplantation.
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outcomes measures
The main primary outcome measure was to assess the percent of eyes with postopera-
tive refractive astigmatism less than or equal to 3.0 diopters (D). Secondary outcome 
measures included topographical astigmatism (EyeMap EH-290, Alcon), uncorrected 
visual acuity (UCVA), BSCVA, manifest refraction, endothelial cell density (Noncon Robo, 
SP 8000, Konan, Hyogo, Japan), and intraoperative and postoperative complications. The 
UCVA and BSCVA were determined using the Early Treatment of Diabetic Retinopathy 
Study letter charts and were converted to logarithm of the minimum angle of resolution 
measurements (21). Vision levels of counting fingers, hand movements, light percep-
tion, and no light perception were substituted by logarithm of the minimum angle of 
resolution values of 1.7, 2.0, 2.5, and 3.0, respectively. Preoperatively, and at 3, 6, and 12 
months follow-up, all visual parameters were recorded, and the endothelial cell density 
was measured at 3, 6, and 12 months follow-up.
sample size
The sample size was calculated based on the reported amounts of astigmatism less than 
3.0 D of 30% for the PK group and 70% for the FLEK group (3). Assuming an α of 0.05 and 
a power of 90%, 28 eyes were needed for analysis in each treatment group.
randomization
Consecutive cases from each clinical population were randomly assigned to treatment 
by FLEK or by PK. The randomization code was generated using a permuted block size of 
2. The assigned treatment plans were then sent to the surgeon.
statistical analysis 
Data were described as mean ± SD for continuous variables and as individual counts and 
percentage for categorical variables. The differences between groups were analyzed 
using a Student’s t test for continuous data. The chi-square test or Fisher’s exact test 
were used to compare categorical data. A linear regression model with three dummy 
variables, which represent the three postoperative moments with the preoperative 
period as the reference, was used to analyze the change of the three postoperative 
moments with preoperative measure-ments within a group. We used this model with 
dummy variables to prevent the problem of multiple testing. If the P value for the three 
dummies together was less than 0.05, it was considered as statistically significant. If this 
P value was lower than 0.05, the P values of the individual periods were reported and 
considered statistically significant if P is less than 0.05. Statistical analysis was performed 
using SPSS for Windows (version 15.0, SPSS, Inc., Chicago, IL).
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results
Participant flow
The patient flow is displayed in Figure 2. Eighty eyes of 80 patients were recruited, with 
40 eyes in each arm. In the FLEK group, four patients did not receive the allocated treat-
ment due to significant preoperative events and were eventually excluded from the 
study analysis. All patients in the PK group received the allocated treatment.
In the FLEK group, 29 eyes were available for analysis at 12 months follow-up. After 
surgery, the cornea of three eyes remained edematous and did not clear up, this was 
defined as primary graft failure. Two eyes underwent PK before the 3 months follow-up, 
and one eye had repeat FLEK after 6 months follow-up. In one eye with a central corneal 
fold and another eye with an immunological graft failure, the endothelial grafts were 
replaced using a DSAEK procedure after 6 months follow-up. Two patients were lost to 
follow-up due to death. In the PK group, 39 eyes completed the 12 months follow-up. 
Only one eye was unavailable at the 12 months time point due to health-related issues.
Patient characteristics
Patients characteristics of the FLEK and PK groups are listed in Table 1. In the FLEK group, 
21 eyes (58.3%) were diagnosed with Fuchs’ endothelial dystrophy and 8 of these 21 
Figure 2. Flow diagram of femtosecond laser-assisted endothelial keratoplasty versus penetrating keratoplasty. FLEK, 
femtosecond laser-assisted endothelial keratoplasty; PK, penetrating keratoplasty.
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eyes (38.1%) also had cataract. These eyes underwent primary cataract extraction with 
intraocular lens implantation (n = 5 eyes) followed by the FLEK procedure or a combi-
nation of FLEK and cataract extraction with intraocular lens implantation (n = 3 eyes). 
Fifteen eyes (41.7%) were diagnosed with pseudophakic bullous keratopathy. In the PK 
group, 20 eyes (50.0%) were diagnosed with Fuchs’ endothelial dystrophy; 12 of these 
20 eyes (60.0%) also showed cataract. Ten of these 12 eyes (83.3%) underwent combined 
procedures of PK and cataract extraction with intraocular lens implantation, and 2 of 
the 12 eyes underwent primary cataract extraction with intraocular lens implantation 
before PK.
refractive outcome and visual outcome
Preoperatively, there was no significant difference in refractive and topographic 
astigmatism between the two groups (P = 0.275 and P = 0.577, Table 2). Refractive and 
topographic astigmatism values remained stable over time in the FLEK group, whereas 
values were initially higher in the PK group (P < 0.001) and showed a tendency to de-
crease after 3 months time in the PK group. At 12 months postoperatively, the percent of 
taBle 1. Preoperative patient characteristics
Flek Pk P
Eyes (n) 36 40 NA
Age in years (mean ± sd) 69.0 ± 8.8 71.4 ± 11.3 0.308
Women (n, %) 21 (58.3%) 27 (67.5%) 0.500
Diagnosis 0.725
Fuchs’ endothelial dystrophy 21 (58.3%) 20 (50.0%)
Pseudophakic bullous keratopathy 15 (41.7%) a 19 (47.5%) a
Posterior polymorphous dystrophy 0 1 (2.5%)
Recipient lens status 0.996
Aphakic 1 (2.8%) a 1 (2.5%) a
Phakic 21 (58.3%) 21 (52.5%)
Pseudophakic 14 (38.9%) 18 (45.0%)
Ocular comorbidity
Age-related macular degeneration/ RPE changes 12 (33.3%) 5 (12.5%) 0.030
Cataract 8 (22.2%) 12 (30.0%) 0.442
Glaucoma 1 (2.8%) 3 (7.5%) 0.357
a One aphakic eye with iris fixated anterior chamber intra ocular lens. FLEK, femtosecond laser-assisted endothelial kerato-
plasty; PK, penetrating keratoplasty; SD, standard deviation; NA, not applicable; RPE, retina
pigment epithelium.
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eyes with refractive astigmatism less than or equal to 3.0 D was 86.2% in the FLEK group 
and 51.3% in the PK group (P = 0.004).
Preoperatively, there was no significant difference in spherical equivalent between 
the FLEK and PK groups (P = 0.09). At 3, 6, and 12 months postoperatively, FLEK eyes 
showed a trend toward hyperopia (P < 0.001) as compared with PK eyes; the amount 
of hyperopic shift was 1.77 ± 2.1 D, 1.90 ± 2.2 D, and 1.73 ± 2.0 D at 3, 6, and 12 months 
follow-up.
Preoperatively and throughout 3, 6, and 12 months follow-up, there was no significant 
difference in UCVA between the FLEK and PK groups (Table 2). Preoperatively, there was 
no significant difference in BSCVA in the FLEK and PK groups. The mean BSCVA was bet-
ter after PK compared with FLEK at 3, 6, and 12 months follow-up (P < 0.001), but BSCVA 
gain at 12 months follow-up was not significantly different between FLEK and PK groups 
(P = 0.103).
Compared with preoperatively, BSCVA in the FLEK group improved at 3 (P = 0.020), 6 
(P = 0.016), and at 12 months follow-up (P < 0.001). In the PK group, there was significant 
improvement of BSCVA at all time points (P < 0.001).
endothelial cell density
The average endothelial cell density of the donor tissue was comparable between the 
FLEK and PK groups (P = 0.348, Table 3). Postoperatively, the average endothelial cell 
density was significantly lower in the FLEK group compared with the PK group (P < 0.001). 
The average endothelial cell loss in the FLEK versus PK groups at 12 months follow-up 
was 65 ± 12% versus 23 ± 15% (P < 0.001).
intraoperative and postoperative complications
In the FLEK group, a pupillary block occurred in three eyes which needed a surgical 
peripheral iridectomy (Table 4). Three of 36 eyes (8.3%) in the FLEK group showed a 
primary graft failure between 1 week and 1 month. Immunological graft failure occurred 
in one eye (2.8%) in the FLEK group, and allograft rejection occurred in one eye (2.5%) 
in the PK group. In the FLEK group, epithelial ingrowth was noted in one eye (2.8%). 
Ten of 36 eyes (27.8%) in the FLEK group showed a dislocation of the endothelial graft, 
which was repositioned by the injection of an air bubble between day 1 and 1 week 
postoperatively.
In the PK group, suture-related problems occurred in 4 of the 40 eyes (10.0%), wound 
dehiscence in two of the eyes (5.0%), suture-revision to correct astigmatism in 4 of the 
40 eyes (10.0%). At 12 months follow-up, only one eye in the PK  group had all sutures 
out, whereas the remaining 39 eyes still had most or all their sutures in. No wound-
related problems occurred in the FLEK. 
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taBle 2. refraction and visual outcomes of Flek and Pk 
FLEK PK P a
Mean ± SD Range Mean ± SD Range
Refractive astigmatism (D)
preoperative -0.98 ± 1.0 -3.5 to 0 -1.27 ± 1.2 -5.50 to 0 0.275
3 mo -1.38 ± 1.2 -5.0 to 0 -4.17 ± 3.4 b -14.0 to 0 < 0.001
6 mo -1.46 ± 1.3 -5.0 to 0 -3.21 ± 1.9 b -8.0 to 0 < 0.001
12 mo -1.22 ± 1.1  -4.0 to 0 -2.98 ± 2.0 b -8.75 to 0 < 0.001
P = 0.358 c P < 0.001 c
Topographic astigmatism (D)
preoperative 1.38 ± 0.6 0.47 - 2.90 2.16 ± 1.4 0.50 - 6.50 0.577
3 mo 1.87 ± 1.1 0.25 - 4.30 4.59 ± 2.9 b 1.00 - 15.70 < 0.001
6 mo 1.72 ± 1.0 0.27 - 4.14 3.74 ± 1.7 b 0.50 - 6.83 < 0.001
12 mo 1.58 ± 1.2 0.27 - 6.40 3.67 ± 1.8 b 1.40 - 7.70 < 0.001
P = 0.469 c P < 0.001 c
Spherical equivalent (D)
preoperative -0.97 ± 2.4 -6.50 to 2.75 0.12 ± 1.9 -4.75 to 4.50 0.090
3 mo 0.84 ± 1.7 b -4.50 to 3.50 -0.93 ± 3.0 -6.75 to 6.0 0.004
6 mo 0.93 ± 1.7 b -4.63 to 3.50 -1.47 ± 3.3 -8.25 to 6.75 < 0.001
12 mo 0.78 ± 1.5 b -3.25 to 3.13 -1.23 ± 3.1 -7.25 to 7.0 < 0.001
P < 0.001 c P = 0.071 c
UCVA (logMAR)
preoperative 1.01 ± 0.4 (20/200) 0.22 - 2.0 0.88 ± 0.4 (20/150) 0.40 - 2.0 0.133
3 mo 0.80 ± 0.2 (20/125) b 0.40 - 1.70 0.71 ± 0.3 (20/100) b 0.10 - 1.36 0.144
6 mo 0.79 ± 0.3 (20/125) b 0.40 - 1.70 0.79 ± 0.3 (20/125) 0.14 - 1.36 0.959
12 mo 0.73 ± 0.3 (20/102) b 0.34 - 1.70 0.68 ± 0.3 (20/96) b 0.10 - 1.46 0.539
P = 0.001 c P = 0.045 c
BSCVA (logMAR)
preoperative 0.82 ± 0.4 (20/132) 0.22 - 2.0 0.73 ± 0.4 (20/105) 0.18 - 2.0 0.316
3 mo 0.65 ± 0.3 (20/90) b 0.22 - 1.70 0.40 ± 0.2 (20/50) b -0.04 to 1.12 < 0.001
6 mo 0.64 ± 0.3 (20/87) b 0.26 - 1.70 0.35 ± 0.2 (20/44) b 0 - 0.86 < 0.001
12 mo 0.55 ± 0.2 (20/70) b 0.16 - 1.10 0.35 ± 0.2 (20/44) b -0.04 to 0.98 < 0.001
P = 0.004 c P < 0.001 c
BSCVA gain (logMAR)
3 mo 0.15 ± 0.4 -1.06 to 1.34 0.33 ± 0.4 -0.48 to 1.48 0.052
6 mo 0.14 ± 0.4 -1.06 to 1.30 0.38 ± 0.4 -0.40 to 1.46 0.017
12 mo 0.24 ± 0.4 -0.34 to 1.50 0.38 ± 0.4 -0.24 to 1.30 0.103
a P value between FLEK and PK. 
b P<0.05 vs. preoperative in a linear regression model.
c P value of a linear regression model with three postoperative periods at the same time in the model.
FLEK, femtosecond laser-assisted endothelial keratoplasty; PK, penetrating keratoplasty; SD, standard deviation; D, di-
opter; UCVA, uncorrected visual acuity; logMAR, logarithm of the minimum angle of resolution; BSCVA, best spectacle-
corrected visual acuity.
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taBle 3. Donor and postoperative endothelial cell density of Flek and Pk
FLEK PK P value a
Mean ± SD Range Mean ± SD Range
Endothelial cell densitiy 
(cells/mm²) 
Donor 2678 ± 159 2300 - 2900 2653 ± 143 2400 - 2900 0.348
3 mo 1202 ± 456 b 545 - 2007 2148 ± 434 b 1065 - 3083 <0.001
6 mo 1095 ± 486 b 440 - 2108 2064 ± 365 b 1325 - 2890 <0.001
12 mo 1067 ± 423 b 418 - 2069 2028 ± 483 b 800 - 3068 <0.001
P < 0.001 c P < 0.001 c
Endothelial cell loss (%)
3 mo vs donor 56 ± 16 31 - 80 20 ± 14 -14 to 59 <0.001
6 mo vs donor 61 ± 16 25 - 83 22 ± 13 -7 to 45 <0.001
12 mo vs donor 65 ± 12 23 - 81 23 ± 15 -14 to 69 <0.001
a P value between FLEK and PK.
b P < 0.05 vs donor endothelial cell density in a linear regression model.
c P value of a linear regression model with three postoperative periods at the same time in the model.
FLEK, femtosecond laser-assisted endothelial keratoplasty; PK., penetrating keratoplasty; SD, standard deviation.
taBle 4. intraoperative and postoperative complications of Flek and Pk
Flek, n (%) Pk, n (%)
Intraoperative pupillary block 2 (5.6%) 0
Postoperative pupillary block 1 (2.8%) 0
Primary graft failure 3 (8.3%) 0
Immunological graft failure 1 (2.8%) 0
Allograft rejection 0 1 (2.5%)
Suture-related problems 0 4 (10%)
Wound dehiscence 0 2 (5.0%)
Suture revision to correct astigmatism 0 4 (10%)
Elevated intraocular pressure 5 (13.9%) 5 (12.5%)
Dislocation and resposition of graft 10 (27.8%) 0
Epithelial ingrowth 1 (2.8%) 0
FLEK, femtosecond laser-assisted endothelial keratoplasty; PK, penetrating keratoplasty.
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Intraocular pressure elevation in the FLEK and PK groups occurred in 5 of the 36 eyes 
(13.9%) and 5 of the 40 eyes (12.5%), which was effectively treated with intraocular pres-
sure lowering drops. In 6 of the 36 eyes (16.7%) in the FLEK group, there was a noticeable 
central stromal haze after deturgescence of the recipient cornea.
DisCussion
Several studies have shown that EK techniques are effective procedures for treating eyes 
with endothelial disease and are becoming a popular alternative for PK (4–6). The pur-
pose of this randomized multicenter trial was to evaluate the efficacy and safety of FLEK, 
where a femtosecond laser is used to prepare the endothelial graft, versus PK during a 
follow-up time of 12 months.
refractive outcome and visual outcome
Our results show that both refractive and topographic astigmatism changed only in PK 
eyes but remained low and stable in FLEK eyes. Astigmatism after PK may be greater 
than 3.0 D in more than 40% of eyes, leading to anisometropia, image distortion, and in-
tolerance of spectacle wear (3, 22–25). Therefore, the important advantage of FLEK and 
other EK techniques over PK is the decreased induction of postoperative topographic 
and refractive astigmatism (26–28). Our study shows that the percentage of eyes with a 
refractive astigmatism more than or equal to 3 D is significantly higher after PK. However, 
long-term follow-up remains necessary for full comparison of the final astigmatism 
results between FLEK and PK eyes, because most PK eyes still have all or most sutures in 
place at the 12-month time point.
Postoperative spherical equivalent was more hyperopic in the FLEK group, which may 
be due to the fact that the endothelial grafts prepared with the femtosecond laser are 
thinner in the center and thicker at the edges (12). The hyperopic shift in our study was 
higher compared with other EK studies (26–30), because we initially did not compensate 
for the expected shift by selecting a higher intraocular lens power, targeting at mild 
myopia (-1.0 to -1.25 D) during cataract surgery (31).
We showed a significant improvement of UCVA in the FLEK group, with no significant 
difference between the FLEK and PK groups at 12 months. Recently, a randomized study 
demonstrated that UCVA in DLEK eyes improved over 12 months time, whereas no im-
provement was noted in PK eyes (32). Another nonrandomized study showed that UCVA 
was lowest in PK eyes compared with EK eyes (15). 
We found a significant improvement of BSCVA in both FLEK and PK eyes with a 
significantly higher value in PK eyes. Our results of BSCVA in PK eyes are comparable 
with other PK studies (3, 15). The previously mentioned randomized study showed that 
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BSCVA was comparable between DLEK and PK eyes over 1 year follow-up (32), whereas 
the nonrandomized comparative study reported that BSCVA was significantly better in 
DLEK, DSEK, and DSAEK eyes compared with PK eyes (15). However, the BSCVA results 
in our FLEK group seem to be lower compared with DSAEK series in the literature which 
report a mean BSCVA of 20/44 to 20/34 with a follow-up of 6 to 12 months (4, 15, 28). 
Possible explanations for these difference are an increased opacification at the interface 
due to keratocyte activation by the femtosecond laser or a suboptimal smoothness of 
the stromal bed as compared with a microkeratome-prepared bed (16, 33). To improve 
the smoothness of the stromal bed, it has been suggested to use a curved interface lens 
with the aim of reducing the circular concentric ridges (34). Furthermore, the 60-kHz 
intralase femtosecond laser has been shown to produce a smoother anterior stromal 
bed in comparison to the microkerotome (35), but it is currently unclear what the effect 
will be on the smoothness when making deep lamellar cuts, to prepare the endothelial 
graft. Because there were significantly more eyes with age-related macular degenera-
tion or retinal pigment epithelium changes in our FLEK group in comparison with the 
PK group we used a multiple linear regression model to adjust for age-related macular 
degeneration and retinal pigment epithelium changes. The analysis showed that the 
BSCVA at 3, 6, and 12 months was still significantly higher in the PK group.
Currently, there are four different femtosecond laser systems available, with different 
corneal applanation lenses and different frequencies. Previous studies with the FEMTEC 
femtosecond laser (FEMTEC, 20/10 Perfect Vision, Heidelberg, Germany) have reported 
a smooth stromal bed without circular concentric ridges when making a deep lamellar 
cut to prepare the endothelial graft (11, 13).
endothelial cell density
An important goal of both EK and PK is to maintain a high endothelial cell density, be-
cause it is an essential factor for long-term graft survival. Endothelial cell loss in the first 
year after PK has been reported to vary between 24.0% and 39.8%, which is comparable 
with our demonstrated endothelial cell loss of 23 ± 15% in the PK group after 12 months 
follow-up (36, 37). Endothelial cell loss after small-incision DSEK and DSAEK has been 
reported to be between 34% and 61% at 12 months follow-up (15, 29, 30, 38, 39). In 
our study, endothelial cell loss in the FLEK group at 12 months was 65 ± 12%, which is 
comparable with the high range of small-incision DSEK and DSAEK. 
Over time, endothelial cell loss was significantly higher in the FLEK group compared 
with the PK group. The finding of endothelial cell loss is a concern for the long-term graft 
survival in EK eyes. FLEK is a challenging new surgical procedure, and the learning curve 
of various surgeons may have influenced the level of endothelial cell loss. Furthermore, 
several steps during the FLEK procedure such as the folding of the endothelial graft 
into a taco-configuration, squeezing of the endothelial graft by forceps during inser-
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tion, unfolding, and long-standing contact with air bubble may have influenced the 
postoperative endothelial cell density (40, 41). Recently, modified techniques have been 
proposed for inserting the endothelial graft during DSEK and DSAEK. Kaiserman et al. 
(14) have compared endothelial cell loss after insertion of the endothelial graft with a 
suture versus forceps, which showed no significant difference between the two groups. 
Other studies have used a glide to insert the endothelial graft and the endothelial cell 
loss varied between 23.5% and 25.3% at 6 and 12 months follow-up (42, 43).
intraoperative and postoperative complications
In our study, no intraoperative complications occurred during PK. Two eyes (5.6%) 
showed a pupillary block during FLEK. After the routine performance of a surgical iridec-
tomy, no further cases of pupillary block glaucoma were seen. Only few intraoperative 
complications have been reported during EK, including donor tissue perforation (with 
hand-dissection), papillary block, and suprachoroidal hemorrhage (27, 44).
Postoperatively, three eyes in the FLEK group showed a primary graft failure. This was 
most likely related to the learning curve of various surgeons and several technical steps 
of the FLEK procedure. None of the PK eyes in this study demonstrated a primary graft 
failure. In the literature, the rate of primary graft failure after DSEK or DSAEK ranges from 
0.5% to 45% (15, 27, 29).
One eye (2.8%) in the FLEK demonstrated an immunological graft failure, and one 
eye (2.5%) in the PK demonstrated an allograft rejection over time. The immunological 
graft failure and rejection rate in our study is similar or even lower than previous reports 
in non-high-risk case series for PK (4.4%–29%), DLEK (4%–4.4%), and DSAEK (2.2%–9%; 
15, 30, 45). A 2-year follow-up study by Allan et al. (46) reported a lower rejection rate 
in the EK group (7.5%) in comparison to the PK group (13%). This can be explained by 
the fact that 80% of the EK patients were still using topical steroids and that most of the 
PK patients had discontinued their topical steroids 1 year postoperatively. In contrast, 
19.4% of the patients in our FLEK group had discontinued their topical steroids after 6 
months, and all patients in the PK group were still using topical steroids at 12 months 
follow-up. This demonstrates that FLEK-treated eyes may require only short-term steroid 
use and indicates that steroid-withdrawal does not necessarily lead to an increased 
rejection rate.
The incidence of steroid-induced glaucoma can be as high as 30% (47). The study by 
Bahar et al. (15) showed a rate of steroid-induced glaucoma of 6.3% in PK eyes, 13.2% 
in DLEK eyes, 12.5% in DSEK eyes, and 6.7% in DSAEK eyes. The incidence of steroid-
induced glaucoma throughout our study (13.9% in FLEK eyes and 12.5% in PK eyes) was 
comparable with previous reports. Currently, it is unclear which is the optimal time point 
for discontinuation of steroid drops in the FLEK group to decrease the risk of steroid-
induced glaucoma even further.
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In our PK group, two eyes (5.0%) showed a wound dehiscence (one eye due to a 
spontaneous wound dehiscence and the other due to blunt ocular trauma), which is 
comparable with previously reported incidences between 2.5% and 7.2% (48, 49). After 
PK, the eye is at risk for suture-related complications until all sutures are removed. 
Suture-related complications after PK are broken and loose sutures (8.3%), infectious 
keratitis (3.3%–50%), and erosions (10.8%; 48, 49). In our PK group, four eyes (10%) 
showed suture-related complications during the 12 months follow-up, which was com-
parable with these reports. 
The most frequent complication in our FLEK series was graft dislocation (27.8% of 
eyes), which is comparable with the incidence in series of small-incision DSEK (0.7%–
50.0%) and of DSAEK (4.0%–34.6%; 4, 6, 27, 28, 30, 44). Patient selection for EK may be 
an important factor in reducing the rate of dislocation, for example, aphakic eyes with a 
floppy iris diaphragm after vitreoretinal surgery may not be suitable for EK procedures.
In our FLEK group, one eye (2.8%) showed postoperative epithelial ingrowth in the 
interface, which probably occurred through the transcorneal incision. The ingrowth 
remained stable during the 12 months follow-up. This infrequent complication has been 
reported after both DSEK and DSAEK (44, 50, 51).
In conclusion, this randomized trial with a follow-up of 12 months demonstrated the 
efficacy of both FLEK and PK for treating endothelial disease with a lower percentage 
of refractive astigmatism (≤ 3.0 D) and a mild hyperopic shift in FLEK eyes as compared 
with PK eyes. After 12 months follow-up, FLEK and PK showed an improvement of 
BSCVA, and the differences of BSCVA gain between the two groups were comparable. 
The major safety concern remains the high endothelial cell loss after FLEK compared 
with previous DSEK and DSAEK studies. Future research on FLEK should be directed 
toward refinements in donor tissue handling with the aim of minimizing endothelial cell 
loss and improvement of the interface optical quality by innovations in femtosecond 
laser technology.
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aBstraCt
Purpose: To compare the quality of vision (straylight and contrast sensitivity) after 
femtosecond laser-assisted Descemet stripping endothelial keratoplasty (FS DSEK) and 
penetrating keratoplasty (PK).
Design: Prospective, randomized clinical trial.
methods: setting: Multicenter (5 ophthalmic centers in The Netherlands). 
study population: Eighty eyes of 80 patients with corneal endothelial dysfunction were 
included and were randomized to FS DSEK or PK. 
observation procedures: FS DSEK and PK.
main outcome measures: Straylight, contrast sensitivity, astigmatism, uncorrected 
visual acuity, best spectacle-corrected visual acuity (BSCVA), and visual symptom score.
results: Straylight at 12 months was 1.37 ± 0.2 logarithm of straylight for FS DSEK 
and 1.46 ± 0.2 logarithm of straylight for PK (P = .151). During 12 months of follow-up, 
there was a significant improvement of straylight and contrast sensitivity after FS DSEK 
(P < .001) and PK (P < .001). The change of straylight and contrast sensitivity correlated 
significantly with the change of BSCVA after FS DSEK (r = -0.645; r = 0.580) and PK (r = 
-0.370; r = 0.659). The visual symptom score was comparable between the 2 groups dur-
ing the 12 months of follow-up.
Conclusions: Improvement of straylight and contrast sensitivity was significantly corre-
lated with an improvement of BSCVA. Straylight and contrast sensitivity were improved 
significantly after FS DSEK and were comparable with those after PK, although BSCVA 
was slightly better in the PK group.
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introDuCtion
Penetrating keratoplasty (PK) has been shown to be a successful treatment for restoring 
vision in eyes with corneal endothelial disease, but disadvantages include a slow visual 
rehabilitation, high irregular astigmatism, and suture-related problems.1–3 In 1956, the 
first posterior lamellar keratoplasty was performed to replace the deep stromal and en-
dothelial layers and to maintain the anterior part of the cornea.4 Posterior lamellar kera-
toplasty was not performed regularly because of difficulties with surgical techniques. 
After major surgical improvements and innovations in surgical instruments, endothelial 
keratoplasty replaced PK as the gold standard surgical technique for corneal endothelial 
disease.5–10
Major advantages of endothelial keratoplasty, compared with PK, are a minimal 
change in corneal astigmatism, a more predictable postoperative spherical equivalent, 
and a stable globe more resistant to trauma.6,8,9 In a recent randomized clinical trial 
of femtosecond laser-assisted Descemet stripping endothelial keratoplasty (FS DSEK) 
versus PK, we showed that FS DSEK effectively reduces postoperative astigmatism, but 
we also showed a lower visual acuity as compared with conventional PK.11
We hypothesized that the lower visual acuity may be the result of the formation of in-
terface haze at the donor–recipient stromal interface. This haze may result in an increase 
of intraocular straylight and a decrease of contrast sensitivity.12,13 Consequently, a dis-
satisfaction with the quality of vision and limitations in daily functioning may occur.14–17
This randomized clinical trial was performed to determine intraocular straylight, con-
trast sensitivity, and subjective visual symptoms after FS DSEK and PK and to correlate 
these quality-of-vision parameters to the refractive and visual outcomes. A secondary 
goal of the present study was to test the clinical use of straylight meter in such a de-
manding setting.
methoDs
This randomized, multicenter trial was conducted at 5 ophthalmic centers in The 
Netherlands. Inclusion criteria were endothelial dysfunction caused by Fuchs endothe-
lial dystrophy, aphakic or pseudophakic bullous keratopathy or posterior polymorphous 
dystrophy, a minimal age of 18 years, and a best spectacle-corrected visual acuity 
(BSCVA) lower than 20/50. Patients were excluded if they had undergone previous 
PK, had human leukocyte antigen typed keratoplasty, or were mentally retarded. The 
medical history was recorded, and all patients underwent a slit-lamp examination. 
Preoperative collected data included patient age, gender, refractive error, preoperative 
lens status, and ocular comorbidities.
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surgical procedures
The surgical techniques of FS DSEK and PK have been described previously.11
outcomes measures
The primary outcome measures were straylight and contrast sensitivity. Secondary 
outcome measures included refractive astigmatism, topographic astigmatism, uncor-
rected visual acuity (UCVA), BSCVA, and visual symptom score. All outcome measures 
were measured before surgery and at 3, 6, and 12 months of follow-up. 
Straylight was measured using a straylight meter (CQuant; Oculus GmbH, Wetzlar, 
Germany), which uses a compensation comparison method with a forced-choice tech-
nique.18 Clinical straylight measurement is a relatively new development to quantify 
quality of vision and was developed originally for visual acuities better than 0.7 loga-
rithm of the minimal angle of resolution (logMAR). However, corneal transplantation 
patients often have visual acuities worse than that. 
The straylight value was expressed as a logarithmic intraocular straylight (log(s)) value. 
Higher values indicate more straylight and an increased sensitivity to glare.19 Two con-
secutive straylight measurements of the study eye and the nonstudy eye were obtained, 
after which an average amount of logarithmic intraocular straylight was calculated. The 
instrument derives a reliability value for each measurement, called the expected standard 
deviation, on the basis of known psychometric principles. A reliable value was defined 
as an expected standard deviation of less than 0.08 log units. The repeated measures 
design of the study checked this reliability estimate against true reliability. Straylight 
values also were compared with a control group obtained from a previous database 
consisting of agematched subjects with a clear cornea and no cataract.19 Eyes that were 
unable to perform the straylight test before surgery were substituted by the highest 
preoperative log(s) plus 0.1.
The contrast sensitivity was measured using the Pelli-Robson chart (Clement Clarke 
Ltd, Harlow, United Kingdom). This chart was chosen from among other available charts 
for its high reliability and validity compared with sinusoidal grating charts such as the 
Vistech and Functional Acuity Contrast Test.20–22 Patients were tested both monocularly 
and binocularly, using the best spectacle correction for distance vision on a testing dis-
tance of 1 m and a luminance of 85 candelas/m2. The last triplet of letters, of which at 
least 2 letters were seen correctly, was recorded and expressed as a logarithmic contrast 
sensitivity value.23 Lower values indicate a better contrast sensitivity. 
Topographic astigmatism was measured using the EyeMap corneal topographer 
(EH-290; Alcon, Fort Worth, Texas, USA). The UCVA and BSCVA were determined using 
the Early Treatment Diabetic Retinopathy Study letter charts and were converted to 
logarithm of the minimal angle of resolution measurements.24 Vision levels of counting 
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fingers, hand movements, light perception, and no light perception were substituted by 
logarithm of the minimal angle of resolution values of 1.7, 2.0, 2.5, and 3.0, respectively.
Double-vision or distorted vision, glare, halo, blurry vision, and differently looking 
colors were reported by patients using a validated questionnaire.25 The grading of 
symptoms ranged from great deal, moderate amount, little, to none, and a score of 3, 2, 
1, or 0 was assigned, respectively. Scores for each of the symptoms then were summed, 
and this resulted in a visual symptom score ranging from 0 (not at all bothered by any of 
the symptoms) to 15 (very bothered by all symptoms).25,26
sample size 
The sample size calculation of the main outcome of this randomized clinical trial has 
been described previously.11
randomization
All included eyes were assigned randomly to either the FS DSEK or the PK group. The 
randomization code was generated using a permuted block size of 2. The assigned treat-
ment plans then were sent to the surgeon.
statistical analysis
Data were described as mean standard deviation for continuous variables and as in-
dividual counts and percentages for categorical variables. Differences between groups 
were analyzed using a Student t test for continuous data. The Pearson chi-square test was 
used to compare categorical data. Comparisons of preoperative data and postoperative 
data within a group were performed using a linear regression model. Correlations were 
assessed using the Pearson correlation coefficient in case of normal distributed data and 
using the Spearman test in case of abnormal distributed data. A P value of less than .05 
was considered to be statistically significant. Statistical analysis was performed using 
SPSS software for Windows version 15.0 (SPSS, Inc, Chicago, Illinois, USA).
results
Participant flow chart
Eighty eyes of 80 patients were recruited, with 40 eyes in each arm (Figure 1). In the FS 
DSEK group, 4 patients did not receive the allocated treatment because of significant 
preoperative events (such as keratitis, corneal ulcers, or both) and eventually were 
excluded from the study analysis. All patients in the PK group received the allocated 
treatment. 
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In the FS DSEK group, 29 eyes were available for analysis at the 12-month follow-up. 
After surgery, the cornea of 3 eyes remained edematous and did not clear up; this was 
defined as primary graft failure. Two eyes underwent PK before the 3-month follow-up, 
and 1 eye underwent repeat FS DSEK after 6 months of follow-up.
Patient characteristics
Patients characteristics of the FS DSEK and PK group are listed in Table 1. The mean age of 
the FS DSEK group and PK group was 69.0 ± 8.8 years and 71.4 ± 11.3 years, respectively 
(P = .308). In the FS DSEK group, 21 of 36 patients (58.3%) were diagnosed with Fuchs 
endothelial dystrophy, and 8 (38.1%) of these 21 patients also had visually significant 
cataract. These patients either underwent primary cataract extraction with intraocular 
lens (IOL) implantation (n = 5, 62.5%) followed by the FS DSEK procedure or a combined 
procedure of FS DSEK and cataract extraction with IOL implantation (n = 3, 37.5%). In the 
PK group, 20 of 40 patients (50.0%) were diagnosed with Fuchs endothelial dystrophy, 
and 12 (60.0%) of these 20 patients also had visually significant cataract. Ten (83.3%) 
of these 12 patients underwent a combined procedure of PK and cataract extraction 
Figure 1. Participant flow chart of femtosecond laser-assisted Descemet stripping endothelial keratoplasty versus pen-
etrating keratoplasty. FS-DSEK = femtosecond laser-assisted Descemet stripping endothelial keratoplasty; PK  = penetrat-
ing keratoplasty; PLD = posterior lamellar disc.
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with IOL implantation, and 2 of the 12 patients (16.7%) underwent a primary cataract 
extraction with IOL implantation before PK. 
Before surgery, 34 patients (85.0%) in the PK group and 30 patients (83.3%) in the FS 
DSEK group required spectacle correction for distance vision; the remaining patients 
used no correction. Twelve months after FS DSEK, 23 patients (79.3%) used spectacles 
and 1 patient (3.4%) used soft contact lenses for distance vision. Five patients (17.2%) 
did not need a correction. Twelve months after PK, 26 patients (66.6%) used spectacles, 
1 patient (2.6%) used a rigid contact lenses for distance vision, and 12 patients (30.8%) 
did not use a correction, with 7 of the 12 patients being unable to wear a correction 
because of anisometropia.
intaocular straylight 
Before surgery, 43% of subjects had a visual acuity lower than the advised limit for stray-
light measurement (0.7 logMAR). This limit seems a bit strict, because only 11 (30.6%) 
of 36 patients in the FS DSEK group and 13 (32.5%) of 40 patients in the PK group were 
unable to complete the straylight test. The mean logMAR BSCVA of these patients’ eyes 
was  significantly higher in comparison with eyes of patients who did complete the test 
taBle 1. Preoperative Patient Characteristics of Femtosecond Laser-Assisted Descemet Stripping Endothe-
lial Keratoplasty and Penetrating Keratoplasty
FS-DSEK PK P Value
Eyes (n) 36 40 NA
Mean age ± SD (y) 69.0 ± 8.8 71.4 ± 11.3 .308
No. women (%) 21 (58.3%) 27 (67.5%) .500
Diagnosis .725
     Fuchs’ endothelial dystrophy 21 (58.3%) 20 (50.0%)
     Pseudophakic bullous keratopathy 15 (41.7%) a 19 (47.5%) a
     Posterior polymorphous dystrophy 0 1 (2.5%)
Recipient lens status .996
     Aphakic 1 (2.8%) a 1 (2.5%) a
     Phakic 21 (58.3%) 21 (52.5%)
     Pseudophakic 14 (38.9%) 18 (45.0%)
Ocular comorbidity
     Age-related macular degeneration/ RPE changes 12 (33.3%) 5 (12.5%) .030
     Cataract 8 (22.2%) 12 (30.0%) .442
     Glaucoma 1 (2.8%) 3 (7.5%) .357
FS DSEK = femtosecond laser-assisted Descemet stripping endothelial keratoplasty; NA = not applicable; PK = penetrating 
keratoplasty; RPE = retinal pigment epithelium; SD = standard deviation. 
a One aphakic eye with iris-fixated anterior chamber intraocular lens.
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(1.17 ±  0.5 logMAR vs 0.67 ± 0.2 logMAR, respectively [P < .001], in the FS DSEK group; 
and 1.00 ± 0.5 logMAR vs 0.59 ± 0.3 logMAR, respectively [P < .002], in the PK group). 
Figure 2 shows repeatability of the straylight measurement for all follow-up visits of 
the study eyes and for the nonstudy eyes (P < .05 for all 4 comparisons, F test). The 
repeated-measures standard deviation was 0.07 for the nonstudy eyes. For the study 
eyes, the repeated-measures standard deviations were slightly higher at 0.10, 0.09, 0.09, 
and 0.11 for preoperative and postoperative values at 3, 6, and 12 months, respectively. 
So, the precision of the straylight measurements was not much less in the study eyes as 
compared with the nonstudy eyes, but the difference was statistically significant (P < .05 
for all comparisons, F test). Repeatability was not dependent on straylight level, is is also 
evident in Figure 2. 
Preoperative straylight values were not significantly different between the FS DSEK 
and PK group (1.97 ± 0.4 log(s) vs 1.97 ± 0.4 log(s), respectively; P = .926). During the 
follow-up, the straylight between the FS DSEK and PK group was comparable (3 months, 
1.43 ± 0.2 log(s) vs 1.40 ± 0.2 log(s) [P = .582]; 6 months, 1.42 ± 0.3 log(s) vs 1.41 ± 0.2 
log(s) [P = .960]; 12 months, 1.37 ± 0.2 vs 1.46 ± 0.2 log(s) [P = .151]). In both groups, 
there was a significant improvement of straylight during the 12 months of follow-up (FS 
DSEK, P < .001; PK, P < .001).
Straylight value as a function of age is shown in Figure 3. Eyes with too severe corneal 
edema that were not able to complete the straylight test were substituted by 2.46 log(s), 
Figure 2. Graph showing the repeatability of intraocular straylight measurement for femtosecond laser-assisted Des-
cemet stripping endothelial keratoplasty, penetrating keratoplasty, and nonstudy eyes. The repeated measures standard 
deviation was 0.07 for the nonstudy eyes and 0.10 overall for the study eyes. Log(s) = logarithmic intraocular straylight 
value.
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which is notable in Figure 3. Before surgery, 13.9% (n = 5) of the patients in the FS DSEK 
group and 12.5% (n = 5) of the patients in the PK group had straylight values within 
the normal age-matched range, whereas the remaining patients had higher straylight 
values. Twelve months after FS DSEK and PK, 38.5% (n = 10) and 45.7% (n = 16) of the 
patients, respectively, had straylight values comparable with the normal age-matched 
range, and 11.5% (n = 3) and 2.9% (n = 1) of the patients, respectively, had lower stray-
light values, whereas 50.0% (n = 13) and 51.4% (n = 18) of the patients, respectively, had 
higher straylight values.
Before surgery, there was a significant correlation between the BSCVA and straylight 
value in the FS DSEK group (r = 0.461; P = .005) and PK group (r = 0.523; P = .001). At 
3, 6, and 12 months after surgery, the correlation between BSCVA and straylight value 
was not significant in the FS DSEK group (r = 0.260, P = .209; r = 0.214, P = .273; and r = 
0.082, P = .696, respectively). In the PK group, the BSCVA was correlated significantly 
with straylight at 3, 6, and 12 months of follow-up (r = 0.363, P = .032; r = 0.492, P =.003; 
and r = 0.569, P < .001).
The change in intraocular straylight and BSCVA values from baseline to 12 months 
after surgery showed a correlation in the PK group (r = -0.370; P = .029), and in the FS 
DSEK group (r = -0.645; P < .001). An improvement of BSCVA was correlated significantly 
with a decrease of straylight in both groups.
Contrast sensitivity
Contrast sensitivities for both groups are shown in Table 2. Before surgery, 3 (8.3%) of 36 
patients in the FS DSEK group and 3 (7.5%) of 40 patients in the PK group were unable 
to see the highest contrast at 1 m distance. Before surgery, contrast sensitivity of the 
study eye, fellow eye, and binocularly were not significantly different between the FS 
DSEK and PK groups.
At 3, 6, and 12 months after surgery, no significant difference in contrast sensitivity 
was found between the FS DSEK and PK groups. In both the FS DSEK and PK groups, 
contrast sensitivity of the study eye increased significantly after surgery. The binocular 
contrast sensitivity improved significantly after PK (P = .006), but not after FS DSEK (P = 
.365).
Before surgery, there was a correlation between BSCVA and contrast sensitivity in both 
the FS DSEK group (r = -0.640; P < .001) and PK group (r = -0.706; P < .001). After FS 
DSEK and PK, the change in contrast sensitivity from baseline to 12 months after surgery 
showed a correlation with the change in BSCVA during the same follow-up period (r = 
0.508, P = .009, and r = 0.659, P < .001, respectively).
In the FS DSEK group, the correlation between straylight and contrast sensitivity was 
r = -0.504 (preoperative, P = .003), r = -0.541 (3-month postoperative, P = .005), r = -0.685 
(6-month postoperative, P <  .01), and r = -0.054 (12-month postoperative, P = .796). In 
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Figure 3. Graphs showing intraocular straylight values as a function of age for the femtosecond laser-assisted Descemet 
stripping endothelial keratoplasty (FS-DSEK) versus penetrating keratoplasty (PK) groups (Left) before surgery and (Right) 
12 months after surgery. The lines represent mean levels of straylight ± 2 standard deviations (SDs). Log(s) = logarithmic 
intraocular straylight value.
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the PK group, the correlation between straylight and contrast sensitivity was r = - 0.434 
(preoperative, P = .007), r = -0.492 (3-month postoperative, P = .003), r = -0.534 (6-month 
postoperative, P = .001), and r = -0.348 (12-month postoperative, P = .040).
astigmatism
Refractive and topographic astigmatism outcomes are shown in Table 3. Before surgery, 
there was no significant difference in refractive and topographic astigmatism between 
the FS DSEK and PK group. At the 12-month follow-up, both refractive and topographic 
astigmatism were significantly higher in the PK group compared with the FS DSEK group 
(refractive, -2.98 diopters [D] vs  -1.22 D, respectively; and topographic, 3.67 D vs 1.58 D, 
respectively). In the FS DSEK group, postoperative refractive and topographic astigma-
tism values were not significantly different from preoperative values. In the PK group, all 
postoperative refractive and topographic astigmatism values were significantly higher 
compared with those before surgery. During follow-up, these values showed a tendency 
to decrease. After 12 months of follow-up, all sutures had been removed in only 1 eye 
(2.5%) in the PK group.
Twelve months after surgery, the percentage of patients with a refractive astigmatism 
of  ≤ 3.0 D was significantly higher in the FS DSEK group compared with the PK group 
(86.2% vs 51.3%, respectively; P = .004).
taBle 3. Preoperative and Postoperative Astigmatism of Femtosecond Laser-Assisted Descemet-Stripping 
Endothelial Keratoplasty and Penetrating Keratoplasty 
FS DSEK, Mean ± SD Range PK, Mean  ± SD Range P Value a
Refractive astigmatism (D)
preoperative -0.98 ± 1.0 -3.5 to 0 -1.27 ± 1.2 -5.50 to 0 .275
3 mos -1.38 ± 1.2 -5.0 to 0 -4.17 ± 3.4 b -14.0 to 0 < .001
6 mos -1.46 ± 1.3 -5.0 to 0 -3.21 ± 1.9 b -8.00 to 0 < .001
12 mos -1.22 ± 1.1 -4.0 to 0 -2.98 ± 2.0 b -8.75 to 0 < .001
P = .358 c P < .001 c
Topographic astigmatism (D)
preoperative 1.38 ± 0.6 0.47 to 2.90 2.16 ± 1.4 0.50 to 6.50 .577
3 mos 1.87 ± 1.1 0.25 to 4.30 4.59 ± 2.9 b 1.00 to 15.70 < .001
6 mos 1.72 ± 1.0 0.27 to 4.14 3.74 ± 1.7 b 0.50 to 6.83 < .001
12 mos 1.58 ± 1.2 0.27 to 6.40 3.67 ± 1.8 b 1.40 to 7.70 < .001
P = .469 c P < .001 c
D = diopters; FS DSEK = femtosecond laser-assisted Descemet stripping endothelial keratoplasty; mos =  months; PK = 
penetrating
keratoplasty; SD = standard deviation.
a P value between FS DSEK and PK.
b P < .05 versus preoperative in a linear regression model.
c P value of a linear regression model with 3 postoperative periods at the same time in the model.
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uncorrected visual acuity and best spectacle-corrected visual acuity
Before surgery and at 3, 6, and 12 months after surgery, there was no significant differ-
ence in UCVA between the FS DSEK and PK groups (Table 4). In the FS DSEK group, UCVA 
was significantly better at all postoperative visits compared with that before surgery. 
The UCVA in the PK group was significantly improved at 3 and 12 months after surgery 
compared with that before surgery.
Before surgery, there was no significant difference in BSCVA between the FS DSEK 
and PK groups (0.82 ± 0.4 logMAR vs 0.73 ± 0.4 logMAR, respectively; P = .316). In both 
groups, BSCVA showed a significant improvement after surgery. After surgery, the mean 
BSCVA in the PK group was significantly better when compared with the FS DSEK group 
at all follow-up visits. The mean gain in BSCVA at 12 months of follow-up was not sig-
taBle 4. Preoperative and Postoperative Visual Outcome of Femtosecond Laser-Assisted Descemet-Strip-
ping Endothelial Keratoplasty and Penetrating Keratoplasty
   
FS DSEK, Mean 
± SD Range PK, Mean ± SD Range P Value a
UCVA (logMAR)
Preoperative 1.01 ± 0.4 (20/200) 0.22 to 2.0 0.88 ± 0.4 (20/150) 0.40 to 2.0 .133
3 mos 0.80 ± 0.2 (20/125) b 0.40 to 1.70 0.71 ± 0.3 (20/100)b 0.10 to 1.36 .144
6 mos 0.79 ± 0.3 (20/125) b 0.40 to 1.70 0.79 ± 0.3 (20/125) 0.14 to 1.36 .959
12 mos 0.73 ± 0.3 (20/102) b 0.34 to 1.70 0.68 ± 0.3 (20/96) b 0.10 to 1.46 .539
P = .001 c P = .045 c
BSCVA (logMAR)
Preoperative 0.82 ± 0.4 (20/132) 0.22 to 2.0 0.73 ± 0.4 (20/105) 0.18 to 2.0 .316
3 mos 0.65 ± 0.3 (20/90) b 0.22 to 1.70 0.40 ± 0.2 (20/50) b -0.04 to 1.12 < .001
6 mos 0.64 ± 0.3 (20/87) b 0.26 to 1.70 0.35 ± 0.2 (20/44) b 0 to 0.86 < .001
12 mos 0.55 ± 0.2 (20/70) b 0.16 to 1.10 0.35 ± 0.2 (20/44) b -0.04 to 0.98 < .001
P = .004 c P < .001 c
BSCVA gain (logMAR)
3 mos 0.15 ± 0.4 -1.06 to 1.34 0.33 ± 0.4 -0.48 to 1.48 .052
6 mos 0.14 ± 0.4 -1.06 to 1.30 0.38 ± 0.4 -0.40 to 1.46 .017
12 mos 0.24 ± 0.4 -0.34 to 1.50 0.38 ± 0.4 -0.24 to 1.30 .103
BSCVA = best spectacle-corrected visual acuity; FS DSEK = femtosecond laser-assisted Descemet stripping endothelial 
keratoplasty; logMAR = logarithm of the minimal angle of resolution; mos =  months; PK = penetrating keratoplasty; SD  = 
standard deviation; UCVA = uncorrected visual acuity.
a P value between FS DSEK and PK.
b P < .05 versus preoperative in a linear regression model.
c P value of a linear regression model with 3 postoperative periods at the same time in the model.
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nificantly different between the FS DSEK and PK group (0.24 logMAR vs 0.38 logMAR, 
respectively P = .103).
visual symptom score
Before surgery, the most commonly reported symptom in the FS DSEK and PK groups 
was blurry vision (Table 5), with a small significant difference between the 2 groups. In 
the FS DSEK group, the percentage of patients reporting no blurry vision increased from 
8.3% before surgery to 25.9% at 12 months after surgery. In the PK group, 43.2% re-
ported no blurry vision at 12 months after surgery as compared with 0% before surgery. 
The number of patients reporting double vision or distorted vision was not significantly 
different  between the FS DSEK and PK groups during the 12 months of follow-up.
taBle 5. Subjective Visual Symptoms after Femtosecond Laser-Assisted Descemet-Stripping Endothelial 
Keratoplasty and Pentrating Keratoplasty
  FS DSEK PK
  Preoperative 3 Mos 6 Mos 12 Mos Preoperative 3 Mos 6 Mos 12 Mos P Value
Blurry vision (%) 
Great deal 41.7 20.0 19.4 3.7 35.0 18.9 7.9 5.4 Preoperative, .046
Moderate amount 36.1 20.0 12.9 11.1 27.5 8.1 15.8 21.6 3 mos, .535
Little 13.9 36.7 32.3 59.3 37.5 45.9 39.5 29.7 6 mos,  .558
None 8.3 23.3 35.5 25.9 0.0 27.0 36.8 43.2 12 mos, .131
Double or distorted vision(%)
Great deal 5.6 10.0 3.2 3.8 7.5 7.9 7.9 2.7 Preoperative, .487
Moderate amount 13.9 10.0 22.6 7.7 10.0 15.8 15.8 10.8 3 mos, .424
Little 36.1 20.0 25.8 42.3 22.5 34.2 36.8 24.3 6 mos, .567
None 44.4 60.0 48.4 46.2 60.0 42.1 39.5 62.2 12 mos, .479
Glare (%)
Great deal 25.0 13.3 9.7 15.4 20.0 13.2 10.5 8.1 Preoperative, .050
Moderate amount 38.9 30.0 19.4 3.8 15.0 21.1 23.7 5.4 3 mos, .812
Little 16.7 40.0 54.8 53.8 37.5 42.1 26.3 45.9 6 mos, .075
None 19.4 16.7 16.1 26.9 27.5 23.7 39.5 40.5 12 mos, .613
Halo (%)
Great deal 19.4 6.7 9.7 3.8 23.1 15.8 5.3 8.1 Preoperative, .241
Moderate amount 22.2 16.7 19.4 19.2 15.4 28.9 18.4 24.3 3 mos, .327
Little 25.0 33.3 29.0 46.2 43.6 23.7 31.6 29.7 6 mos, .911
None 33.3 43.3 41.9 30.8 17.9 31.6 44.7 37.8 12 mos, .580
Colors look different (%)
Great deal 5.6 0.0 6.5 0.0 5.0 0.0 2.6 2.7 Preoperative, .428
Moderate amount 2.8 13.8 3.2 3.8 7.5 5.3 0.0 0.0 3 mos, .321
Little 22.2 10.3 9.7 15.4 10.0 5.3 13.2 13.5 6 mos. .572
None 69.4 75.9 80.6 80.0 77.5 89.5 84.2 83.8 12 mos, .536
FS DSEK = femtosecond laser-assisted Descemet stripping endothelial keratoplasty; Mos  = months; PK = penetrating 
keratoplasty.
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In both the FS DSEK and PK groups, a relatively high percentage of patients reported 
glare and halo symptoms before surgery (glare, 80.6% vs 72.5%, respectively; halo, 
66.7% vs 82.1%, respectively). During 12 months of follow-up, the percentage of pa-
tients reporting glare symptoms (severity score 3) decreased from 25.0% to 15.4% in 
the FS DSEK group and from 20.0% to 8.1% in the PK group (Table 5). The percentage 
of patients reporting halos decreased from 19.4% before surgery to 3.8% at 12 months 
after surgery in the FS DSEK group and from 23.1% before surgery to 8.1% at 12 months 
after surgery in the PK group (Table 5).
Before surgery, there was no significant difference in visual symptom score between 
the FS DSEK and PK groups (6.33 ± 3.0 and 5.70 ± 2.7; P = .343). During follow-up, the dif-
ference in visual symptom score between the FS DSEK and PK groups was not significant 
(3 months, 4.70 ± 3.5 vs 4.74 ± 3.2 [P = .964]; 6 months, 4.52 ± 3.7vs 3.97 ± 2.7 [P = .484]; 
12 months, 3.78 ± 2.8 vs 3.49 ± 2.9 [P = .694]). In both groups, there was a significant 
improvement of visual symptom score at all time points (FS DSEK, P = .017; PK, P = .006).
DisCussion
The purpose of this randomized, multicenter trial was to evaluate the quality of vision 
(intraocular straylight and contrast sensitivity) and to correlate these quality-ofvision 
parameters to the refractive and visual outcomes after FS DSEK and PK. Previous studies 
reported limited visual outcomes after lamellar keratoplasty because of an interface 
haze, which may increase straylight.13,27 The main conclusion of our study is that both 
FS DSEK and PK are very effective at improving straylight, and no significant difference 
between the 2 groups was found. Although postoperative straylight is still increased, 
the increase is only 2-fold when compared with age-matched controls. In this group 
of patients with severely impaired vision, the reliability parameter (expected standard 
deviation) for straylight measurements proved to be very effective to ensure accurate 
measurements before and after surgery (Figure 2). This compared well with published 
values between 0.08 and 0.06 as well as with the limit values used for expected standard 
deviation of 0.08.19
The straylight values in our study showed a significant improvement during the 12 
months of follow-up in the FS DSEK and PK group. The largest improvement was seen 
from baseline to 3 months after surgery, and after that, straylight values remained stable 
up to 12 months of follow-up. A previous randomized clinical trial comparing deep 
lamellar endothelial keratoplasty (DLEK) with PK showed no significant change in stray-
light values after surgery.12 This difference in outcome may be explained by several fac-
tors. First, the preoperative straylight value reported in our study obviously was higher 
than in the study by Patel and associates, which may be the result of a higher degree of 
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corneal edema resulting from long-term corneal decompensation.12 Furthermore, the 
preoperative BSCVA was better in the study by Patel and associates, which also may 
indicate a lower degree of corneal edema or a shorter duration of corneal decompensa-
tion.12
After surgery, the percentage of patients with straylight values within the normal age-
matched range increased from 13.9% to 38.5% in the FS DSEK group and from 12.5% 
to 45.7% in the PK group. Despite the FS DSEK and PK procedure, 50.0% of the FS DSEK 
patients and 51.4% of the PK patients did not return to a normal straylight level. In con-
trast to the previously reported correlation between age and straylight after DSEK, we 
did not find a significant correlation between age and straylight after FS DSEK and PK.28 
Postoperative straylight values were compared with those of normal age-matched con-
trols, but the age of the donor cornea was not age-matched with the recipient cornea. 
This also may explain why the postoperative straylight values of the study eyes did not 
return to a normal straylight level. Also, 6 of 36 eyes in the FS DSEK group had residual 
central corneal haze after deturgescence of the recipient cornea. However, because the 
group of patients with a central corneal haze was small, we only can speculate whether 
this may influence the postoperative straylight value. 
It has been suggested that BSCVA after endothelial keratoplasty is limited because 
of increased straylight values associated with the lamellar interface.12,13 In our study, 
the gain of BSCVA and straylight values was not statistically significant between the 
2 groups. The correlation between the change in straylight and BSCVA from baseline 
to 12 months after surgery was significantly higher in the FS DSEK compared with the 
PK group, which was comparable with the results of a previous study.12 It also was re-
ported that the greatest improvement of BSCVA after PK and DLEK occurred in the first 
3 months after surgery, which was comparable with our speed of improvement of UCVA 
and BSCVA in the FS DSEK and PK group.
Contrast sensitivity can be affected by corneal edema, distortion, or cataract. In our 
study, we found a significant improvement of contrast sensitivity after FS DSEK and PK. 
There was no significant difference in contrast sensitivity between the FS DSEK and PK 
groups during the 12 months of follow-up. The contrast sensitivity test was performed 
with the best spectacle correction in place, which corrected the higher astigmatism in 
the PK group. The contrast sensitivity reported in our study is comparable with that of 
previous randomized studies comparing deep anterior lamellar keratoplasty or DLEK 
and PK and lower than the contrast sensitivity of healthy eyes.12,29,30
Improvement of BSCVA correlated with an increase in contrast sensitivity after FS 
DSEK and PK. The lamellar interface prepared with the FS laser showed no significant 
decrease in contrast sensitivity when compared with the PK group. Furthermore, the 
largest improvement in contrast sensitivity was seen in the first 3 months after surgery, 
which was comparable with our other outcomes (straylight, UCVA, and BSCVA). When 
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evaluating the binocular contrast sensitivity, there was a significant improvement in the 
PK group, but not in the FS DSEK group. This may be explained by the difference of the 
contrast sensitivity between the study eye and fellow eye within the 2 study groups. 
The difference between the study eye and the fellow eye in the PK group was larger 
as compared with that of the FS DSEK group. It can be speculated that a fellow eye in 
the PK group with a higher contrast sensitivity will provide a better binocular contrast 
sensitivity.
The BSCVA in our study was significantly better in the PK group compared with the 
FS DSEK group. This is in comparison with earlier studies and may be explained by a 
possible interface haze or irregularities of the interface.1,31 However, a randomized study 
showed a comparable BSCVA in DLEK and PK eyes during the 1-year follow-up.12 Recent 
DSAEK studies have reported a mean BSCVA of 20/34 to 20/44 at 6 to 12 months after 
surgery, respectively,6,31,32 which is higher than our results for the FS DSEK group. This 
may be explained by an increased opacification at the interface as a result of keratocyte 
activation by the FS laser or of a suboptimal smoothness of the stromal bed as compared 
with a microkeratome-prepared bed.33,34 Further, as previously mentioned, there were 
6 patients in the FS DSEK group with residual central haze after deturgescence of the 
recipient cornea, and this may influence the final BSCVA.
Before surgery, blurry vision was the most frequently reported symptom in both the 
FS DSEK and PK groups, which is comparable with the results of the study by Boisjoly 
and associates.26 Twelve months after surgery, the percentage of patients with blurry 
vision decreased from 91.7% to 74.1% in the FS DSEK group and from 100% to 56.8% 
in the PK group. The preoperative visual symptom scores of our FS DSEK and PK groups 
were slightly higher when compared with those of a previous study.26 This may be ex-
plained by the difference of the different diagnosis of the graft candidates between the 
2 studies.
Although astigmatism was significantly higher in the PK group, the percentage of 
patients with symptoms of double vision or distorted vision was comparable between 
the FS DSEK and PK groups. Patients were instructed to answer the questions on visual 
symptoms when using their spectacle or contact lens correction, which could have in-
fluenced their response.
In the PK group, there were 7 patients who were unable to wear a correction because 
of anisometropia, in contrast to no patients in the FS DSEK group. The anisometropia can 
be explained by the higher amount of astigmatism in the PK group. This illustrates a clear 
advantage of FS DSEK in comparison with PK, which is a lower and stable astigmatism, as 
has been described previously.11
In conclusion, this randomized study showed that FS DSEK resulted in an equally good 
improvement of straylight and contrast sensitivity when compared with PK. In addition, 
corneal astigmatism did not increase after FS DSEK. However, although the UCVA in 
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both groups was comparable and the visual symptom score decreased in both groups, 
BSCVA was slightly better in the PK group. Our results indicate that the quality of vision 
measured by contrast sensitivity, straylight, and changes in visual acuity after FS DSEK is 
comparable with that achieved after PK.
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aBstraCt
Purpose: To evaluate cost-effectiveness of penetrating keratoplasty (PK), femtosecond 
Descemet stripping endothelial keratoplasty (FS-DSEK) and Descemet stripping auto-
mated endothelial keratoplasty (DSAEK).
Design: Cost-effectiveness analysis based on data from a randomized multicenter clini-
cal trial and a noncomparative prospective study.
methods: Data of 118 patients with corneal endothelial dysfunction were analyzed in 
the economic evaluation. Forty patients were included in the PK group, 36 in the FS-
DSEK group, and 42 in the DSAEK group. The primary incremental cost-effectiveness 
ratio (ICER) was the incremental costs per clinically improved patient, defined as a 
patient with a combined effectiveness of both a clinically improved BSCVA (defined as 
an improvement of at least 2 lines) and a clinically acceptable refractive astigmatism 
(defined as less than or equal to 3.0 diopters). Analysis was based on a 1-year follow-up 
period after transplantation.
results: The percentage of treated patients who met the combined effectiveness mea-
sures was 52% for DSAEK, 44% for PK and 43% for FS-DSEK. Mean total costs per patient 
were € 6674 (US$ 7942), € 12443 (US$ 14807) and € 7072 (US$ 8416) in the PK group, 
FS-DSEK group and DSAEK group, respectively. FS-DSEK was less effective and more 
costly compared to both DSAEK and PK. DSAEK was more costly but also more effective 
compared to PK, resulting in incremental costs of € 4975 (US$ 5920) per additional clini-
cally improved patient. 
Conclusions: The results of this study show that FS-DSEK was not cost-effective com-
pared to PK and DSAEK. DSAEK, on the other hand, was more costly but also more effec-
tive compared to PK. Including societal costs, a longer follow-up period and preparation 
of the lamellar transplant buttons in a national cornea bank could improve the cost-
effectiveness of DSAEK. 
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introDuCtion
For many years, penetrating keratoplasty (PK) has been the gold-standard technique for 
corneal transplantation resulting from endothelial disease or endothelial dysfunction. 
Several studies have shown that the technique is safe and effective.1,2 However, PK has 
several drawbacks, including slow visual recovery, suture-related events, graft failure, 
and wound healing problems.3
In recent years, interest has grown in endothelial keratoplasty (EK), in which only 
the diseased endothelium is transplanted and the healthy anterior stromal tissue is 
preserved. As compared to PK, EK shows faster visual recovery, less change in astig-
matism, better stability and predictability of the postoperative refraction, and fewer 
suture-related problems.4–6 However, several EK studies found an increased risk of graft 
dislocation and higher endothelial cell loss.4,7–10
In EK, different techniques have been developed for the preparation of the donor 
cornea, including Descemet stripping automated endothelial keratoplasty (DSAEK), 
where the donor cornea is prepared with a microkeratome,11,12 and femtosecond laser-
assisted  Descemet stripping endothelial keratoplasty (FS-DSEK), where the donor tissue 
is prepared with a femtosecond laser.13–15
The efficacy and visual outcomes of EK techniques vs PK have been well studied.16–18 
However, the efficiency of the techniques is less elucidated. In an economic evaluation, 
outcomes and costs of interventions are compared19 with the aim to improve resource 
allocation decisions by policymakers and insurers. One type of economic evaluation is 
the cost-effectiveness analysis, in which the costs of an intervention are related to a 
single outcome measure, for example “clinical success.”
In this study, we performed an evaluation of the cost-effectiveness of FS-DSEK, DSAEK, 
and PK, for which data from a randomized multicenter clinical trial and a noncompara-
tive prospective study were used.
Patients anD methoDs
study population
In this study, costs and effects of PK and 2 different techniques of EK (ie, FS-DSEK and 
DSAEK) were compared. Empirical data were obtained from 2 sources. First, PK and 
FS-DSEK were compared in a randomized clinical trial, the Dutch Lamellar Corneal 
Transplantation Study (DLCTS), which was performed between April 2005 and April 
2007. Patients were included in 5 ophthalmic centers in The Netherlands. The study was 
approved by the institutional review boards of all participating centers. Before inclusion, 
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informed consent was obtained from all patients. More details about the safety, efficacy 
and quality of vision of PK vs FS-DSEK are described elsewhere.16,20
Second, a third group of patients who received a DSAEK transplantation in Maastricht 
University Medical Center between April 17, 2008 and March 11, 2010 was included in 
the study. Inclusion in the economic evaluation was based on the completion of quality-
of-life questionnaires on at least 2 out of 3 measurements.
For all 3 groups, inclusion criteria were patients with Fuchs endothelial dystrophy, 
aphakic or pseudophakic bullous keratopathy (ABK/PBK), posterior polymorphous 
dystrophy, or iridocorneal endothelial syndrome; a minimum patient age of 18 years; 
and best spectacle-corrected visual acuity (BSCVA) lower than 20/50. Patients with 
mental retardation, previous PK, and human leukocyte antigen–typed keratoplasty 
were excluded.
All patients underwent a comprehensive ophthalmic examination and completed 
quality-of-life questionnaires. Data were obtained at study inclusion (T0) and 6 (T1) and 
12 (T2) months after the transplantation, which was 9 and 15 months after baseline 
measurement, respectively.
surgical procedures
In the FS-DSEK group, all donor posterior lamellar discs (PLDs) were prepared in 
Maastricht University Medical Center (MUMC) with a 30-kHz femtosecond laser (AMO-
Intralase Corp, Irvine, California, USA), as previously described.15 In the DSAEK group, 
the PLDs were created with the use of a microkeratome (Moria Inc, Doylestown, 
Pennsylvania, USA). In both groups, an 8.0-mm donor corneal disc was trephined from 
the corneoscleral button with a disposable Barron trephine. In the recipient, a 5.0-mm 
corneoscleral incision and 2 limbal paracenteses were made. The Descemet membrane 
was scored and a circle of 7.5 mm Descemet membrane and endothelium was stripped 
from the posterior stroma. Four transcorneal incisions were made in the midperipheral 
recipient cornea to drain fluid between the recipient cornea and PLD. After coating the 
endothelial surface with viscoelastic material, the PLD was gently folded into a taco con-
figuration and inserted. The corneoscleral incision was closed with 4 10-0 nylon sutures. 
An air bubble was injected to unfold the PLD and to press the PLD against the recipient 
cornea. 
In the PK group, the recipient cornea was trephined using a 7.75-mm or 8.0-mm 
Hessburg-Barron vacuum trephine (Barron Precision Instruments, Grand Blanc, Michigan, 
USA), whereas the donor cornea was trephined with an 8.0-mm or 8.25-mm disposable 
trephine (Medical Workshop, De Meern, The Netherlands). In all cases, a combined sutur-
ing technique of a running 11-0 nylon suture with 8 interrupted 10-0 nylon sutures was 
performed. Selective suture removal was based on topographic astigmatism pattern.
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In all treatment groups, patients with cataract either underwent primary cataract 
extraction with posterior chamber intraocular lens (IOL) implantation either before the 
corneal transplantation or combined with EK or PK in 1 surgical session. 
economic evaluation
The economic evaluation was performed from a health care perspective with a time 
horizon of 15 months, from study inclusion (about 3months before surgery) up to 12 
months after surgery. All relevant resources consumed within the health care sector 
were taken into account. 
Effectiveness was based on 3 outcome measures. Two clinical outcome measures 
were used, namely the BSCVA and the refractive astigmatism. Furthermore, the National 
Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) was used as an outcome 
measure, reflecting vision-specific health-related quality of life.
To evaluate cost-effectiveness, incremental cost-effectiveness ratios (ICERs) were cal-
culated by dividing the difference in costs by the difference in effectiveness between 2 
treatments. The primary ICER was the incremental costs per clinically improved patient, 
defined as a patient with a combined effectiveness of both a clinically improved BSCVA 
and a clinically acceptable refractive astigmatism. In the secondary analyses, other out-
come measures were used, namely costs per improved patient on the NEI VFQ-25 and 
costs per improved patient on all 3 outcome measures.
Best spectacle-corrected visual acuity
The BSCVA was determined using the Early Treatment of Diabetic Retinopathy Study 
(ETDRS) letter charts and was converted to logarithm of the minimal angle of resolution 
(logMAR) measurements.21 Vision levels of counting fingers, hand movements, light 
perception, and no light perception were substituted by logMAR values of 1.7, 2.0, 2.5, 
and 3.0, respectively. A patient with an improvement of at least 2 lines on the ETDRS 
letter chart between T0 and T2 was considered to be clinically improved.22,23
Refractive astigmatism
Refractive astigmatism was used as an outcome measure because a lower level of 
postoperative astigmatism is a major advantage of EK techniques compared to PK and 
refractive astigmatism is considered to be more important for the patient compared 
to topographic astigmatism.24 In this study, a postoperative refractive astigmatism less 
than or equal to 3.0 diopters (D) at T2 was considered to be clinically acceptable.16
National eye institute visual functioning questionnaire
The NEI VFQ-25 is a vision-specific health-related quality-of-life questionnaire that mea-
sures domains related to daily visual functioning that are most important for patients 
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with vision deficits. The NEI VFQ-25 consists of 25 questions that can be expanded with 
13 additional items. All questions comprise 12 subscales. Eleven of them can eventually 
be converted into 1 single score. The remaining subscale (general health) is included in 
the questionnaire to provide robust information about an individual’s general health 
status. After recoding, the scores of the subscales and the single composite score 
range from 0 (worst possible value) to 100 (best possible value). As several studies have 
suggested that a 10-point change in the composite score is clinically important,25–27 a 
patient with a minimum gain of 10 points in the composite score at T2 as compared to 
T0 was considered to be clinically improved in this study. 
Cost analysis
All relevant health care costs of the 3 interventions were assessed according to the 
Dutch guidelines for cost calculations.28 Costs outside the health care sector, such as 
productivity losses, were excluded from analyses. Costs were calculated by multiplying 
the volumes of resource use by the cost price per resource unit. All costs were converted 
to 2010 Euros. Costs occurring after 12 months were discounted at an annual rate of 4%. 
All costs are  reported in Euros (€) and United States dollars (US$) (€1 = US$1.19).29
Resources included preparation, preservation, allocation, and transportation of the 
donor corneas, which were provided by the Bio Implant Services (BISLIFE) Foundation 
(Leiden, The Netherlands); outpatient visits; diagnostic procedures; preparation of the 
donor PLD; surgical procedures; hospitalization; and postoperative drugs use. Data of 
outpatient visits, surgical and diagnostic procedures, and hospitalization were obtained 
from the registries of the participating hospitals.
Services of the BISLIFE Foundation were valued using Dutch reimbursement rates, 
as no unit prices were available. Costs of outpatient visits, surgical procedures, hospi-
talization hospitalization, and diagnostic procedures were valued using standardized 
integral unit prices (consisting of personnel, material, capacity, and overhead costs) as 
calculated by MUMC, in which 71% of the patients were included. Integral cost prices 
of surgical procedures depended on the operation time per patient and were based on 
2 cost drivers, namely general operating room costs and specific ophthalmology costs. 
Costs of preparation of the donor PLD were based on the costs of the femtosecond laser 
and microkeratome, costs of disposables, and personnel costs. Costs of postoperative 
drugs were obtained from the Dutch Pharmacotherapeutic Compass.30
statistical analysis
Outcomes were analyzed according to the intention-to-treat principle. Incomplete data 
from the NEI VFQ-25, incomplete cost data, and missing data concerning the BSCVA 
and refractive astigmatism were imputed, using SPSS Multiple Imputation (version 17.0 
for Windows, SPSS Inc, Chicago, Illinois, USA), under the assumption that the data were 
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missing at random. A linear regression model was used with a total run length of 100 
iterations. Covariates included in the imputation model were visual outcome measures, 
which were obtained at T0, T1, and T2. Furthermore, age, sex, study group, and results 
on additional questions to measure patient satisfaction after a corneal transplantation 
were included in the model. In total, 5 imputed data sets were obtained. Data analyses 
were performed with each of these sets and the results were pooled.
For continuous data, the differences between groups were analyzed using 1-way 
ANOVA or a linear regression model with 2 dummy variables representing the groups 
with PK as the reference. The Pearson chi-square test was used to compare categorical 
data. To analyze the change between the postoperative measurements and the preop-
erative measurement, a paired sample t test was used. A P value of less than .05 was 
considered to be statistically significant.
As cost data regularly are highly skewed, traditional parametric and nonparametric 
statistical methods are not appropriate to analyze the difference in mean costs between 
groups.31 Therefore, we performed nonparametric bootstrapping with 1000 replications 
to estimate the uncertainty in the incremental costs and effects, using Microsoft Excel 
for Windows (Microsoft Corp, Redmond, Washington, USA).
To investigate cost-effectiveness, ICERs were calculated. For this purpose, the treat-
ments were ranked from the most effective to the least effective. A treatment that was 
less effective and more costly than at least 1 alternative was said to be dominated and 
ruled out from the calculation of ICERs. Then, each treatment was compared to the next 
most effective treatment by calculating the ICER. Each treatment with a higher ICER 
than that of a more effective intervention was ruled out based on so-called extended 
dominance.32,33
In order to show the probability of each treatment being the optimal choice for a 
range of ceiling ratios representing the maximum amount of money that the decision 
maker is willing to pay for an additional health effect, cost-effectiveness acceptability 
curves (CEACs) were created.34 Based on these curves, the cost-effectiveness frontier can 
be determined, which indicates which strategy is to be preferred for a range of ceiling 
ratios.35
sensitivity analyses
Sensitivity analyses were performed to test the robustness of the results. First, the cut-
off point for a patient with an improved BSCVA was at least 2 lines on the ETDRS letter 
chart between T0 and T2. In the sensitivity analyses, we tested the impact on the primary 
analysis of changing this to at least 1 line and at least 3 lines.
Second, postoperative refractive astigmatism less than or equal to 3.0 D at T2 was 
considered to be clinically acceptable. In the sensitivity analyses, we tested the impact 
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on the primary analysis of changing this to less than or equal to 2.0 D and less than or 
equal to 4.0 D.
Third, it has been stated that a 5-point change in the composite score of the NEI VFQ-
25 is clinically relevant.25,27 Therefore, we considered a patient with a gain of 5 points in 
the composite score at 12 months postoperatively to be clinically improved.
Fourth, we replaced the cost prices as determined in the MUMC by standardized Dutch 
unit prices—if available—determined by Oostenbrink and associates.28
Finally, the cost price of the femtosecond laser was based on the actual use at the time 
of the study. Currently, however, the laser is also used for the implantation of intracor-
neal ring segments in about 30 keratoconus patients per year and in the future will be 
used for about 300 LASIK procedures per year.
subgroup analysis
In all treatment groups, a number of patients with cataract underwent primary cataract 
extraction with posterior chamber IOL implantation combined with EK or PK in 1 surgical 
session. As this resulted in an increased operation time for these patients, this could bias 
the costs per patient. In addition, these patients may have a lower preoperative BSCVA 
compared to patients who do not have cataract. Therefore, we performed a subgroup 
analysis on the  patients who had only EK or PK surgery without cataract surgery.
results
study population 
Data of 118 patients were analyzed in the economic evaluation. Forty patients were 
included in the PK group, 36 in the FS-DSEK group, and 42 in the DSAEK group. 
In Table 1, baseline patient characteristics of the 3 treatment groups are shown. The 
mean age was 71.4 ± 11.3, 68.9 ± 8.8, and 70.8 ± 11 years in the PK group, FS-DSEK group, 
and DSAEK group, respectively (P = .59). In all groups, the main reason for keratoplasty 
was Fuchs endothelial dystrophy and pseudophakic bullous keratopathy. In the DSAEK 
group, more patients were pseudophakic (27/42; 64.3%) as compared to the PK patients 
(18/40; 45.0%) and FS-DSEK patients (17/36; 47.2%), but this was not significantly differ-
ent (P = .08).
At 12 months follow-up, only 1 eye in the PK group had all sutures out, whereas the 
remaining 39 eyes still had most or all of their sutures in.
effectiveness
In Table 2, preoperative and postoperative BSCVA and refractive astigmatism are dis-
played. Preoperatively, mean logMAR BSCVA was 0.72, 0.82, and 0.76 in the PK group, 
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taBle 1.  Baseline Characteristics of study Population (n = 118)
Pk Fs-Dsek Dsaek P value
eyes (n) 40 36 42 NA
age in years (mean ± sD) 71.4 ± 11.3 68.9 ± 8.8 70.8 ± 11 0.59b
Women, n (%) 27 (67.5%) 21 (58.3%) 27 (64.3%) 0.70c
Diagnosis, n (%) 0.66c
Fuchs endothelial dystrophy
Pseudophakic bullous keratopathy
Posterior polymorphous dystrophy
Iridocorneal endothelial syndrome
20 (50%)
19 (47.5%)
1 (2.5%)
0 (0%)
21 (58.3%)
15 (41.7%)
0 (0%)
0 (0%)
22 (52.4%)
19 (45.2%)
0 (0%)
1 (2.4%)
recipient lens status ,n (%) 0.08c
Aphakic
Phakic
Pseudophakic 
1 (2.5%)a
21 (52.5%)
18 (45%)
0 (0%)
19 (52.8%)
17 (47.2%)
3 (7.1%)a
12 (28.6%)
27 (64.3%)
DSAEK = Descemet stripping automated endothelial keratoplasty; FS-DSEK = femtosecond laser–assisted Descemet strip-
ping endothelial keratoplasty; NA = not applicable; PK = penetrating keratoplasty; SD = standard deviation.
aAphakic eyes with iris-fixated anterior chamber intraocular lens.
b1-way ANOVA.
c chi-square test.
taBle.2 Preoperative and Postoperative Best spectacle-Corrected visual acuity and refractive 
astigmatism (Pooled Data) for the 3 treatment groups
Pk Fs-Dsek Dsaek
BsCva (logmar), mean ± sD 
preoperative 0.72 ± 0.38 0.82 ± 0.42 0.76 ± 0.45
6 months 0.35 ± 0.25a 0.62 ± 0.30a, b 0.34 ± 0.26a
12 months 0.36 ± 0.25a 0.50 ± 0.18a, b 0.31 ± 0.19a
BsCva gain (logmar), mean ± sD
6 months 0.37 ± 0.38 0.20 ± 0.48 0.42 ± 0.39
12 months 0.36 ± 0.38 0.31 ± 0.42 0.45 ± 0.39
refractive astigmatism (D), mean 
± sD
Preoperative -1.27 ± 1.2 -0.99 ± 1.02 -1.27 ± 1.23
6 months -3.17 ± 1.9a -1.53 ± 1.44a, b -1.92 ± 1.1a, c
12 months -2.95 ± 1.96a -1.47 ± 1.32a, b -2.01 ± 2.01a, c
BsCva gain 12 months, n (%) 7 (17.5) 7 (19.4) 4 (9.5)
< 0.0 logMAR 9 (22.5) 11 (30.6) 10 (23.8)
0.0 – 0.2 logMAR 10 (25) 7 (19.4) 10 (23.8)
0.2 – 0.4 logMAR 4 (10) 3 (8.3) 6 (14.3)
0.4 – 0.6 logMAR 3 (7..05) 2 (5.6) 3 (7.1)
0.6 – 0.8 logMAR 7 (17.5) 6 (16.7) 9 (21.4)
> 0.8 logMAR
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FS-DSEK group, and DSAEK group, respectively (P = not significant [NS]). At 6 and 12 
months postoperatively, mean BSCVA was significantly better in the PK and DSAEK 
groups as compared to the FS-DSEK group. However, mean BSCVA gain was not signifi-
cantly different. Preoperatively, mean refractive astigmatism was -1.27 ± 0.19 D,  -0.99 ± 
0.17 D, and  -1.27 ± 0.19 D in the PK, FS-DSEK, and DSAEK groups, respectively (P = NS). 
At 6 and 12 months postoperatively, mean refractive astigmatism was significantly lower 
in the FS-DSEK group and DSAEK group as compared to the PK group.
Table 3 shows the preoperative and postoperative mean composite score on the 
NEI-VFQ 25. Preoperatively, mean scores were 60.9, 58.2, and 56.1 in the PK, FS-DSEK, 
and DSAEK groups, respectively (P = NS). At 6 and 12 months postoperatively, mean 
scores were found to be significantly higher in all groups as compared to the scores 
preoperatively. However, the change scores showed no significant differences between 
the groups.
At 12 months postoperatively, pooled data showed that 44% of the patients in the 
PK group were clinically improved (defined as both a clinically improved BSCVA and a 
clinically acceptable refractive astigmatism), 43% in the FS-DSEK group and 52% in the 
DSAEK group.
taBle.2 Preoperative and Postoperative Best spectacle-Corrected visual acuity and refractive 
astigmatism (Pooled Data) for the 3 treatment groups (continued)
Pk Fs-Dsek Dsaek
refractive astigmatism at 12 
months, Cumulative n (%)
< 1D 5 (12.5) 11 (30.6) 8 (19.0)
< 2D 17 (42.5) 27 (75.0) 24 (57.1)
< 3D 21 (52.5) 30 (83.3) 32 (76.2)
< 4D 32 (80.0) 36 (100.0) 39 (92.9)
BSCVA = best spectacle-corrected visual acuity; D = diopter; DSAEK = Descemet stripping automated  endothelial kera-
toplasty; FS-DSEK = femtosecond laser–assisted Descemet stripping endothelial keratoplasty; logMAR = logarithm of the 
minimal angle of resolution; PK = penetrating keratoplasty; SD = standard  deviation.
aP < .05 between preoperative measurement and postoperative measurement.
bP < .05 between FS-DSEK and PK.
cP < .05 between DSAEK and PK.
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Costs
Table 4 shows the mean resource use and mean costs per patient. Mean total costs per 
patient were €6674 (US$7942), €12 443 (US$14 807), and €7072 (US$8416) in the PK 
group, FS-DSEK group, and DSAEK group, respectively. Differences in costs were mainly 
caused by the costs of the preparation of the posterior lamellar disc.
taBle 3. Preoperative and Postoperative Composite scores on the national eye institute visual 
Functioning questionnaire (Pooled Data) for 3 treatment groups
Pk Fs-Dsek Dsaek
mean ± sD mean ± sD mean ± sD
Preoperative 60.9 ± 2.6 58.2 ± 3.0 56.1 ± 2.3
6 months 69.8 ± 2.7a 67.2 ± 3.4a 69.3 ± 1.7a
12 months 73.3 ± 2.4a 69.5 ± 2.8a 71.2 ± 2.2a
Change scores 
T1 – T0b 8.8 ± 2.2 9.0 ± 2.4 13.2 ± 2.5
Change scores 
T2 – T0b 12.4 ± 2.2 11.3 ± 2.1 15.2 ± 2.6
DSAEK = Descemet stripping automated endothelial keratoplasty; FS-DSEK = femtosecond laser–assisted Descemet strip-
ping endothelial keratoplasty; PK = penetrating keratoplasty; SE = standard error of the mean.
aP < .05 between preoperative measurement and postoperative measurement.
bT0 = preoperatively; T1 =  6 months postoperatively; T2  = 12 months postoperatively.
taBle 4. mean resource use and mean Costs per Patient (n = 118) for the 3 treatment groups
mean resource use mean Costs ± sD (€)
Costs Per 
unit (€)
Pk
(n = 40)
Fs-Dsek
(n = 36)
Dsaek
(n = 42)
Pk
(n = 40)
Fs-Dsek
(n = 36)
Dsaek
(n = 42)
Preoperative costs
    BISLIFE foundation services 3747/cornea 1 1 1 3747 3747 3747
    Out-patient visits 27/visit 0.7 0.6 1 19 18 28
    Diagnostic procedures Variable 0.7 1.4 0.5 13 26 8
Subtotal preoperative costs 3779 3790 3783
Surgical procedures
  Preparation PLD
    Costs femto-second laser 4821/lamel - 1 - - 4821 -
    Costs microkeratome 433/lamel - - 1 - - 433
    transplantation
    Operating room costs 9.68/minute 103 139 126 999 1343 1217
    Ophthalmology costs 6.30/minute 73 95 88 463 596 554
    Intraocular lens 138/lens 0.3 0.1 0.1 45 19 18
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Cost-effectiveness
Table 5 shows the results of the primary analysis. As FS-DSEK was less effective and more 
costly for costs per clinically improved patient, FS-DSEK was dominated by DSAEK and 
PK. For DSAEK vs PK, the ICER was €4975 (US$5920) per clinically improved patient. The 
probability of DSAEK being cost-effective ranged from 22% at a ceiling ratio of €2500 
(US$2975) to 68% at a ceiling ratio of €10 000 (US$11 900).
In the Figure, the CEACs for the primary analysis are displayed, showing a probability 
of 0% that FS-DSEK is cost-effective for the full range of ceiling ratios. The cost-effective-
ness acceptability frontier (not shown) showed that PK has the highest probability of 
being cost-effective until the ceiling ratio reached €5115 (US$6087) and DSAEK has the 
highest probability of being cost-effective for all values above €5115 (US$6087).
secondary analyses
In Table 5, the results of the secondary analyses are shown. In all secondary analyses, 
FS-DSEK was dominated by DSAEK and PK or extended dominated by DSAEK. In the 
secondary analyses with other outcome measures, the ICERs for DSAEK vs PK were €13 
267 (US$15 788) per improved patient on the NEI VFQ-25 and €3980 (US$4736) per 
improved patient on all 3 outcome measures.
taBle 4. mean resource use and mean Costs per Patient (n = 118) for the 3 treatment groups (con-
tinued)
mean resource use mean Costs ± sD (€)
Costs Per 
unit (€)
Pk
(n = 40)
Fs-Dsek
(n = 36)
Dsaek
(n = 42)
Pk
(n = 40)
Fs-Dsek
(n = 36)
Dsaek
(n = 42)
Additional procedures
    Operating room costs 9.68/minute 25 38 2 246 371 22
    Ophthalmology costs 6.30/minute 8 20 1 50 127 8
Subtotal surgical procedures 1802 7277 2252
Hospitalisation
    Day care 232/day 0.3 - - 70 - -
    Admission 252/day 2.4 3.7 3.1 557 865 732
Subtotal hospitalization 627 865 732
Follow-up visits
    Outpatient visits 27/visit 11 10.3 7.1 301 280 194
    Diagnostic procedures Variable 6.2 10.6 4.9 124 191 71
Subtotal follow-up visits 425 471 265
Postoperative drugs 10/bottle 4 4 4 40 40 40
total costs (€)
6674
 ± 82
12443
 ± 97
7072
 ± 30
BIS = Bio Implant Services; DSAEK = Descemet stripping automated endothelial keratoplasty; FS-DSEK = femtosecond 
laser–assisted Descemet stripping endothelial keratoplasty; PK = penetrating keratoplasty; PLD = posterior lamellar disk.
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In the sensitivity analyses, the ICERs for DSAEK vs PK varied from €2653 (US$3157) to 
€9950 (US$11 840) per improved patient, showing that the main cost-effectiveness data 
are robust.
In the subgroup analysis, we analyzed the subgroup of patients who had only a PK (n = 
27), FS-DSEK (n = 31), or DSAEK (n = 37) without cataract surgery. The ICER for DSAEK vs 
PK was €2300 (US$2737) per clinically improved patient.
DisCussion
This economic evaluation compared the cost-effectiveness of 2 different techniques of 
endothelial keratoplasty (FS-DSEK and DSAEK) and penetrating keratoplasty (PK). The 
results show that based on the point estimates FS-DSEK was dominated by DSAEK and 
PK or extended dominated by DSAEK for all outcome measures. DSAEK was found to 
be more costly, but also more effective on all outcome measures, as compared to PK. 
The base-case bootstrap analysis and secondary analyses showed that results were 
consistent in that FS-DSEK has a very low to zero probability of being a cost-effective 
technique compared to DSAEK and PK. At a lower range of threshold values for cost-
effectiveness PK has the highest probability of being cost-effective, whereas at a higher 
range of threshold values DSAEK has the highest probability of being cost-effective. In 
between a range of €2500 (US$2975) and €7500 (US$8925), the uncertainty around the 
Figure. Cost-effectiveness acceptability curves for the incremental costs per clinically improved patient for penetrating 
keratoplasty (PK), femtosecond laser–assisted Descemet stripping endothelial keratoplasty (FS-DSEK), and Descemet strip-
ping automated endothelial keratoplasty (DSAEK). The curve shows the probability (vertical axis) of which technique is 
cost-effective over a range of values for the maximum acceptable ceiling ratio (horizontal axis).
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ICERs is quite large, as within this range of threshold values probabilities vary between 
40% and 60%.
Economic evaluations aim to facilitate decisions on allocation of resources by  policy-
makers and insurers. The data on clinical outcomes used in economic evaluations can be 
drawn from clinical trials, but it is not uncommon that the complete dataset may have 
to be drawn from a wider set of study designs.36 One type of economic evaluation is the 
cost-utility analysis, in which costs of 2 or more alternatives are expressed in monetary 
terms and the effectiveness is expressed in a measure that comprises both quality and 
length of life.37 For this purpose, quality-adjusted life years (QALYs) are calculated. As a 
QALY is a generic outcome measure, it facilitates comparisons of different interventions 
in health care. Threshold values for cost-effectiveness can be used to make decisions 
on the allocation of resources. In The Netherlands, threshold values range from €20 000 
(US$23 800) per QALY to €80 000 (US$95 200) per QALY.38
Beauchemin and associates evaluated the cost-utility of EK compared to PK in a hypo-
thetical cohort of 100 patients waiting for a corneal graft.39 They constructed a Markov 
model to analyze the cost-utility from a health system perspective over a lifetime period. 
EK was more effective and less costly compared to PK. The differences between the 2 
treatments were mainly caused by a lower incidence of irreversible graft failure and 
postoperative complications in EK patients.
In a cost-effectiveness study, costs of 2 or more alternatives are expressed in monetary 
terms and effects are expressed in natural health units, depending on the interventions 
being evaluated.40 In this study, we choose to measure the effectiveness in 3 ways, namely 
clinically improved BSCVA (defined as an improvement of at least 2 lines), clinically ac-
ceptable refractive astigmatism (defined as less than or equal to 3.0 D), and improved 
vision-related quality of life (a minimum gain of 10 points in the composite score of the 
NEI VFQ-25). We acknowledge that there will be patients who have a clinically improved 
BSCVA and a clinically acceptable refractive astigmatism, but who are not improved in 
terms of quality of life. However, several studies16,22,23 used these outcome measures and 
we believe that not only the subjective quality of life but also the more objective BSCVA 
and refractive astigmatism are important outcome measures in patients who undergo 
corneal transplantation.
Contrary to cost-utility analysis with QALYs as an outcome measure, the interpreta-
tion of the cost-effectiveness with these outcome measures is difficult, as it is not 
known what a hospital, health insurance company, or government is willing to pay for 
an improved patient. Furthermore, as no other studies are performed that evaluated 
cost-effectiveness using these outcome measures, it is hard to relate our results to other 
studies.
The ICER for DSAEK vs PK was €4975 (US$5920) per clinically improved patient. 
Although comparison with a threshold value of €20 000 (US$23 800) per QALY is dif-
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ficult, this ICER is far below this threshold and seems to be an acceptable price to pay for 
an additional improved patient.
In EK patients, a large part of the mean costs per patient is associated with the prepa-
ration of the PLDs, which is performed with a femtosecond laser in the FS-DSEK group 
and a microkeratome in the DSAEK group. In the sensitivity analyses, it was shown that 
the cost of the laser can be lowered to €8192 (US$9748) when including additional pro-
cedures. In the future, the transplants can be produced under standardized conditions 
in a national cornea bank and the present infrastructure can be used to distribute the 
lamellar transplant buttons to transplanting surgeons all over The Netherlands. This can 
significantly lower the mean costs per patient for the preparation of the lamellar disks in 
FS-DSEK and DSAEK patients.
Some limitations of this study need to be addressed. First, the patients in the DSAEK 
group were included based on the completion of quality-of-life questionnaires. In 
Maastricht University Medical Center it is the standard of care to distribute quality-of-
life questionnaires preoperatively and postoperatively to patients who receive a corneal 
transplantation. However, some patients forget to send back the completed question-
naires. Therefore, only 42 of the potential 73 DSAEK patients (58%) could be included in 
the study. Since the  inclusion criteria are equal for all groups in the study and baseline 
characteristics are comparable, we believe no selection bias is present.
Second, we included only costs within the health care sector. The costs associated with 
the correction of astigmatism (for example, spectacles or contact lenses with cylinder 
correction) were not included. As the mean refractive astigmatism is significantly lower 
in the FS-DSEK group and DSAEK group as compared to the PK group, it can be assumed 
that the mean costs per patient for the correction of astigmatism will be lower in the EK 
groups. Furthermore, the costs of productivity losses were not assessed. As EK shows 
more rapid freedom from work-related activity restriction and faster recovery of useful 
vision as compared to PK, these costs may be lower in the EK groups.
Third, the follow-up period of the study was only 12 months. Therefore, this study only 
provides an indication of the short-term cost-effectiveness of EK vs PK. Although costs 
within 1 year after surgery were higher in EK patients, it could be argued that long-term 
costs are lower and long-term effects are higher as compared to PK, because of the ef-
fects of suture removal in the PK group and a reduced risk of complications in the EK 
groups (eg, wound dehiscence and infectious keratitis), with fewer hospital visits and 
emergency surgical procedures to be expected.7,41,42 This will have a positive effect on 
the long-term cost-effectiveness of EK. However, a longer follow-up period is needed to 
evaluate this effect further. 
The results of this study show that FS-DSEK was not cost-effective compared to PK and 
DSAEK. DSAEK, on the other hand, was more costly and also more effective, resulting in 
an ICER of €4975 (US$5920) per clinically improved patient. It depends on the threshold 
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value for cost-effectiveness whether DSAEK or PK is the preferred technique. Within a 
broad range of threshold values both DSAEK and PK might be cost-effective. However, 
preparing lamellar transplant buttons in a national cornea bank can significantly lower 
the costs per patient in the DSAEK group, which could improve the cost-effectiveness of 
DSAEK and could lower the uncertainty around the ICERs. Studies with a longer follow-
up period are necessary to evaluate the long-term cost-effectiveness.
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aBstraCt
Purpose: To evaluate best-corrected visual acuity (BCVA), refractive outcome, corneal 
topography, optical coherence tomography, and endothelial cell density 12 months 
after femtosecond laser–assisted inverted mushroom keratoplasty. 
methods: We performed a prospective study of a surgical case series of 5 patients under-
going femtosecond laser–assisted inverted mushroom keratoplasty for pseudophakic 
bullous keratopathy or pre-Descemet X-linked ichthyosis. The femtosecond laser was 
used to create a top-hat configuration in the donor cornea and recipient cornea. Laser 
parameters were as follows: energy, 4.0 (anterior inner vertical side cut and horizontal 
lamellar cut) and 7.0 µJ (posterior outer vertical side cut); spiral pattern with a firing rate 
of 15 kHz. The size of the anterior inner diameter was 7.4 mm in the donor cornea and 7.0 
mm in the recipient cornea. The posterior outer diameter was 9.0 mm in all eyes.
results: At 6 and 12 months after surgery, all corneal grafts were clear and showed 
an excellent adaptation of the lamellar donor and recipient wound surfaces. At 12 
months post-operatively, BCVA averaged 20/32 (range, 20/60–20/20), refractive cylinder 
averaged -3.20 ± 2.0 D, topographical cylinder averaged 3.26 ± 2.1 D, and the mean 
endothelial cell density was 1793 ± 491 cells/mm2 (range, 954–2237 cells/mm2). The 
mean central corneal thickness and thickness of the posterior shelf was 517 ± 3 and 175 
± 8 μm, respectively.
Conclusions: The femtosecond laser–assisted inverted mushroom keratoplasty shows 
good promise in surgical treatment of corneal diseases. The multiplanar fit between the 
donor and recipient cornea allows early suture removal and visual rehabilitation.
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introDuCtion
Full-thickness penetrating keratoplasty has been the preferred corneal transplantation 
technique since the first description of successful corneal transplantation in 1905 by 
Zirm.1 In penetrating keratoplasty, the recipient cornea is trephined in the vertical direc-
tion, and the donor cornea is sutured into the wound bed by using a variety of suture 
techniques. Although penetrating keratoplasty nowadays generally results in clear 
corneal grafts with a graft survival up to 72% at 5 years,2,3 the procedure is frequently 
complicated by refractive imperfections and wound healing problems.4,5 Postoperative 
high irregular astigmatism and ametropia may result in many patients that cannot be 
optically rehabilitated with glasses. Treatment modalities for postkeratoplasty astigma-
tism and ametropia are rigid gas-permeable contact lens wear, corneal laser refractive 
surgery, and implantation of toric intraocular lenses.6–8 Wound healing after penetrating 
keratoplasty is often unstable and may lead to infection, vascularization, and wound 
dehiscence with risks for long-term graft survival.9,10
Recently, Busin11 has made popular the use of a so-called inverted mushroom lamellar 
dissection technique for creating a top-hat configuration of the donor. This technique 
may result in faster healing of the lamellar wound surfaces that facilitates earlier suture 
removal and a faster visual rehabilitation of the corneal graft patient.
We describe a new method of preparing a top-hat graft and cutting the recipient 
bed in a standardized and automated fashion by using a femtosecond laser, thereby 
introducing femtosecond laser technology in penetrating keratoplasty surgery. 
materials anD methoDs
Three patients with pseudophakic bullous keratopathy and 2 patients with pre-Des-
cemet X-linked ichthyosis underwent femtosecond laser–assisted inverted mushroom 
keratoplasty. Investigational review board approval for this study was obtained from the 
University Hospital Maastricht, and informed consent was obtained from the patients. 
All procedures were performed in the University Hospital Maastricht by the same sur-
geon (R.N.), and the patients were prospectively followed.
Preoperatively, the medical history of each patient was recorded, and a complete 
eye examination was performed including visual acuity testing, slit-lamp examination, 
and ophthalmoscopy. Postoperatively, patients were seen at 1 week and 1, 3, 6, and 12 
months. From 1 month after surgery, best-corrected visual acuity (BCVA) was measured, 
and the refractive outcome and corneal topography parameters (Eyemap EH-290; Alcon, 
Fort Worth, TX) were determined. Specular microscopy (Konan Noncon Robo, SP 8000; 
Konan, Hyogo, Japan) for measurement of endothelial cell density was performed at 
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6 and 12 months after surgery. Suture removal was performed at the discretion of 
the surgeon to decrease induced corneal astigmatism. The preoperative central and 
midperipheral corneal thickness of the recipient eyes were measured by ultrasonic 
pachymetry (Quantel Medical). The estimated thickness of the posterior shelf and the 
measured thickness of the central and midperipheral corneal graft were determined by 
optical coherence tomography (Visante OCT; Carl Zeiss, Oberkochen, Germany) at 1 year 
postoperatively. 
General anesthesia was used in 4 patients, and in 1 patient, local anesthesia was 
administered with a retrobulbar injection of a mixture of 2% lidocaine and 0.5% bupi-
vacainehydrochloride. We used organ-cultured donor corneas that were obtained from 
the Cornea Bank Amsterdam. 
A femtosecond laser (AMO-IntraLase Corp., Irvine, CA) was installed in the operating 
theatre and equipped with a software package for producing custom-made corneal 
incisions in the donor and recipient corneas. A so-called top-hat configuration in the 
recipient cornea and in the donor cornea was created in all 5 patients (Fig. 1). The top-
hat configuration consists of an anterior inner vertical side cut, a horizontal lamellar cut, 
and a posterior outer vertical side cut. The vertical cuts have an overlap of 0.1 mm and an 
angulation of 90º with the corneal surface to assure that complete cutting at the inter-
secting wound edges is performed. The dimensions of the cut are shown in Figure 2. For 
the donor cornea, in all cases the diameter of the anterior inner vertical side cut was 7.4 
mm, and the diameter of the posterior outer vertical side cut was 9.0 mm. Preoperative 
corneal thickness was used for establishing the cutting dimensions of the femtosecond 
laser. The goal for the thickness of the posterior shelf (distance between endothelium 
and horizontal lamellar interface) was 200 µm. The energy level of the femtosecond laser 
for preparation of the anterior inner vertical side cut and the horizontal lamellar cut 
was 4.0 µJ and for the posterior outer vertical side cut was 7.0 µJ, respectively. We used 
a spiral spot pattern with a firing rate of 15 kHz. The laser starts cutting in the anterior 
chamber at a depth of  ~900 µm from the epithelial side and first makes the posterior 
outer vertical side cut at 9.0 mm diameter for an estimated thickness of 200 µm for the 
posterior shelf. The horizontal lamellar side cut is created from 9.0 to 7.0 mm inward. 
Figure 1. Schematic overview of the top-hat configuration in the donor cornea and recipient cornea. The diameter of the 
anterior inner vertical side cut of the donor cornea was 7.4 (A) and 7.0 mm in the recipient (B). The posterior outer diameter 
was 9.0 mm in all corneas.
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Finally, the anterior vertical side cut is created until the gas bubbles escape from the 
epithelial side of the cornea. The duration for the laser procedure was ~2.5 minutes.
The donor button was mounted on an artificial anterior chamber (Moria, Anthony, 
France) and perfused with a solution of balanced salt solution (BSS Plus; Alcon) after a 
viscoelastic substance (Healon; AMO, Uppsala, Sweden) was placed on the endothelium. 
The eye was pressurized, and the intraocular pressure was checked with a Barraquer 
tonometer (Bausch and Lomb, Munich, Germany). Pachymetry measuring central and 
midperipheral corneal thickness was performed to calculate the depth of the horizontal 
lamellar plane. The center of the cornea was marked with a 7.0-mm trephine to guard a 
symmetric applanation by the applanation cone of the laser. No suction ring was needed 
in the donor eyes. After the laser procedure, the corneal graft was lifted from the host 
cornea, and isolated tissue bridges were excised.
In the recipient cornea, a suction ring was applied, and an applanation lens was used; 
then, the laser procedure was performed. After the injection of a viscoelastic substance 
into the anterior chamber, the cornea was dissected, and adhesions were gently 
removed. The corneal graft was sutured by using eight 10-0 nylon interrupted sutures 
in combination with an 11-0 nylon 24-bite continuous suture. Selective suture removal 
was used starting at 3 months postoperatively. The postoperative regimen consisted of 
dexamethasone 0.1% drops 6 times daily in a tapering dose for the first 6 months and 
thereafter 1 time daily for the first postoperative year. Chloramphenicol 0.4% drops were 
used 3 times daily for 3 months and then discontinued.
Figure 2. The setting of the femtosecond laser to create a top-hat configuration in the recipient cornea.
The vertical cuts have an overlap of 0.1 mm with the horizontal lamellar cut to assure a complete cutting.
CHAPTER 9
162
results
The results are presented as mean ± SD. In Table 1, the demographic and preoperative 
data of the patients are shown. The age varied from 42 to 75 years. Preoperative BCVA 
ranged from hand motions to 20/30. Preoperatively, the mean endothelium cell density 
of the donor corneas was 2680 ± 45 cells/mm2 (range, 2600–2700 cells/mm2). No opera-
tive complications were noted. 
Three of the 5 patients (cases 2, 3, and 5) complained of photophobia during the first 
postoperative month. All 3 cases showed an increased level of stromal edema centrally 
and at the peripheral interface that gradually resolved (Fig. 3). 
At 6 months postoperatively, the mean BCVA was 20/50 (range, 20/40–20/60). In 3 
eyes, the postoperative BCVA was limited by age-related macular degeneration (case 3), 
cellophane maculopathy (case 4), and amblyopia (case 5). The mean refractive cylinder 
was -4.75 ± 2.4 D (range, -2.0 to -8.0 D). The mean topographic cylinder was 5.3 ± 3.5 D 
(range, 2.1–10.3 D). The mean endothelial cell density at 6 months postoperatively was 
1917 ± 155 cells/mm2 (range, 1751–2117 cells/mm2). The central corneal thickness was 
513 ± 46 µm (range, 474–575 µm).
The 12-month postoperative data are shown in Table 2. All corneal grafts were clear 
and showed an excellent adaptation of the lamellar donor and recipient wound surfaces 
(Figs. 4 and 5). At 12 months, the mean BCVA was 20/32 (range, 20/60–20/20). The mean 
refractive cylinder was -3.20 ± 2.0 D (range, -0.75 to -5.5 D). The mean topographic cylin-
der was 3.26 ± 2.1 D (range, 0.6–5.6 D). The mean endothelial cell density at 12 months 
post-operatively was 1793 ± 491 cells/mm2 (range, 954–2237 cells/mm2). In case 5, the 
endothelial cell density decreased from 2117 cells/mm2 at 6 months to 954 cells/mm2 
at 12 months post-operatively. The central corneal thickness was 517 ± 3 µm (range, 
468–561µm; Table 3). The mean thickness of the posterior shelf was 175 ± 8 µm (range, 
168–185 µm; Fig. 6).
taBle 1. Demographic Preoperative Data
No., Age (y),
Sex, OD(S)
Indication for Surgery Concomitant 
Disease
BCVA Refraction Topographic 
Astigmatism (D)
1, 47, male, OS Pre-descemet dystrophy 
X-linked ichtychosis
- 20/30 +1.25 -1.0 @73 0.6
2, 42, male, OS Pre-descemet dystrophy 
X-linked ichtychosis
- 20/60 +4.50 -1.50 @ 85 1.0
3, 75, male, OD PBK ARMD HM Plano NA
4, 72, female, OD PBK Cellophane 
maculopathy
20/60 +1.0 1.6
5, 75, female, OS PBK Amblyopia 20/100 -2.25 NA
PBK, pseudophakic bullous keratopathy; ARMD, age-related macular degeneration; HM, hand movement; NA, not avail-
able.
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Figure 3. Case 2, left eye. Slit-lamp photograph after femtosecond laser–assisted inverted mushroom keratoplasty. At 1 
week postoperatively, an increased stromal edema centrally and at the peripheral interface was noted.
taBle 2. Postoperative Data at 12-month Follow-up
No. BCVA Refraction Topographic
Astigmatism (D)
Most Recent Postoperative
ECD (cells/mm2)
Sutures all out/ 
partly out
1 20/20* +1.25 -5.0 @ 175 5.1 2237 All, 19#
2 20/25 +5.0 -2.75 @ 25 2.1 1897 All, 21#
3 20/60 +4.0 -5.5 @ 82 5.6 1856 Partly out
4 20/30 +3.75 -2.0 @ 120 0.6 2015 Partly out
5 20/40 -1.75 -0.75 @ 65 2.9 954 Partly out
ECD, endothelial cell density. 
*Best contact lens–corrected visual acuity.
#Number of weeks after keratoplasty.
Figure 4. Case 5, left eye. Slit-lamp photographs after femtosecond laser–assisted inverted mushroom keratoplasty. A, 
Preoperatively, a pseudophakic bullous keratopathy was seen. B, One month postoperatively, the cornea is clear, and an 
excellent fit between the graft and recipient was noted.
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Figure 5. Case 4, right eye. Slitlamp photographs at 3 months postoperatively. The cornea is centrally clear (A–C), and the 
adhesion between the graft and the recipient at the peripheral lamellar interface is excellent (D and E). Note the higher 
reflectivity of the interface (arrow).
Figure 6. Case 1, left eye. Optical coherence tomography image after femtosecond laser–assisted inverted mushroom 
keratoplasty. This figure shows the top-hat configuration in the 180º–0º  meridian. The central corneal thickness is 520 µm, 
and the posterior shelf varies from 211 to 217 µm.
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DisCussion
In conventional penetrating keratoplasty, surgeons are still faced with problems related 
to insufficient healing such as unstable refraction and wound dehiscence after the su-
tures have been removed. Recently, new lamellar transplantation techniques such as 
deep lamellar endothelial keratoplasty and Descemet-stripping automated endothelial 
keratoplasty in corneal transplantation surgery may result in a better stabilization of 
the anterior surface of the cornea.12–16 The deep donor–recipient lamellar interface in 
deep lamellar endothelial keratoplasty and Descemet-stripping automated endothelial 
keratoplasty may reduce the potential visual acuity because of optical interference, and 
interface haze has been a major reason for the low acceptance of lamellar transplanta-
tion techniques among corneal surgeons.17 
To combine the advantages of a clear optical center of a penetrating graft and the 
increased wound healing of a lamellar graft, a mixed technique of a full-thickness graft 
with a peripheral lamellar wound has been advocated. For this purpose, Busin11 and 
Busin and Arffa18 have popularized a mushroom configuration by using a mechanical 
trephination technique. In a case report of a patient with a deep stromal scar, a micro-
keratome-assisted mushroom technique was used consisting of a large 9.0-mm anterior 
stromal lamella and a small 5.0-mm posterior button.18 This resulted in minimal removal 
of recipient endothelium with fast postoperative healing and preservation of most of 
the recipient endothelium. Complete suture removal was performed 3 months after sur-
gery. Best spectacle-corrected visual acuity improved from 20/60 to 20/20 at 6 months 
postoperatively, and refraction was –2.50 -1.00 x 20º. In another study of 8 eyes, Busin11 
showed that an inverted mushroom lamellar dissection technique for creating a top-hat 
configuration allowed complete suture removal by 3 months postoperatively. Refractive 
astigmatism before and after suture removal was minimized to 4 D or less in all eyes. In 
addition, because the 7.0-mm anterior surface of the donor button is smaller than the 
9.0-mm posterior one, more endothelial cells can be transplanted, thereby prolonging 
the longevity of the graft. 
Ideally, the optimal penetrating keratoplasty procedure would consist of a custom-
made nonmechanical trephination that allows the formation of a self-sealing donor/
recipient apposition. Seitz et al19 were the first to report in a laboratory study the feasibil-
ity of an industrial femtosecond laser source to create an inverse mushroom shape in 
polymethylmethacrylate blocks and porcine corneas. In porcine eyes, light microscopy 
displayed trephination edges delineated by partly confluent gas bubbles with tissue 
bridges in between. Electron microscopy showed normal adjacent collagen fibers.19 
Another laboratory study has shown a reduction in wound leakage of a top-hat configu-
ration compared with a standard penetrating keratoplasty configuration.20,21
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Recently, the femtosecond laser was effectively used for preparing the posterior 
corneal disc in endothelial transplantation techniques in an in vitro study22 and in a 
patient.23 We coined the term femtosecond Descemet-stripping endothelial kerato-
plasty (FS-DSEK) for this procedure.23 This study showed that a femtosecond laser with 
programmable software and hardware configurations can create custom-made (inverse) 
mushroom corneal grafts. The BCVA was 20/40 or better in 4 of 5 cases and limited in 3 
cases by amblyopia and macular disease. Best potential macular acuity (pinhole acuity) 
was 20/50 in case 3, 20/30 in case 4, and 20/40 in case 5. The mean refractive astigmatism 
at 12 months was -3.20 ± 2.0 D, and 2 of 5 patients had >3 D of refractive astigmatism. 
Buratto and Bohm24 used the femtosecond laser for penetrating keratoplasty in a series 
of 7 cases. At 3 months, all grafts were clear with good endothelial cell counts and nor-
mal corneal thickness in each case. High levels of astigmatism after suture removal may 
still be a problem, even after femtosecond laser–inverted mushroom keratoplasty as 
seen in our study in case 1. The creation of orientation teeth by the femtosecond laser, 
which has been described before with other lasers, may result in better astigmatism 
management.25 The endothelial cell density was adequate in 4 cases after 12 months 
and decreased in 1 patient from 2117 cells/mm2 at 6 months to 954cells/mm2 at 12 
months postoperatively. We noticed no early rejection period that might be responsible 
for the endothelial cell loss. It is unclear whether the long-term endothelial cell loss 
after femtosecond laser–assisted inverted mushroom keratoplasty will be the same 
as in penetrating keratoplasty, where an endothelial cell loss as high as 53% has been 
shown 3 years after transplantation.26 The measured thickness of the posterior shelf was 
in accordance with the preoperatively estimated thickness (175 vs. 200 µm). However, 
an exact match for the horizontal lamellar plane in graft and host cornea is difficult to 
obtain when the preoperative thicknesses of both corneas are different because of a 
different hydration state. A disparity of the graft/host anterior stromal cornea above the 
lamellar plane could result in a suboptimal fit of the graft into the host wound bed and 
higher levels of astigmatism.
Three patients complained of photophobia during the first postoperative month 
that resolved after increasing the topical steroid treatment. It was suspected that the 
photophobia resulted from the high levels of energy (up to 7.0 µJ) with the 15-kHz laser 
used for making the posterior outer vertical side cut. Recently, studies showed that cut-
ting a laser in situ keratomileusis flap with a 15-kHz laser caused stromal cell death and 
inflammatory cell infiltration that decreased after the introduction of the 30- and 60-kHz 
laser.27,28 A similar mechanism may apply for lamellar cuts made deeper in the cornea 
during femtosecond laser–assisted keratoplasty. Modifications of the femtosecond laser 
in energy levels (down to 3.0 µJ) and firing rate with the introduction of a femtosecond 
60-kHz laser for performing femtosecond laser–enabled keratoplasty will result in a pre-
sumably lower incidence of photophobia. A decreased incidence of the transient light 
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sensitivity syndrome has also been seen after femtosecond laser energy reduction in the 
course of cutting the laser in situ keratomileusis flap.29,30
Fast wound healing was shown in 2 cases where all sutures were removed at 19 (case 
1) and 21 weeks (case 2) after surgery. In the other 3 cases, the sutures were only partially 
removed because of the satisfactory level of astigmatism. 
Femtosecond laser–assisted penetrating keratoplasty techniques will revolution-
ize corneal transplant surgery because cutting techniques and dimensions may be 
individualized. In the near future, eye banks will be able to produce custom-designed 
corneal grafts on the basis of the specifications of a corneal surgeon. The laser prepara-
tion of the donor tissue is automated and thereby reduces the technical difficulties and 
risks involved with the preoperative manual dissection of an (inverse) mushroom graft. 
This will allow eye banks to control the quality of grafts after the femtosecond laser 
procedure, thereby enhancing quality management of corneal transplantation surgery 
in general.
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aBstraCt
objective: To compare endothelial cell (EC) loss, visual and refractive outcomes, and 
complications after deep anterior lamellar keratoplasty (DALK) and penetrating kerato-
plasty (PK).
Design: Randomized, multicenter clinical trial.
Participants: Fifty-six eyes of 56 patients with a corneal stromal pathology not affecting 
the endothelium were randomized to DALK or PK.
methods: The DALK procedure was performed according to Anwar’s big-bubble tech-
nique. Patients underwent an ophthalmic examination preoperatively and 3, 6, and 12 
months postoperatively.
main outcome measures: Endothelial cell loss, refractive and topographic astigmatism, 
spherical equivalent, uncorrected visual acuity, and best spectacle-corrected visual acu-
ity (BSCVA) were measured, and complications were recorded.
results: Endothelial cell loss was significantly higher after PK compared with DALK 
procedures performed without perforation of Descemet’s membrane (12 months: 27.7% 
± 11.1% vs. 12.9% ± 17.6%). The BSCVA was significantly better in the PK group at 3 and 
6 months after surgery but was not significantly different 12 months after surgery (0.39 
± 0.3 logarithm of the minimum angle of resolution [logMAR] in DALK and 0.31 ± 0.3 
logMAR in PK). At 12 months postoperatively, refractive and topographic astigmatism 
in the DALK and PK groups were -3.37 ± 2.3 diopters (D) and -3.76 ± 2.1 D (P = 0.53), and 
3.57 ± 2.3 D and 4.16 ± 2.0 D (P = 0.34), respectively. (Micro)perforation of the Descemet’s 
membrane occurred in 32% (9/28) of the DALK eyes, and 18% (5/28) of the patients 
required conversion to PK. Endothelial cell loss was not significantly different between 
DALK and PK when cases with perforation of Descemet’s membrane were included 
in the (intention-to-treat) analysis (12 months: 19.1 ± 21.6 vs. 27.7 ± 11.1 P = 0.112). 
Rejection episodes were reported in 1 patient in the DALK group (epithelial rejection) 
and 3 patients in the PK group (all endothelial rejections). No graft failure occurred.
Conclusions: One year after DALK performed without perforation of Descemet’s mem-
brane, EC loss is significantly lower, whereas the BSCVA is comparable to that in the 
PK group. In addition, no endothelial rejection occurred in the DALK group. However, 
Descemet’s membrane perforation remains a major complication in DALK and warrants 
improvements to standardize the big-bubble technique.
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introDuCtion
Corneal stromal pathologies, such as keratoconus, keratitis sequelae, and stromal 
dystrophies, account for more than one third of the indications for keratoplasty.1 
Penetrating keratoplasty (PK) has been shown to be a safe technique, achieving good vi-
sual outcomes in these patients. However, graft failure remains a problem and has been 
reported in 18% to 34% of the  cases.2,3 The major reasons for graft failure are endothelial 
rejection and endothelial failure, which account for more than 50% of graft failures.4 
After PK, endothelial cell (EC) counts have been shown to decrease approximately 70% 
in 10 years, having a major impact on long-term graft survival.4
Although the concept of lamellar grafting was first introduced more than 150 years 
ago, lamellar transplantation techniques that only transplant the anterior side of the 
cornea underwent a recent revival in popularity. In deep anterior lamellar keratoplasty 
(DALK), the corneal stroma is removed down to the Descemet’s membrane or a thin layer 
of stroma is left on top of the Descemet’s membrane. The corneal stroma is replaced with 
a lamellar donor button, preserving the recipient’s Descemet’s membrane and endothe-
lium. This technique can be performed in patients with corneal stroma pathologies not 
affecting the endothelium. A main advantage of DALK is prevention of long-term EC 
loss. In addition, because the endothelium (which is the major target for rejection) is not 
grafted, the incidence of immunologic rejection is reduced. Other theoretic advantages 
of DALK include shorter postoperative steroid therapy and a reduced risk of anterior 
synechiae or intraocular infection due to a “closed eye” procedure.
Many countries have a shortage in corneas suitable for donation. Major reasons for 
discarding donor corneas are abnormalities of the anterior corneal stroma and a de-
creased vitality of the corneal endothelium. Approximately one third of the corneas are 
unsuitable for PK because of a low endothelial cell density (ECD) (<2000 cells/mm2 in 
most cornea  banks).1,5 Shortage of donor tissue has resulted in a considerable wait-
ing time for corneal transplantation in many countries, including The Netherlands. 
Previously discarded corneas because of abnormalities of the endothelium may be used 
in DALK, reducing the waiting lists of eye banks.
Visual outcomes of DALK might be limited compared with PK if baring of Descemet’s 
membrane is incomplete and interface haze occurs. Deep dissection at the level of the 
Descemet’s membrane is thought to lead to better visual outcomes because of the ab-
sence of stromal scarring at the graft– host stromal interface.6,7 Various techniques have 
been used to accomplish baring of the Descemet’s membrane, including intrastromal 
air injection,8,9 hydrodelamination,6 viscoelastic dissection using an-air-to-endothelium 
interface,10 and blunt spatula delamination.11 Anwar and Teichmann12 introduced the 
“big-bubble” technique, in which partial thickness trephination is followed by stromal air 
injection to form an air bubble to dissect the Descemet’s membrane from the posterior 
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stroma. This facilitates a safer exposure of Descemet’s membrane and produces a smooth 
surface for high-quality vision. Several interventional studies using this technique 
showed promising results regarding visual outcome and graft survival.13–15 However, 
this big-bubble technique is technically challenging and may result in perforations of 
Descemet’s membrane in up to 57% of the cases.16 No randomized controlled studies 
have been performed to compare the effect of the Anwar’s big-bubble DALK technique 
with PK. The Dutch Lamellar Corneal Transplantation Study has been designed to com-
pare EC loss, visual and refractive outcomes, and complication profile after DALK and PK.
materials anD methoDs
This randomized multicenter trial (Dutch Lamellar Corneal Transplantation Study) was 
conducted at 5 centers in The Netherlands. The institutional review boards of all par-
ticipating centers approved the study. Informed consent was obtained from all patients. 
The patients were recruited between April 2005 and February 2008. Since December 11, 
2006, the trial was registered at the Dutch trial register as the Dutch Lamellar Corneal 
Transplantation Study (http://www.trialregister.nl, no. ISRCTN02191620) and performed 
in accordance to the principles of the Declaration of Helsinki. 
Inclusion criteria were patients with keratoconus intolerant for contact lens wear 
(without prior hydrops or Descemet’s rupture) and stromal opacifications not reach-
ing Descemet’s membrane and without concomitant endothelial disease. Exclusion 
criteria were best-corrected visual acuity ≥ 20/50, keratoconus with previous hydrops 
or Descemet’s rupture, or corneal stromal opacification reaching Descemet’s membrane. 
The medical history was recorded, and all patients underwent a comprehensive oph-
thalmic examination. Preoperative data included patient age, gender, refractive error, 
intraocular pressure (IOP), preoperative lens status, and ocular comorbidities. All donor 
corneas were obtained from the same Cornea Bank in The Netherlands (Cornea Bank 
Amsterdam). The method to measure the ECDs of the donor tissue was described by 
Pels and Schuchard.17
surgical procedures
The selection criteria of the donor cornea for the DALK and PK group were the same. The 
surgical procedure in the DALK group was performed according to Anwar’s big-bubble 
technique.12 The recipient cornea was trephined for approximately 60% of its thickness 
using a 7.75- or 8.0-mm Hessburg–Barron vacuum trephine. A partial-thickness anterior 
keratectomy was then performed. A 30-gauge needle, attached to a 1- to 3-ml air-filled 
syringe was brought into the remaining stroma in a paracentral position. A bubble was 
formed by pressing the air-filled syringe. A 15-degree knife was used to make an incision 
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in the anterior wall of the big bubble. A blunt spatula was introduced in the space left 
by the collapsed bubble and used to form a dissection plane that was subsequently 
filled with a cohesive viscoelastic. The stromal layers were divided in 4 quadrants and 
excised with blunt-tipped microscissors. After removal of the Descemet’s membrane 
and endothelium, the corneal donor button was trephined with a 8.0- or 8.25-mm 
Hessburg–Barron trephine and sutured into the bed using 8 interrupted 10-0 nylon 
sutures and a continuous 11-0 nylon suture. Suture removal was based on the level of 
refractive astigmatism and guided by topographic astigmatism patterns in both groups.
In the PK group, the recipient cornea was trephined using a 7.75- or 8.0-mm Hessburg–
Barron vacuum trephine, and the donor cornea was trephined with a 8.0- or 8.25-mm 
Hessburg–Barron trephine. In all cases a combined suturing technique of 8 interrupted 
10-0 nylon sutures with a continuous 11-0 nylon suture was used. Selective suture re-
moval was based on the topographic astigmatism pattern.
Postoperatively, all patients in the DALK and PK groups received the same topical 
schedule. Topical dexamethasone 0.1% drops (Ratiopharm, Zaandam, The Netherlands) 
were tapered after surgery with the following schedule: 6 times daily for 1 month, 4 
times daily for 1 month, 3 times daily for 1 month, 2 times daily for 3 months, 1 time 
daily for 6 months, and thereafter 1 time daily on alternate days until all sutures were 
removed. Topical  chloramphenicol 0.5% drops (Ratiopharm) were given 3 times daily for 
the first 3 months and then stopped.
outcome measures
The main outcome measure is the amount of EC loss. Endothelial cell densities are 
measured using the Noncon Robo SP 8000 (Konan, Hyogo, Japan). Three specular pho-
tographs were taken, and each image was analyzed by selecting 50 cells in the center of 
the image to reduce sampling error. Secondary outcome measures included uncorrected 
visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction, 
refractive astigmatism, topographic astigmatism (EyeMap EH-290, Alcon, Fort Worth, 
TX), and intra- and post-operative complications. The UCVA and BSCVA were determined 
using the Early Treatment of Diabetic Retinopathy Study letter charts and converted to 
logarithm of the minimum angle of resolution (logMAR) measurements. Vision levels of 
counting fingers, hand movements, light perception, and no light perception were sub-
stituted by logMAR values of 1.7, 2.0, 2.5, and 3.0, respectively. All outcome parameters 
were recorded preoperatively and at 3, 6, and 12 months after surgery.
sample size
The sample size was calculated on the basis of an EC loss of 8% after DALK and 45% 
after PK in 1 year, based on our preliminary experiences and reported amounts of EC 
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loss in previous studies.18–20 By assuming an α of 0.05, a power of 90%, and 10% loss to 
follow-up, 28 patients were required in each treatment group.
randomization and blinding
Consecutive patients in each center were randomly assigned to DALK or PK treatment. 
The randomization code was generated using a permuted block size of 2. The assigned 
treatment plans were then sent to the surgeon.
statistical analysis
Intention-to-treat analysis was performed for all outcomes measures, and additional 
analysis was performed for the EC loss without perforation of the Descemet’s mem-
brane. Data were described as mean ± standard deviation for continuous variables and 
as individual counts and percentages for categoric variables. Continuous data were ana-
lyzed using the Student t test for differences between groups. The chi-square or Fisher 
exact test was used to compare categoric data. Comparisons of preoperative data and 
postoperative data within a group were performed using a linear regression model. A P 
value of less than 0.05 was considered to be statistically significant. Statistical analysis 
was performed using SPSS for Windows (version 15.0, SPSS Inc., Chicago, IL).
results
Participant flow
The patient flow is displayed in Figure 1 (available at http://aaojournal.org). Fifty-six eyes 
of 56 patients were included, with 28 patients in both the DALK and PK groups. Five 
patients in the DALK group did not receive the allocated treatment and were converted 
to a PK because of Descemet’s membrane perforations. 
All patients in the PK group received the allocated treatment. All 28 patients in the 
DALK group completed the 3-month postoperative follow-up visit. One patient was lost 
to follow-up 6 months postoperatively. This was a young patient who was satisfied with 
the postoperative result and refused to attend further follow-up visits. In the PK group, 
all patients completed the follow-up visits.
Patient characteristics
Patient characteristics are listed in Table 1 (available at http://aaojournal.org). The mean 
age in the DALK group was not significantly different from the mean age in the PK group 
(43.4 ± 15.9 years and 42.9 ± 14.1 years, respectively; P = 0.899). Twenty-six patients in 
the DALK group and 25 patients in the PK group were phakic, which was not significantly 
different. In addition, 6 patients (3 in the DALK group, 3 in the PK group) were diagnosed 
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taBle 1. Preoperative Patient Characteristics
Dalk Pk P value
eyes (N) 28 28
age in years (mean ± SD) 43.4 ± 15.9 42.9 ± 14.1 0.899
Women (N, %) 13 (46%) 13 (46%)
Diagnosis
Keratoconus 15 (53.6%) 15 (53.6%)
Herpes simplex virus keratitis 7 (25.0%) 9 (32.1%)
Corneal ulcer 6 (21.4%) 1 (3.6%)
Pre-Descemet dystrophy 0 2 (7.1%)
Groenouw stromal dystrophy 0 1 (3.6%)
recipient lens status
Phakic 26 (92.9%) 25 (89.0%) 0.263
Pseudophakic 2 (7.1%) 3 (11%)
DALK = deep anterior lamellar keratoplasty; PK = penetrating keratoplasty; N = number of eyes; 
SD = standard deviation
N = 23 received DALK 
N = 5 converted to PK 
N = 28 received PK 
 
3 months follow-up 
N = 28 
3 months follow-up 
N = 28 
6 months follow-up 
N = 27 
N = 1 lost to follow-up 
6 months follow-up 
N = 28 
12 months follow-up 
N = 27 
 
12 months follow-up 
N = 28 
N = 56 randomized 
DALK: N = 28 PK: N = 28 
Figure 1. Participant Flow
DALK = deep anterior lamellar keratoplasty; PK = penetrating keratoplasty; N = number of patients
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with cataract. In these patients, cataract extraction was performed at least 12 months 
after keratoplasty. No patients underwent primary cataract surgery or a combined 
procedure.
Keratoconus and corneal scarring caused by herpes simplex virus keratitis were the 
most important reasons for keratoplasty in both the DALK and PK groups. In the DALK 
group, 6 patients required a keratoplasty for a corneal ulcer, compared with 1 patient 
in the PK group. Three patients in the PK group required a keratoplasty for a corneal 
dystrophy.
endothelial cell density
The ECDs for both groups are shown in Table 2. Specular photographs of sufficient qual-
ity could not be obtained in all patients in the DALK group because of stromal scarring 
(preoperatively) or microfolds of the interface (postoperatively). In the intention-to-treat 
analysis, the preoperative ECDs were significantly higher in the PK group (P = 0.045). 
Post-operative ECDs did not differ significantly between the DALK and PK groups. The EC 
loss was determined for all patients in the DALK and PK groups with available preopera-
tive and postoperative ECDs. The EC loss was comparable between the 2 groups at all 
follow-up visits.
The analysis without perforation of the Descemet’s membrane showed that the EC 
loss in the PK group was significantly higher at all follow-up visits compared with the 
DALK group. The EC loss continued in both groups but was significantly higher in the PK 
taBle 2. Preoperative/Donor and Postoperative endothelial Cell loss of Deep anterior lamellar 
keratoplasty and Penetrating keratoplasty
Dalk Pk P value *
Mean ± SD (N) Range Mean ± SD (N) Range
Endothelial cell density 
(cells/mm2)
Preoperative 2489 ± 318 (22) 1820 - 2855 2712 ± 109 (28) 2500 - 2900 0.045 
3 mos 2018 ± 643 ‡ (20) 449 - 2725 2111 ± 301 ‡ (28) 1654 - 2930 0.547
6 mos 1831 ± 647 ‡ (24) 441 - 2635 2095 ± 297 ‡ (28) 1683 - 2882 0.097
12 mos 1936 ± 643 ‡ (24) 576 - 3000 1966 ± 321 ‡ (28) 1256 - 2427 0.849
P = 0.038 † P < 0.01 †
Endothelial cell loss (%) §,#
3 mos 16.1 ± 24.5 (20) -9.3 ± 79.2 22.4 ± 9.8 (28) -8.5 ± 36.4 0.375
6 mos 18.5 ± 24.3 (22) 3.7 ± 79.6 22.5 ± 10.9 (28) -6.8 ± 36.1 0.599
12 mos 19.1 ± 21.6 (22) 12.2 ± 73.3 27.7 ± 11.1 (28) 12.4 ± 55.1 0.112
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group and reached 27.7% ± 11.1% in the PK group and 12.9% ± 17.6% in the DALK group 
(P = 0.007) at 12 months postoperatively.
visual outcomes
Visual outcomes are shown in Table 3. The preoperative UCVA in the DALK and PK 
groups was comparable. After surgery, there was a significant improvement in UCVA 
in both groups. Three months postoperatively, the UCVA was significantly better in the 
PK group, compared with the DALK group (0.72 ± 0.4 logMAR and 0.95 ± 0.4 logMAR, 
respectively; P = 0.021). However, the UCVA in the DALK group continued to improve 
and was comparable to that in the PK group at both 6 and 12 months postoperatively.
The BSCVA was comparable in the DALK and PK groups before surgery. After surgery, 
there was a significant improvement in BSCVA in both groups. Three and 6 months 
postoperatively, the BSCVA was significantly better in the PK group compared with the 
DALK group. However, the BSCVA continued to improve in the DALK group and was not 
significantly different from the PK group 12 months postoperatively (0.39 ± 0.3 logMAR 
and 0.31 ± 0.3 logMAR, respectively; P = 0.368). In addition, the BSCVA gain in the DALK 
and PK groups was comparable. One year after surgery, the BSCVA gain was 0.52 logMAR 
in the DALK group and 0.50 logMAR in the PK group (P = 0.897).
In the PK group there were 4 eyes at 3 months, 5 eyes at 6 months, and 5 eyes at 12 
months with a BSCVA of logMAR ≤0 (≥20/20). In the DALK group there were 2 eyes with 
a BSCVA of logMAR ≤0 (≥20/20) at 3, 6, and 12 months postoperatively.
taBle 2. Preoperative/Donor and Postoperative endothelial Cell loss of Deep anterior lamellar 
keratoplasty and Penetrating keratoplasty (continued)
Dalk Pk P value *
Mean ± SD (N) Range Mean ± SD (N) Range
Endothelial cell loss (%) §,¶
3 mos 6.6 ± 17.1 (17) -9.3 to 42.5 22.4 ± 9.8 (28) -8.5 to 36.4 0.003
6 mos 9.9 ± 16.8 (18) -3.7 to 43.4 22.5 ± 10.9 (28) -6.8 to 36.1 0.024
12 mos 12.9 ± 17.6 (18) -12.2 to 42.2 27.7 ± 11.1 (28) 12.4 - 55.1 0.007
DALK = deep anterior lamellar keratoplasty; N = number of eyes; PK = penetrating keratoplasty; SD = standard deviation.
*P value between the DALK and PK groups (t test).
†P value between preoperative and postoperative data within a group (linear regression model).
‡P < 0.05 between a specific postoperative visit and the preoperative visit (linear regression model).
§Endothelial cell loss is determined in patients with available preoperative and postoperative ECDs (paired data).
#Based on intention-to-treat analysis.
¶Based on analysis without perforation of the Descemet’s membrane.
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refractive outcomes
Refractive outcomes are shown in Table 4. Preoperatively and at all postoperative follow-
up visits, the spherical equivalent, refractive astigmatism, and topographic astigmatism 
in the DALK and PK groups were not significantly different.
There was a trend toward less myopia after DALK and PK; however, this was not sig-
nificant. Refractive astigmatism was significantly increased in the PK group at 3 and 12 
months after surgery, compared with the preoperative situation. Topographic astigma-
tism was significantly reduced after surgery at all follow-up visits in the PK group and at 
12 months follow-up in the DALK group, compared with preoperatively.
taBle 4.  Preoperative and Postoperative refractive outcomes of Deep anterior lamellar kerato-
plasty and Penetrating keratoplasty
Dalk Pk P value *
Mean ± SD  (N) Range Mean ± SD (N) Range
Spherical equivalent (D)
Preoperative -3.39 ± 6.7 (28) -17.00 to 7.38 -3.71 ± 5.3 (28) -15.50 to 3.75 0.851
3 mos -2.68 ± 3.2 (28) -14.63 to 2.38 -1.53 ± 3.2 (28) -13.25 to 2.50 0.201
6 mos -2.88 ± 3.6 (27) -13.50 to 2.50 -2.14 ± 3.5 (28) -11.00 to 3.63 0.450
12 mos -2.02 ± 3.0 (27) -10.25 to 1.63 -2.30 ± 3.8 (28) -12.50 to 2.00 0.774
P = 0.738 † P = 0.278 †
Refractive astigmatism (D)
Preoperative -2.63 ± 2.9 (28) -11.0 to 0.0 -2.26 ± 3.3  (28) -11.0 to 0.0 0.667
3 mos -4.11 ± 2.6 (28) -12.0 to 0.0 -4.17 ± 1.7 ‡ (28) -8.0 to -1.0 0.918
6 mos -3.88 ± 2.8 (27) -12.0 to 0.0 -3.33 ± 1.9 (28) -7.0 to -0.5 0.415
12 mos -3.37 ± 2.3 (27) -9.5 to 0.0 -3.76 ± 2.1 ‡ (28) -8.0 to -0.2 0.526
P = 0.167 † P = 0.030 †
Topographic astigmatism 
(D)
Preoperative 6.61 ± 4.9 (23) 1.50 - 17.51 6.90 ± 6.4 (22) 0.60 - 26.60 0.863
3 mos 5.64 ± 3.0 (28) 0.43 - 16.83 4.70 ± 2.7 ‡  (28) 0.60 - 9.08 0.250
6 mos 4.74 ± 3.2 (27) 0.83 - 13.27 3.77 ± 2.4 ‡ (28) 0.60 - 10.25 0.232
12 mos 3.57 ± 2.3 ‡ (27) 0.40 - 9.72 4.16 ± 2.0 ‡ (28) 1.01 - 8.98 0.337
P = 0.023 † P = 0.026 †
D = diopters; DALK = deep anterior lamellar keratoplasty; N = number of eyes; PK = penetrating keratoplasty;
SD = standard deviation.
*P value between the DALK and PK groups (t test).
†P value between preoperative and postoperative data within a group (linear regression model).
‡P < 0.05 between a specific postoperative visit and the preoperative visit (linear regression model).
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A refractive astigmatism of more than 3 diopters (D) was present preoperatively 
in 44% of the DALK group and 32% of the PK group (P = 0.263). Postoperatively, this 
percentage did not differ significantly between the 2 groups either (12 months: 58% of 
the DALK group vs. 64% of the PK group, P = 0.455). A topographic astigmatism of more 
than 3 D was present in 70% of the DALK group and 73% of the PK group before surgery 
(P = 0.538). After surgery, there was a trend toward a decreased number of patients with 
more than 3 D topographic astigmatism in the DALK group compared with the PK group, 
but this did not reach statistical significance (12 months: 50% vs. 76%, respectively, P = 
0.055).
intraoperative and postoperative complications
Complications are shown in Table 5 (available at http://aaojournal.org). No statistical 
tests were performed because of sparse data. The big bubble could be achieved in 19 
eyes (82.6%), and in 4 eyes (17.4%) manual dissection was performed. Intraoperative 
perforation of the Descemet’s membrane occurred in 9 of 28 patients (32%), and 5 of 
these patients (18%) required conversion to a PK. In the remaining 4 patients, the perfo-
ration was managed preoperatively (n = 3) with injection of air in the anterior chamber 
or after a postoperative air injection in the anterior chamber (n = 1). Six of 9 patients with 
a perforation had stromal scarring caused by herpes simplex virus keratitis, 2 patients 
had keratoconus, and 1 patient had a corneal ulcer.
Suture reactions occurred in 8 of 23 patients in the DALK group (35%) and 7 of 33 
patients in the PK group (21%). At 12 months follow-up, complete suture removal had 
been performed in 22% of the patients in the DALK group and 20% of the patients in the 
PK group. No wound dehiscence occurred.
taBle 5. Complications of Deep anterior lamellar keratoplasty and Penetrating keratoplasty
Complication Dalk
N (%)
Pk
N (%)
Microperforation Descemet membrane 9 (32%) -
Conversion to PK 5 (18%) -
Suture reactions 8 (35%) 7 (21%)
Wound dehiscence 0 0
Elevated intraocular pressure 5 (22%) 3 (9%)
Cataract 0 0
Rejection episodes 1 (4%) 3 (9%)
Graft failure 0 0
DALK = deep anterior lamellar keratoplasty; PK = penetrating keratoplasty; N = number of patients
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During the 12-month follow-up, an elevated IOP, defined as an IOP greater than 21 
mmHg, was recorded in 5 patients (22%) in the DALK group and 3 patients (9%) in the 
PK group. All patients in both the DALK and PK groups were still using topical steroid 
treatment after 12 months of follow-up. 
A rejection episode occurred in 1 patient in the DALK group and 3 patients in the PK 
group. The patient in the DALK group was diagnosed with epithelial rejection, and the 3 
patients in the PK group were diagnosed with endothelial rejection. All 4 patients were 
treated with steroids, and no graft failure occurred.
DisCussion
This randomized multicenter trial compares EC loss, visual and refractive outcomes, and 
complication profile after DALK and PK during a follow-up of 12 months. We found a 
lower EC loss, comparable UCVA and BSCVA, comparable refractive outcomes, and no 
endothelial rejections in the DALK group compared with the PK group. Perforation of 
Descemet’s membrane occurred in 32% of the patients, and 18% of the patients required 
conversion to a PK. These results are in accordance with a previous randomized clinical 
trial comparing DALK and PK.21
Preoperative ECDs were significantly lower in DALK eyes than PK eyes. Six patients in 
the DALK group required a keratoplasty for a corneal ulcer, and all 6 patients previously 
had severe keratouveitis with hypopyon formation. A few studies have suggested that 
severe anterior segment inflammation might lead to a decreased preoperative ECD. 22,23 
An additional explanation might be that in vitro ECDs in donor corneas are not entirely 
comparable to in vivo measurements.   Moreover, the selection of donor cornea is also 
based on ECD with a minimum of 2300 cells/mm2.
In the intention-to-treat analysis, the EC loss was comparable between the DALK and 
PK groups during all postoperative follow-up visits. However, the EC loss in patients 
without microperforations of the Descemet’s membrane was significantly higher in the 
PK group compared with the DALK group. A sufficiently high ECD is one of the major fac-
tors contributing to long-term graft survival. The higher EC loss in PK-treated eyes is in 
accordance with previous studies.18,19,21,24–26 A large cohort study with a 15-year follow-up 
showed that the ECD continues to decrease after a PK, until it stabilizes approximately 
10 years after surgery.4 At this time, total EC loss is estimated at 70%.
Three months after DALK surgery, EC loss was 6.6%, compared with the preoperative 
situation. Surgically induced EC loss in DALK-treated eyes has been reported to be 10%22 
or approximately 400 cells/mm2.27 This is in accordance with our results (~400 cells/mm2 
between the preoperative visit and 3-month follow-up). After 1-year follow-up, EC loss 
in the DALK group was 12.9%. Previous studies show an EC loss ranging from 6% to 20% 
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in the first year after DALK surgery.15,22,24,28 Shimazaki et al21 performed a randomized 
controlled trial comparing DALK and PK and found a stabilization of EC loss 6 months 
after a DALK procedure. In addition, van Dooren et al27 described an initial decrease 
in ECDs of approximately 11% in 6 months, followed by a physiologic rate of cell loss. 
However, we found no evidence for EC loss stabilization within 12 months of a DALK 
procedure. A longer follow-up is needed to evaluate this further.
Initial postoperative visual outcomes in our study were significantly better in the PK 
group compared with the DALK group. However, 6 to 12 months after surgery, both 
the UCVA and BSCVA in the DALK group reached the same level as in the PK group. This 
indicates that Anwar’s big-bubble technique achieves a deep dissection up to the level 
of the Descemet’s membrane and does not lead to substantial interface hazing. Earlier 
stabilization of visual outcomes after a PK, compared with a DALK, has also been sug-
gested by a previous study.28 Although a significantly better best-corrected visual acuity 
(BCVA) after DALK has been reported,16 the majority of the studies report similar values 
in DALK eyes compared with PK patients.18,21,24,25,28–31 One study reported better BCVA in 
PK patients, but this might be due to incomplete stromal removal in DALK eyes.32
In our study, refractive astigmatism values after DALK were comparable to PK with an 
average refractive astigmatism of -3.37 and -3.76 D, respectively, after 12 months follow-
up. This is in comparison with previous studies.24,30,33 However, in our study only approxi-
mately 20% of the patients in both the DALK and PK groups had all sutures removed. 
Because suture removal is likely to influence astigmatism values, a longer follow-up is 
needed to evaluate final astigmatism values after suture removal. One study, in which 
sutures had been removed in all patients in both the DALK and PK groups, reported 
comparable median refractive astigmatism values of -4.00 D (range -5.00 to -2.00 D) in 
the DALK group and -3.25 D (range -4.50 to -2.25 D) in the PK group after a follow-up of 
28 months.30
The high preoperative topographic astigmatism values in both the DALK and PK eyes 
(6.61 ± 4.9 D and 6.90 ± 6.4 D, respectively) may be caused by corneal irregularities due 
to epithelial irregularities, corneal scars, or keratoconus. Postoperative topographic 
astigmatism in the DALK group did not differ from the PK group. However, the influence 
of suture removal is unknown. A randomized study with all sutures in situ did not find a 
significant difference in topographic astigmatism either after a follow-up of 6 months.21A 
different study evaluated keratometric astigmatism values 1 month after suture removal 
(4 months for DALK and 1 year for PK) and reported a lower degree of astigmatism in 
DALK eyes.19 On the other hand, Ardjomand et al7 did not find a significant difference in 
astigmatism after suture removal.
The main complication of a DALK procedure is intraoperative perforation of the 
Descemet’s membrane. Studies using comparable deep-dissection techniques report a 
perforation rate ranging from 6% to 57%.12,14 –16,24,26,31 However, the reported perforation 
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rates also depend on whether discrimination is made between microperforations and 
larger perforations that require a conversion. We report a total perforation (microperfo-
rations and larger perforations) rate of 32% and 18% of the patients required conversion 
to PK. This might be partially explained by a learning curve of the surgeon. An additional 
explanation is that 6 of 9 patients with Descemet’s membrane perforations in our study 
had been diagnosed with severe stromal scarring caused by herpes simplex virus kerati-
tis. Al-Torbak et al34 showed that the perforation rate is significantly higher in eyes with 
deep corneal scars. They hypothesize that scarring leads to tight junction formation 
between deep stromal lamellae and the Descemet’s membrane, which causes perfora-
tion during deep dissection. More research is needed to evaluate whether a PK should 
be preferred over a DALK in eyes with severe scarring in the posterior stroma. However, 
we advise caution when using the big-bubble technique in eyes with stromal scarring.
Preservation of healthy endothelium in DALK procedures has several advantages. 
Earlier discontinuation of topical steroids and consequently a reduced incidence of 
glaucoma and cataract have been suggested.21 However, because all patients in our 
study were still using topical steroids 1 year after surgery, we did not expect to find 
a lower incidence of IOP elevation in DALK-treated eyes. An additional advantage of 
endothelium preservation is a reduced incidence of immunologic rejection. Endothelial 
rejection, one of the major reasons for graft failure, occurred in 3 patients in the PK 
group, but did not occur in any patient in the DALK group in this study. Epithelial rejec-
tion did occur in 1 patient in the DALK group in our study. Both epithelial and stromal 
rejections have been reported incidentally in DALK eyes, but affected corneas generally 
make a good recovery once the inflammatory response is controlled.26,32,35
In conclusion, DALK procedures performed without perforation of Descemet’s mem-
brane resulted in a significantly lower EC loss, while at the same time achieving equally 
good visual outcomes as a PK procedure. However, in the occurrence of intraoperative 
perforation of Descemet’s membrane, this advantage is lost. Because complete suture 
removal was only performed in the minority of DALK and PK eyes, a final comparison in 
post-operative visual outcomes, astigmatism differences, and suture-related problems 
will only be possible after all sutures have been removed. At this moment, the relatively 
high incidence of Descemet’s membrane perforation in DALK warrants the presence of a 
donor cornea with good endothelial vitality because the donor cornea has to be suitable 
for a PK in case of conversion. Further surgical improvements are needed to standardize 
the big-bubble technique to reduce the perforation rate.
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aBstraCt
aim: To compare the quality of vision after deep anterior lamellar keratoplasty (DALK) 
using the big-bubble technique and penetrating keratoplasty (PK). 
methods: Fifty-six eyes of 56 patients with a corneal stromal pathology and healthy 
endothelium were included and were randomized to DALK or PK. The surgical procedure 
in the DALK group was performed according to Anwar’s big-bubble technique. Patients 
underwent an extensive ophthalmic examination prior to surgery and 3, 6 and 12 
months postoperatively.
results: Straylight was not significantly different after DALK compared to PK at 12 
months follow-up (1.34 ± 0.3 logarithm of straylight vs 1.38 ± 0.3 logarithm of straylight, 
P = 0.642). During the 12 months follow-up, there was a significant improvement in 
straylight and contrast sensitivity after DALK and PK. The change in straylight was sig-
nificantly correlated with the change of best spectacle-corrected visual acuity (BSCVA) 
in the DALK, but not in the PK group. The change in contrast sensitivity correlated 
significantly with the change of BSCVA in both groups. 
Conclusions: Straylight and contrast sensitivity showed a significant improvement after 
both DALK and PK, whereas BSCVA was comparable between groups. Our results show 
that the quality of vision, measured by straylight, contrast sensitivity, and visual acuity, 
after DALK is comparable with that attained after PK.
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introDuCtion
Penetrating keratoplasty (PK) has been the standard treatment for diseases of the 
corneal stroma that not affect the endothelium, such as keratoconus, infectious kera-
titis and stromal keratitis.1 PK has been shown to be a safe technique, achieving good 
visual outcomes. However, graft failure remains a problem, and is primarily caused by 
endothelial rejection and endothelial failure which account for more than 50% of graft 
failures.2
In recent years, deep anterior lamellar keratoplasty (DALK) has become increasingly 
popular. The major advantage of DALK is that the host’s healthy endothelium can be 
preserved, which avoids the risk of immunologic rejection against the endothelium. 
Furthermore, long-term endothelial cell loss is lower following DALK as compared to PK.3 
Other advantages of DALK include shorter postoperative steroid therapy, a reduced risk 
of intraocular infection due to a “closed eye” procedure, and earlier removal of sutures.1, 4 
In a recent randomized clinical trial (RCT) of DALK vs PK we showed that the best 
spectacle-corrected visual acuity (BSCVA) was significantly better in the PK group at 
3 and 6 months follow-up, but was not significantly different from the DALK group at 
12 months follow-up.5 We hypothesized that the lower visual acuity may be due to the 
formation of interface haze at the donor-recipient stromal interface. This haze might 
result in an increase in intraocular straylight and a decrease in contrast sensitivity.6, 7 
The present study was performed to evaluate intraocular straylight, and contrast 
sensitivity after DALK and PK, and to correlate these quality of vision parameters to the 
visual outcomes. 
materials anD methoDs
This randomized multicentre trial was conducted at 5 ophthalmic centers in the 
Netherlands. The institutional review boards of all participating centres have approved 
the study. The trial was performed in accordance to the principles of the Declaration of 
Helsinki, and informed consent was obtained from all patients. 
Inclusion criteria were patients with keratoconus intolerant for contact lens wear and 
stromal opacifications not reaching Descemet’s membrane and without concomitant 
endothelial disease. Exclusion criteria were best-corrected visual acuity greater than or 
equal to 20/50, keratoconus with previous hydrops or Descemet’s rupture, or corneal 
stromal opacification reaching Descemet’s membrane. The medical history was recorded 
and all patients underwent a comprehensive ophthalmic examination. Preoperative 
data included patient age, gender, refractive error, preoperative lens status and ocular 
comorbidities. 
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All included eyes were randomly assigned to either the DALK or the PK group. The 
randomization code was generated using a permuted block size of 2. The surgical tech-
niques for DALK and PK have been described previously.5
Straylight was measured using a straylight meter (C-Quant, Oculus GmbH, Wetzlar, 
Germany), which uses a compensation comparison method with a forced-choice 
technique.8 Clinical straylight measurement is a relatively new development to quantify 
quality of vision and was originally developed for visual acuities better than 0.7 logarithm 
of the minimum angle of resolution (logMAR). The straylight value was expressed as a 
logarithmic intraocular straylight (log(s)) value. Higher values indicate more straylight 
and an increased sensitivity to glare.9 Two consecutive straylight measurements of the 
study eye and the non-study eye were performed, after which an average amount of 
log(s) was calculated. Straylight values were also compared to a control group obtained 
from a previous database, consisting of age-matched subjects with a clear cornea and 
no cataract.9 Eyes that were unable to perform the straylight test preoperatively due to 
turbidity and limited visual acuity were substituted by the highest preoperative log(s) 
plus 0.1 assigning a straylight value of log(s) = 2.33. 
Contrast sensitivity was measured using the Pelli-Robson chart (Clement Clarke Ltd, 
Harlow, United Kingdom).10, 11 Patients were tested both monocularly and binocularly, 
using the best spectacle correction for distance vision, a testing distance of 1 meter and 
a chart luminance of 85 candelas/m2. The last triplet of letters of which at least 2 letters 
were correctly seen was recorded and expressed as a logarithmic contrast sensitivity 
(log(c)) value. Higher values indicate a better contrast sensitivity.
The uncorrected visual acuity (UCVA) and BSCVA were determined using the Early 
Treatment of Diabetic Retinopathy Study letter charts and were converted to logMAR 
values. Vision levels of counting fingers, hand movements, light perception, and no light 
perception were substituted by logMAR values of 1.7, 2.0, 2.5 and 3.0, respectively. All 
outcome measures were measured preoperatively and at 3, 6 and 12 months follow-up.
sample size and statistical analysis
The sample size calculation of the main outcome of this randomized clinical trial has 
been described previously.5 Data were described as mean ± standard deviation for 
continuous variables and as individual counts and percentages for categorical variables. 
Differences between groups were analyzed using a Student’s t test for continuous data. 
The Pearson’s chi-square test was used to compare categorical data. Comparisons of 
preoperative data and postoperative data within a group were performed using a linear 
regression model. Correlations were assessed using the Pearson correlation coefficient 
in case of normal distributed data, and using the Spearman test in case of abnormal 
distributed data. A P value of less than 0.05 was considered to be statistically significant. 
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Statistical analysis was performed using SPSS for Windows (version 16.0, SPSS, Inc., 
Chicago, IL).  
results
Fifty-six eyes of 56 patients were included, with 28 patients in both the DALK and PK 
groups (figure 1). Five patients in the DALK group did not receive the allocated treat-
ment and were converted to a PK due to Descemet’s membrane perforations.Patient 
characteristics of the DALK and PK group are listed in table 1. 
Preoperatively, 10 patients (35.7%) in the DALK group and 8 patients (28.6%) in 
the PK group required spectacle correction for distance vision. In both groups there 
were 5 patients (17.9%) who required rigid contact lenses and 2 patients (7.1%) who 
required sclera lenses for distance vision. The remaining patients used no correction for 
N = 23 received DALK 
N = 5 converted to PK 
N = 28 received PK 
 
3 months follow-up 
N = 28 
3 months follow-up 
N = 28 
6 months follow-up 
N = 27 
N = 1 lost to follow-up 
6 months follow-up 
N = 28 
12 months follow-up 
N = 27 
 
12 months follow-up 
N = 28 
N = 56 randomized 
DALK: N = 28 PK: N = 28 
Figure 1. Participant Flow
DALK = deep anterior lamellar keratoplasty,  PK = penetrating keratoplasty
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distance vision. Twelve months postoperatively, 8 patients (28.6%) in the DALK group 
used spectacles, 1 patient (3.6%) used rigid contact lenses, 2 patients (7.1%) used sclera 
lenses, and 17 patients (60.7%) did not use a correction for distance vision, with 7 of 
the 17 being unable to wear a correction because of anisometropia. In the PK group, 
13 patients (46.4%) used spectacles, 1 patient (3.6%) used sclera lenses, and 14 patients 
(50.0%) did not use a correction for distance vision with 7 of the 14 being unable to wear 
a correction because of anisometropia.
Preoperatively, 43% of patients had a visual acuity lower than the advised limit for 
straylight measurement (0.7 logMAR). Twelve of 28 patients (42.9%) in both the DALK 
and PK groups were unable to complete the straylight test. The mean logMAR BSCVA in 
these DALK eyes was significantly higher in comparison with eyes of patients who did 
complete the test (1.21 ± 0.3 logMAR vs 0.66 ± 0.3 logMAR, P < 0.001). In the PK group 
the mean logMAR BSCVA of the eyes that were unable to complete the test was higher 
in comparison with eyes of patients who did complete the test, but this difference was 
not significant (0.98 ± 0.4 logMAR vs 0.69 ± 0.4 logMAR, P = 0.089). 
In the present study population, preoperative straylight values were not significantly 
different between the DALK and PK groups (1.82 ± 0.5 log(s) vs 1.80 ± 0.5 log(s), respec-
tively, P = 0.917). During follow-up straylight values between the DALK and PK groups 
taBle 1. Preoperative Patient Characteristics
Dalk Pk P value
eyes (N) 28 28
age in years (mean ± SD) 43.4 ± 15.9 42.9 ± 14.1 0.899
Women (N, %) 13 (46%) 13 (46%)
Diagnosis
Keratoconus 15 (53.6%) 15 (53.6%)
Herpes simplex virus keratitis 7 (25.0%) 9 (32.1%)
Corneal ulcer 6 (21.4%) 1 (3.6%)
Pre-Descemet dystrophy 0 2 (7.1%)
Groenouw stromal dystrophy 0 1 (3.6%)
recipient lens status
Phakic 26 (92.9%) 25 (89.0%) 0.263
Pseudophakic 2 (7.1%) 3 (11%)
DALK = deep anterior lamellar keratoplasty; PK = penetrating keratoplasty; N = number of eyes; 
SD = standard deviation
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1,8
2
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2,4
2,6
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s)
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age normal age normal +2SD age normal -2SD DALK PK
Intraocular Straylight Preoperatively
0,6
0,8
1
1,2
1,4
1,6
1,8
2
2,2
2,4
2,6
10 20 30 40 50 60 70 80 90
lo
g(
s)
age
Intraocular Straylight 12 Months Postoperatively
age normal age normal +2SD age normal -2SD DALK PK
Figure 2. intraocular straylight values as Function of age for Deep anterior lamellar keratoplasty versus 
Penetrating keratoplasty
The lines represent mean levels of straylight ± 2 SDs. DALK = deep anterior lamellar keratoplasty,  PK = penetrating kerato-
plasty, SD = standard deviation, Log(s) = logarithmic intraocular straylight value.
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were comparable at 3 months (1.32 ± 0.2 log(s) vs 1.27 ± 0.2 log(s), P = 0.443), 6 months 
(1.33 ± 0.3 log(s) vs 1.31 ± 0.2 log(s), P = 0.835), and 12 months (1.34 ± 0.3 log(s) vs 1.38 
± 0.3 log(s), P = 0.642). In both groups, there was a significant improvement in straylight 
from preoperatively to 12 months follow-up (DALK, P < 0.001 and PK, P < 0.001).
Straylight value as function of age is shown in figure 2. Preoperatively, 4 patients 
(14.3%) in the DALK group and 3 patients (10.7%) in the PK group had straylight values 
within the normal age-matched range, while remaining patients had higher straylight 
values. Twelve months postoperatively, 25.9% (n = 7) of DALK eyes and 28.6% (n = 8) 
of PK eyes had straylight values within the normal age-matched range, whereas other 
patients had higher straylight values. The change in intraocular straylight and BSCVA 
values from baseline to 12 months postoperatively showed a correlation in the DALK 
group (r = 0.694, P < 0.001), but not in the PK group (r = 0.330, P = 0.124). 
Contrast sensitivity for both groups are shown in table 2. At baseline, 6 patients (21.4%) 
in the DALK group and 5 patients (17.9%) in the PK group were unable to see the highest 
contrast at 1 meter distance. In both the DALK and PK groups, contrast sensitivity of the 
study eye improved significantly after surgery. Preoperatively, there was a correlation 
between BSCVA and contrast sensitivity in the DALK group (r = -0.725, P < 0.01) and 
PK group (r = -0.477, P = 0.021). The change in contrast sensitivity from baseline to 12 
months postoperatively showed a correlation with the change in BSCVA for both the 
DALK and PK groups (r = -0.480, P = 0.038, and r = -0.725, P < 0.001, respectively).
Refractive and visual outcomes are shown in table 3. In the DALK and PKP group, the 
refractive and topographic astigmatism were not correlated with straylight during the 
follow-up. 
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DisCussion
The purpose of this randomized multicenter trial was to evaluate the quality of vision 
(intraocular straylight and contrast sensitivity) after DALK in comparison with PK. 
Previous studies reported that the donor-recipient interface in lamellar keratoplasty 
may contribute to increased intraocular straylight, which may limit visual outcomes.7 
Some studies reported no significant differences in visual acuity between DALK and PK, 
whereas others report better visual acuity after DALK.1, 4, 5, 12-14 The main conclusion of 
our study is that both DALK and PK resulted in lower intraocular straylight values, better 
contrast sensitivity and comparable visual acuity after 12 months follow-up.
As has been explained on basic optical grounds, straylight and visual acuity derive 
from very different aspects of optical disturbances.15 Visual acuity is dominated by dis-
turbances of aberrometric nature, whereas straylight is dominated by light scattering 
originating from volumetric scattering processes. Only, if an underlying disease process 
affects both aspects, a correlation will be found.9 
Our results indicate that both DALK and PK are successful at improving intraocular 
straylight and result in comparable straylight values. The major improvement was seen 
from preoperatively to 3 months postoperatively, after which straylight values remained 
stable up to 12 months postoperatively. However, postoperative straylight values in 
both groups are still increased compared with age-matched controls. 
From preoperatively to 12 months follow-up, the percentage of patients with stray-
light values within the normal age-matched range improved from 14.3% to 25.9% in the 
DALK group and from 10.7% to 28.6% in the PK group. Although there was a significant 
improvement in straylight after DALK and PK at 12 months follow-up, the majority 
of  patients in both groups did not return to normal straylight levels. This finding was 
consistent with the results of patients after Descemet stripping endothelial keratoplasty 
and PK in comparison with normal eyes.16, 17 Postoperative straylight values were com-
pared with those of normal age-matched controls, but the age of the donor cornea was 
not age-matched with the patient. Our hypothesis was that the older transplant age 
probably could explain the increased postoperative straylight values of the study eyes. 
However, further analysis showed that an additional 3 eyes in the DALK group and 2 
eyes in the PK group had straylight values within the band width of an age-matched 
population. At 12 months, there was a marked outlier (figure 2) in the PK group. The 
straylight value of this outlier may be explained by an increase in visually significant 
cataract during 12 months follow-up. After cataract surgery the straylight values of this 
patient decreased to 1.24 log(s). 
It is suggested that BSCVA after DALK may be limited as a result of increased straylight 
values due to the lamellar interface.18 In our study, the gain in BSCVA and the gain in 
straylight was comparable between the 2 groups. The correlation between the changes 
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in straylight and BSCVA from baseline to 12 months postoperatively was statistically 
significant in the DALK group, but not in the PK group, which was comparable with the 
results of a previous study.6 Also, in a RCT of endothelial keratoplasty (manual technique 
vs mechanical microkeratome) and an RCT of Femtosecond laser assisted endothe-
lial keratoplasty vs PK the interface did not result in different straylight levels between 
groups.6, 19
Contrast sensitivity may be influenced by ocular pathologies, such as corneal edema, a 
corneal scar or cataract. In this study, we observed a significant improvement in contrast 
sensitivity following DALK and PK in a heterogeneous group of stromal disorders dur-
ing the 12 months follow-up. The difference between the 2 groups was not significant. 
Other randomized and nonrandomized studies on DALK and PK also showed similar 
improvements in contrast sensitivity.4, 18, 20, 21 Furthermore, the contrast sensitivity in our 
study improved during follow-up, but remained lower in comparison with normal age-
matched controls.22 Other studies evaluating PK in patients with keratoconus reported 
similar results.23 Improvements in BSCVA correlated with improvements in contrast 
sensitivity after DALK and PK. The lamellar interface in the DALK group did not result 
in significant differences in contrast sensitivity in comparison with the PK group. The 
largest improvement in contrast sensitivity was seen in the first 3 months postopera-
tively, which was also in accordance with improvements in other visual outcomes (UCVA, 
BSCVA) and improvements in straylight. 
The refractive and topographic astigmatism were comparable between the DALK and 
PK groups, and there was no significant correlation between straylight and astigmatism 
in both groups. These results were consistent with those of Rozema et al. who did not 
find a correlation between straylight and astigmatism in healthy eyes.24
Initially, the visual outcomes in our study were significantly better in the PK group 
compared with the DALK group. However, at 12 months postoperatively the BSCVA in 
the DALK and PK groups was comparable. This indicates that Anwar’s big-bubble tech-
nique, which achieves a deep dissection down to the level of the Descemet’s membrane, 
does not lead to extensive interface haze. Earlier stabilization of visual outcomes after 
PK, compared with DALK, has been suggested by a previous study.13 Even though a sig-
nificantly better BSCVA after DALK has been reported,  the majority of studies reported 
similar results in DALK eyes compared with PK eyes.1, 4, 14 Some studies have reported 
better visual outcomes following PK compared with DALK, but this might be due to 
incomplete stromal removal in DALK eyes.20, 25 
In conclusion, this randomized clinical trial showed that DALK resulted in similar 
improvements in straylight and contrast sensitivity compared with PK. Our results show 
that straylight, contrast sensitivity, and visual acuity, after DALK is comparable with that 
attained after PK and that the interface in DALK does not result in a decreased quality 
of vision.
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aBstraCt
Purpose: To evaluate the cost effectiveness of deep anterior lamellar keratoplasty 
(DALK) versus penetrating keratoplasty (PK) in The Netherlands.
Design: Cost-effectiveness analysis alongside a randomized, multicenter clinical trial.
methods: Fifty-three patients with corneal stromal pathologic features not affecting the 
endothelium were included with 28 patients in the DALK group and 25 in the PK group. 
Quality of life was measured before surgery and 3, 6, and 12 months after surgery. The 
main outcome measures were incremental cost-effectiveness ratios per clinically im-
proved patient on the 25-item National Eye Institute Visual Functioning Questionnaire 
and per patient with endothelial cell loss of maximally 20% within the first year.
results: Mean total bootstrapped costs per patient were €7607 (US$10 498) in the DALK 
group and €6552 (US$9042) in the PK group. The incremental cost-effectiveness ratios 
were €9977 (US$13 768) per clinically improved patient on the 25-item National Eye 
Institute Visual Functioning Questionnaire and €6900 (US$9522) per patient with cell 
loss of maximally 20%. In patients without perforation of the Descemet membrane, the 
incremental cost-effectiveness ratio was €5250 (US$7245) per patient.
Conclusions: This study shows that DALK is more costly and more effective as compared 
with PK. Results on the 25-item National Eye Institute Visual Functioning Questionnaire 
were in favor of DALK, and endothelial cell loss in DALK patients remained stable after 6 
months, whereas cell loss in PK patients continued. Furthermore, DALK procedures per-
formed without perforation of the Descemet membrane were more effective. However, 
because it is unknown what society is willing to pay for an additional improved patient, 
cost effectiveness of DALK within a limited follow-up period of 12 months is unclear. 
Cost effectiveness of DALK may improve over time because of lower graft failure.
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introDuCtion
For many years, penetrating keratoplasty (PK) has been the standard treatment for 
diseases of corneal stroma with unaffected endothelium such as keratoconus, infectious 
keratitis, and  stromal dystrophies.1–4 Although it has been proven to be a safe and effec-
tive technique that achieves good visual outcomes,5 graft failure is reported in 18% to 
34% of the patients.5–7 Graft failure is caused mainly by endothelial rejection and endo-
thelial failure, which account for more than 50% of graft failures.7 After PK, endothelial 
cell counts have been shown to drop by approximately 70% at 5 to 10 years,7,8 having a 
major impact on long-term graft survival.
In the last decade, interest has grown in lamellar transplantation techniques in which 
only the anterior side of the cornea is transplanted. The main clinical aim to develop 
lamellar techniques was to preserve the endothelial layer, assuming that this will reduce 
the risk of endothelial rejection and will prevent endothelial cell loss of the corneal 
graft. Postoperative visual function should be comparable with PK to justify lamellar 
techniques.9,10 In deep anterior lamellar keratoplasty (DALK), the corneal stroma tissue 
is removed down to the Descemet membrane or a thin layer of stroma is left on top of 
the Descemet membrane. The corneal stroma is replaced by donor tissue. The healthy 
Descemet membrane and endothelium of the recipient is not grafted, which reduces 
the risk of graft failure. Furthermore, long-term endothelial cell loss is lower after DALK 
as compared with PK.4,9,11 However, the procedure is technically challenging and may 
result in perforation of the Descemet membrane in a significant number of cases (range, 
4% to 39%).3,4,12–14
Although several studies evaluated the efficacy and visual outcomes of DALK versus 
PK,3,4,9,15 the efficiency of the techniques has not yet been established. An economic 
evaluation is a method to compare outcomes and costs of interventions16 with the aim 
to improve resource allocation decisions by policy makers and insurers. One type of eco-
nomic evaluation is the cost-effectiveness analysis, in which the costs of an intervention 
are related to a single outcome measure, for example clinical success.17 In this study, a 
cost-effectiveness analysis was performed, comparing DALK with PK.
methoDs
study population
The trial-based economic evaluation was conducted alongside the Dutch Lamellar 
Corneal Transplantation Study, a randomized multicenter clinical trial that evaluated the 
efficacy and safety of DALK versus PK. Patients were included between July 2005 and 
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February 2008 at 5 clinical centers in The Netherlands. Informed consent was obtained 
from all patients.
Inclusion criteria were patients with keratoconus intolerant of contact lens wear (with-
out prior hydrops or Descemet rupture) and stromal opacifications not reaching the 
Descemet membrane and without concomitant endothelial disease. Exclusion criteria 
were best-corrected visual acuity more of 20/50 or worse, keratoconus with previous 
hydrops or Descemet rupture, or corneal stromal opacification reaching the Descemet 
membrane.
In each medical center, consecutive cases were assigned randomly to treatment by 
DALK or by PK. A permuted block size of 2 was used to generate the randomization 
code. All patients underwent a comprehensive ophthalmic examination and completed 
a vision-related quality-of-life questionnaire. Data were obtained at randomization and 
at 3, 6, and 12 months after the transplantation, which is 4.5, 7.5, and 13.5 months after 
baseline measurement, respectively.
In the Dutch Lamellar Corneal Transplantation Study, the sample size was calculated 
based on an endothelial cell loss of 8% after DALK and 45% after PK in 1 year, based 
on our preliminary experiences and reported amounts of endothelial cell loss in previ-
ous studies.11,18,19 Assuming an α of 0.05, a power of 90%, and 10% loss to follow-up, 28 
patients were needed in each treatment group.
surgical procedures
In the DALK group, the surgical procedure was performed using the big-bubble tech-
nique described previously.20,21 Partial thickness trephination of approximately 60% 
depth was performed,followed by a partial-thickness anterior keratectomy. An air bubble 
was inserted into the remaining stroma using a 30-gauge needle. An incision was made 
in the anterior wall of the bubble and a blunt spatula was used to form 4 sections in the 
anterior stromal layers that then were excised with blunt-tipped microscissors. A donor 
button subsequently was sutured into the bed using 8 interrupted 10-0 nylon sutures 
and a continuous 11-0 nylon suture. 
In the PK group, the recipient cornea was trephined using a 7.75- or 8.0-mm Hessburg-
Barron vacuum trephine (Jed Med, St Louis, Missouri), and the donor cornea was tre-
phined with an 8.0- or 8.25-mm Hessburg-Barron trephine. In all patients, a combined 
suturing technique of 8 interrupted 10-0 nylon sutures with a continuous 11-0 nylon 
suture was used. Selective suture removal was based on the topographic astigmatism 
pattern.
economic evaluation
The economic evaluation was performed from a health care perspective with a time 
horizon of 13.5 months, from randomization (approximately 1.5 months before surgery) 
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up to 12 months after surgery. All relevant resources consumed within the health care 
sector were taken into account. Effectiveness was expressed in 2 ways. First, the 25-item 
National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) was used, which is 
specified for vision related quality-of-life.22 Second, because preservation of the host en-
dothelium is the main advantage of DALK, the amount of endothelial cell loss was used 
as an outcome measure. Incremental cost-effectiveness ratios (ICERs) were calculated by 
dividing the difference in costs (DALK minus PK) by the difference in effectiveness (DALK 
minus PK) between the 2 treatments.
Twenty-five–item National Eye Institute Visual Functioning Questionnaire. The NEI VFQ-
25 measures generic health dimensions and task-oriented domains related to daily 
visual functioning that are most important for patients with a chronic eye disease. The 
NEI VFQ-25 consists of 25 questions that can be expanded with 13 additional items. 
The questions comprise 12 subscales, of which 11 eventually can be converted into a 
single score. The remaining subscale (general health) is included in the questionnaire to 
provide robust information about an individual’s general health status. After recoding, 
all scores range from 0 (worst possible value) to 100 (best possible value).
Several studies have suggested that a 10-point change in the composite score is 
clinically important.23–25 Therefore, a patient with a minimum gain of 10 points in the 
composite score at 12 months after surgery was considered to be clinically improved. An 
ICER was calculated that expressed the incremental costs per clinically improved patient. 
Endothelial cell loss. Endothelial cell densities were measured at randomization and 
at 3, 6, and 12 months after surgery using the specular microscopy Noncon Robo SP 
8000 (Konan, Hyogo, Japan). To reduce the sampling error, 3 specular photographs were 
obtained at each measurement and each image was analyzed by selecting 50 cells in the 
center of the image. Studies show an endothelial cell loss in the first year ranging from 
6% to 20% after DALK surgery4,26–28 and from 20% to 43% after PK surgery.4,9,29,30 In this 
study, an ICER was calculated that expressed the incremental costs per patient with an 
endothelial cell loss of maximally 20% within the first year after surgery.
Cost analysis
All direct medical costs of the 2 interventions were assessed according to the Dutch 
guidelines for cost calculations.31 Because direct nonmedical costs and indirect costs 
were assumed to be equal in both intervention groups, these costs were excluded from 
analyses. Costs were calculated by multiplying the volumes of resource use by the cost 
price per resource unit. All costs were converted to 2008 Euros, and costs occurring after 
12 months were discounted at an annual rate of 4%. All costs are reported in Euros (€) 
and United States dollars (US$) (€1 = US$1.38).32
Resources included preparation, preservation, allocation, and transportation of the 
donor corneas, which were provided by the Bio Implant Services Foundation; outpatient 
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visits; diagnostic procedures; surgical procedures; hospitalization; and postoperative 
drugs use. Data for outpatient visits, surgical and diagnostic procedures, and hospital-
ization were obtained from the registries of the participating hospitals.
The services of the Bio Implant Services Foundation were valued using Dutch reim-
bursement rates, because no unit prices were available. Costs of outpatient visits, surgical 
procedures, hospitalization, and diagnostic procedures were valued using standardized 
integral unit prices (consisting of personnel, material, capacity, and overhead costs) as 
calculated by Maastricht University Medical Centre in which 68% of the patients were 
included. Integral costs prices of surgical procedures depended on the operation time 
per patient and were allocated to 2 cost drivers, namely general operating room costs 
and specific ophthalmology costs. Costs of postoperative drugs were obtained from the 
Dutch Pharmacotherapeutic Compass.33
statistical analysis
Outcomes were analyzed according to the intention-to-treat principle. Incomplete data 
of the NEI VFQ-25 (5%), incomplete cost data (3%), and incomplete data considering the 
endothelial cell density (22%) and visual acuity (0.4%) were imputed using SPSS Multiple 
Imputation software version 17.0 for Windows (SPSS, Inc, Chicago, Illinois, USA), under 
the assumption that the data were missing at random. Patients who had not completed 
the baseline NEI VFQ-25 were not included in the economic evaluation. A linear regres-
sion model was used with a total run length of 100 iterations. Covariates included in 
the imputation model were manifest refraction, refractive astigmatism, and topographic 
astigmatism, which were obtained in the Dutch Lamellar Corneal Transplantation Study 
at randomization and at 3, 6, and 12 months after surgery. Furthermore, age, sex, ran-
domization group, and results on additional questions to measure patient satisfaction 
after a corneal transplantation were included in the model. Five imputed data sets were 
obtained. All analyses were performed with each of these data sets and the results were 
pooled.
Because cost data generally are highly skewed, traditional parametric and non-
parametric statistical methods are not appropriate to analyze the difference in mean 
costs between groups.34 Therefore, to estimate the uncertainty in costs and effects, 
nonparametric bootstrapping with 1000 replications was performed on the incremen-
tal costs and effects, using Microsoft Excel for Windows (Microsoft Corp, Redmond, 
Washington, USA). The bootstrapped incremental cost-effectiveness ratios were plotted 
in a cost-effectiveness plane in which the horizontal axis represents the difference in 
effects between the 2 treatment groups and the vertical axis represents the difference in 
costs between the 2 treatment groups (Figure 1). Cost-effectiveness pairs can be located 
in 1 of 4 areas: (1) in the southeast area, DALK is dominant over PK (less costly and more 
effective); (2) in the northwest area, DALK is inferior over PK (more costly and less effec-
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tive); (3) in the southwest area, DALK is less costly and less effective as compared with 
PK; (4) in the northeast area, DALK is more costly and more effective as compared with 
PK. In addition, cost-effectiveness acceptability curves were created, showing the prob-
ability that DALK is cost-effective using a range of ceiling ratios, which represents the 
maximum amount of money that the decision maker is willing to pay for an additional 
health effect (ie, a clinically improved patient).
secondary analyses
To test the robustness of the results, secondary analyses were performed. First, an ad-
ditional analysis was performed in which we excluded the patients with perforation 
of the Descemet membrane. Second, we replaced the cost prices as determined in 
the Maastricht University Medical Centre by standardized Dutch unit prices—if avail-
able— determined by Oostenbrink and associates.31 Third, several studies stated that 
a 5-point change in the composite score of the NEI VFQ-25 is clinically relevant.23,24 
Therefore, we considered a patient with a gain of 5 points in the composite score at 12 
months after surgery to be clinically improved. Finally, 5 patients who were randomized 
to DALK required conversion to PK. Therefore, instead of an intention-to-treat analysis, 
an as-treated analysis was conducted in our secondary analysis, in which the converted 
patients were analyzed in the PK group.
results
A total of 56 patients were eligible for inclusion in the study. In 3 patients (5.4%), base-
line data on the NEI VFQ-25 were missing. Consequently, a total of 53 eyes in 53 patients 
were included in the economic evaluation, with 28 patients in the DALK group and 25 
Additional effects
Additional costs
DALK more costly and 
more effective
DALK less costly and 
less effective
DALK is inferior: more 
costly and less effective
DALK is dominant: less 
costly and more effective
Figure 1. Cost-effectiveness plane for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK).
CHAPTER 12
214
in the PK group. Because of perforations of the Descemet membrane, 5 patients in the 
DALK group did not receive the allocated treatment and were converted to PK. However, 
according to the intention-to-treat principle, these patients were analyzed in the DALK 
group. In the PK group, all patients received the allocated treatment. 
In Table 1, the baseline characteristics of the patients included in the study are shown. 
The mean age was 43.4 ± 15.9 years and 42.9 ± 14.1 years in the DALK group and the PK 
group, respectively (P = .9). Twenty-seven patients in the DALK group and 22 patients in 
the PK group were phakic, which is not significantly different (P = .26). In both treatment 
groups, the main reason for keratoplasty was keratoconus and corneal scarring caused 
by herpes simplex virus keratitis. The mean baseline composite score on the NEI VFQ-25 
was 63.5 and 68.3 in the DALK and PK groups, respectively (P = .33).
In Table 2, visual outcomes are displayed, showing comparable preoperative UCVA 
and BSCVA in the DALK and PK group. At 12 months after surgery, UCVA, BSCVA, and 
BSCVA gain were not significantly different between both groups. Further details of this 
population have been described elsewhere.35
effectiveness
In Figure 2, mean outcomes on the NEI VFQ-25 composite scale and mean endothelial 
cell losses are displayed for the 2 treatment groups at the four measurements. At 12 
months after surgery, pooled data showed that 59% of the patients were clinically 
improved (minimum gain of 10 points in the NEI VFQ-25 composite score) in the DALK 
group and 48% in the PK group. An endothelial cell loss of maximally 20% within the first 
table 1 . Baseline Characteristics of study Population (n=53) Dalk versus Pk
Dalk Pk P value
eyes (n) 28 25
age in yrs (mean ± sD) 43.4 ± 15.9 42.9 ± 14.1 0.9
Women (n, %) 13 (46%) 11 (44%) 0.86
recipient lens status
Phakic 27 (96%) 22 (88%) 0.26
Pseudophakic 1 (4%) 3 (12%)
Diagnosis
Keratoconus 15 (54%) 14 (56%)
Herpes simplex virus keratitis 7 (25%) 7 (28%)
Corneal ulcer 6 (21%) 1 (4%)
Pre-Descemet dystrophy 0 2 (8%)
Groenouw stromal dystrophy 0 1 (4%)
Composite score NEI VFQ-25 (mean ± SD) 63.5 ± 20.1 68.3 ± 15.2 0.33
DALK = deep anterior lamellar keratoplasty; NEI VFQ-25 = 25-item National Eye Institute Visual Functioning Questionnaire; 
PK = penetrating keratoplasty; SD = standard deviation.
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year was found in 39% of the patients in the DALK group and 24% of the patients in the 
PK group. In Table 3, the outcomes on the NEI VFQ-25 questionnaire are shown. In both 
groups, scores on all subscales increased at 12 months after surgery as compared with 
randomization.
table 2. Preoperative and Postoperative visual outcomes for Dalk versus Pk (Pooled Data)
DALK PK P value a
Mean ± SD Mean ± SD
UCVA (logMAR)
Preoperative 1.13 ± 0.07 (20/270) 1.20 ± 0.07 (20/315) 0.49
3 months 0.95 ± 0.07 (20/180) 0.72 ± 0.07 (20/105) b 0.02
6 months 0.89 ± 0.08 (20/160) b 0.78 ± 0.08 (20/120) b 0.32
12 months 0.74 ± 0.08 (20/110) b 0.71 ± 0.08 (20/100) b 0.79
BSCVA (logMAR)
Preoperative 0.90 ± 0.08 (20/160) 0.81 ± 0.08 (20/130) 0.4
3 months 0.59 ± 0.08 (20/80) b 0.32 ± 0.04 (20/40) b 0.01
6 months 0.52 ± 0.07 (20/65) b 0.30 ± 0.05 (20/40) b 0.02
12 months 0.39 ± 0.06 (20/50) b 0.31 ± 0.07 (20/40) b 0.37
BSCVA gain (logMAR)
3 months 0.32 ± 0.1 0.49 ± 0.09 0.19
6 months 0.39 ± 0.09 0.51 ± 0.1 0.34
12 months 0.52 ± 0.08 0.50 ± 0.11 0.92
BSCVA = best spectacle-corrected visual acuity; DALK = deep anterior lamellar keratoplasty; logMAR = logarithm of the 
minimal angle of resolution; PK = penetrating keratoplasty; UCVA = uncorrected visual acuity.
aP value between DALK and PK (t test).
bP <.05 between one of the postoperative visits and the preoperative visit (linear regression model).
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Figure 2. Graph showing the effectiveness outcomes for deep anterior lamellar keratoplasty (DALK) versus penetrating 
keratoplasty (PK). NEI VFQ-25 = 25-item National Eye Institute Visual Functioning Questionnaire; T0 = preoperative mea-
surement; T1 = 3-month postoperative measurement; T2 = 6-month postoperative measurement; T3 = 12-month postop-
erative measurement.
table 3. outcomes on nei vFq-25 for Dalk versus Pk
t0 t1 t2 t3 Change scores 
t3 – t0
Dalk Pk Dalk Pk Dalk Pk Dalk Pk Dalk Pk
nei vFq-25 
subscales
General vision 50.4 51.4 53.2 56.2 59.7 61.4 58.1 60.2 7.8 8.8
Ocular pain 51.8 59.5 59.2 70.0 70.3 75.5 69.9 76.5 18.1 17.0
Near activities 64.3 67.8 70.8 79.7 76.2 81.8 79.2 82.0 14.9 14.2
Distance activities 61.9 67.0 69.1 73.5 75.7 79.7 77.3 80.5 15.4 13.5
Social functioning 81.8 89.3 85.1 91.0 88.2 92.3 90.7 92.7 8.8 3.3
Mental health 60.2 63.4 68.7 72.2 73.3 77.8 74.6 72.4 14.4 9.0
Role difficulties 55.1 56.8 60.8 66.8 67.7 73.3 71.3 68.3 16.2 11.5
Dependency 77.9 83.5 84.1 87.5 85.7 89.8 89.4 89.0 11.5 5.5
Driving 50.1 56.9 53.7 54.8 55.6 71.7 65.5 70.9 15.4 14.0
Color vision 88.9 89.0 90.0 92.0 93.4 95.0 91.6 96.0 2.7 7.0
Peripheral vision 58.9 67.0 66.3 76.0 74.6 79.0 77.0 79.0 18.0 12.0
Composite score 63.6 68.3 69.2 74.5 74.6 79.8 76.8 78.9 13.2 10.5
General health 62.9 61.4 65.3 63.4 64.8 65.8 64.1 60.5 1.2 -0.9
DALK = deep anterior lamellar keratoplasty; NEI VFQ-25 = 25-item National Eye Institute Visual Functioning Questionnaire; 
PK = penetrating keratoplasty; T0 =  preoperative measurement; T1 = 3-month postoperative measurement; T2 =  6-month 
postoperative measurement; T3 = 12-month postoperative measurement.
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Costs
Table 4 shows the mean resource use andpooled costs per patient. Mean total costs per 
patient were €7607 (US$10 498) in the DALK group compared with €6552 (US$9042) 
in the PK group. Differences in costs were caused mainly by the costs in the surgical 
procedures. Preoperative costs accounted for the highest costs in both groups, but were 
comparable.
table 4: mean resource use and pooled costs per patient (n=53) for Dalk versus Pk
resources Costs 
(€, standard error of mean)
Costs per 
unit (€)
Dalk
(n=28)
Pk
(n=25)
Dalk
(n=28)
Pk
(n=25)
Preoperative costs
BIS foundation services 3599/cornea 1 1 3599 3599
Out-patient visits 27/visit 1 0.6 28 (4) 16 (3)
Diagnostic procedures variable 1 0.9 18 (4) 17 (4)
Subtotal 3645 3632
Surgical procedures
Transplantation
Operating room costs 9.50/minute 148 115 1407 (51) 1096 (68)
Ophthalmology costs 6.20/minute 117 85 725 (29) 529 (39)
Additional procedures
Operating room costs 9.50/minute 20 4 193 (63) 39 (23)
Ophthalmology costs 6.20/minute 17 2 107 (31) 13 (7)
Subtotal 2432 1677
Hospitalization
Day care 229/day 0.3 0.2 71 (20) 49 (19)
Admission 248/day 3.4 2.7 848 (113) 679 (55)
Laboratory tests variable 0.9 0.9 48 (7) 32 (5)
Subtotal 967 760
Follow-up visits
Outpatient visits 27/visit 11.5 10.2 311 (18) 276 (18)
Diagnostic procedures variable 9.6 6.8 212 (24) 167 (22)
Subtotal 523 443
Postoperative drugs 10/bottle 4 4 40 40
total costs (€) 7607 (232) 6552 (128)
BIS = Bio Implant Services; DALK = deep anterior lamellar keratoplasty; PK = penetrating keratoplasty.
CHAPTER 12
218
Cost-effectiveness
Costs per clinically improved patient on the 25-item National Eye Institute Visual 
Functioning Questionnaire. The ICER is €9977 (US$13 768) per clinically improved pa-
tient on the NEI VFQ-25. In Figure 3, the cost-effectiveness plane of the bootstrapped 
results is shown to estimate the uncertainty in costs and effects. Ninety-four percent 
of the incremental cost-effectiveness pairs is located in the northeast quadrant (more 
costly, more effective),  whereas 6% is situated in the inferior northwest quadrant. The 
cost-effectiveness acceptability curve (Figure 4) shows that the probability of DALK 
being cost-effective ranges from 4% at a ceiling ratio of €5000 (US$6900) to 79% at a 
ceiling ratio of €20 000 (US$27 600).
Costs per patient with an endothelial cell loss of maximally 20% within the first year. 
The ICER is €6900 (US$9522) per patient with an endothelial cell loss of maximally 20% 
within the first year. The cost-effectiveness plane of the bootstrapped results shows that 
almost all incremental cost-effectiveness pairs are located in the northeast quadrant 
(Figure 5). In Figure 6, the cost-effectiveness acceptability curve shows that the prob-
ability that DALK is cost effective is 15% at a ceiling ratio of €5000 (US$6900), increasing 
to 96% at a ceiling ratio of €20 000 (US$27 600).
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Figure 3. Scatterplot showing cost-effectiveness plane for the costs per clinically improved patient on the 25-item Na-
tional Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) for deep anterior lamellar keratoplasty (DALK) versus 
penetrating keratoplasty (PK). Costs are plotted on the vertical axis and effects are plotted on the horizontal axis, so an 
incremental cost-effectiveness pair in the northeast quadrant means that DALK is more effective and more costly than PK 
for that pair.
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Figure 4. Cost-effectiveness acceptability curve for the costs per clinically improved patient on the 25-item National Eye 
Institute Visual Functioning Questionnaire composite score for deep anterior lamellar keratoplasty (DALK) versus penetrat-
ing keratoplasty (PK). The curve shows the probability (vertical axis) that DALK is cost-effective compared with PK over a 
range of values for the maximum acceptable ceiling ratio (horizontal axis). ICER = incremental cost-effectiveness ratio.
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Figure 5. Scatterplot showing cost-effectiveness plane for the costs per patient with an endothelial cell loss of maximally 
20% within the first year for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK). Costs are 
plotted on the vertical axis and effects are plotted on the horizontal axis, so an incremental cost-effectiveness pair in the 
northeast quadrant means that DALK is more effective and more costly than PK for that pair.
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secondary analyses
Table 5 shows the results of the primary and secondary analyses. Costs per clinically 
improved patient ranged from €7917 (US$10 925) in the secondary analysis of exclu-
sion of patients with perforation of the Descemet membrane to €18 095 (US$24 971) 
in the secondary analysis of a 5-point change on the NEI VFQ-25, compared with €9977 
(US$13 768) in the primary analysis. The probability that DALK is cost effective at a maxi-
mum ceiling ratio of €20 000 (US$27 600) ranged from 55% to 88%, compared with 79% 
in the primary analysis. Costs per patient with an endothelial cell loss of maximally 20% 
within the first year ranged from €5250 (US$7245) in the secondary analysis of exclusion 
of patients with perforation of the Descemet membrane to €8975 (US$12 385) in the 
secondary analysis of standardized Dutch unit prices, compared with €6900 (US$9522) 
in the primary analysis. The probability that DALK is cost effective at a maximum ceil-
ing ratio of €20 000 (US$27 600) ranged from 91% to 100%, compared with 96% in 
the primary analysis. These results of the secondary analyses show that the main cost-
effectiveness data are robust.
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Figure 6. Cost-effectiveness acceptability curve for the costs per patient with an endothelial cell loss of maximally 20% 
within the first year for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK). The curve shows 
the probability (vertical axis) that DALK is costeffective compared with PK over a range of values for the maximum accept-
able ceiling ratio (horizontal axis). ICER = incremental cost-effectiveness ratio.
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DisCussion
This economic evaluation comparing DALK with PK demonstrated that DALK was more 
costly than PK. However, change scores on the NEI VFQ-25 composite score were higher 
in the DALK group, resulting in an ICER of €9977 (US$13 768) per clinically improved 
patient on the NEI VFQ-25. Furthermore, endothelial cell loss was lower in DALK patients 
as compared with PK patients, resulting in an ICER of €6900 (US$9522) per patient with 
an endothelial cell loss of maximally 20% within the first year. In the additional analysis 
with patients without perforation of the Descemet membrane, an ICER of €7917 (US$10 
925) per clinically improved patient on the NEI VFQ-25 and an ICER of €5250 (US$7245) 
per patientwith an endothelial cell loss of maximally 20% was found.Visual outcomes 
were comparable between DALK and PK patients.
Cost-effectiveness analysis aims to improve decisions on allocation of resources by 
policy makers and insurers. To compare 2 treatments, an ICER can be calculated, indicat-
ing the additional costs per extra unit of effect. This study shows that DALK costs society 
€9977 (US$13 768) per additional clinically improved patient and €6900 (US$9522) per 
additional patient with an endothelial cell loss of maximally 20% within the first year. 
table 5: results of primary and secondary analyses for Dalk versus Pk
analysis Costs (€) effects (€) iCer (€) Probability Dalk 
cost-effective at 
a ceiling ratio of 
€5000 / €10000 / 
€20000 (%)
DALK PK DALK PK
Primary analysis
  Clinically improved on the NEI VFQ-25 7607 6552 0.59 0.48 9977 4 / 49 / 79
  Endothelial cell loss of maximally 20% 7607 6552 0.39 0.24 6900 15 / 81 / 96
exclusion of patients with perforation of the Descemet’s membrane
  Clinically improved on the NEI VFQ-25 7502 6552 0.60 0.48 7917 14 / 66 / 88 
  Endothelial cell loss of maximally 20% 7502 6552 0.42 0.24 5250 46 / 95 / 100 
standardized Dutch unit prices
  Clinically improved on the NEI VFQ-25 9465 8093 0.59 0.48 12977 0 / 29 / 74 
  Endothelial cell loss of maximally 20% 9465 8093 0.39 0.24 8975 2 / 59 / 91 
5-point change on nei vFq-25
  Clinically improved on the NEI VFQ-25 7607 6552 0.71 0.66 18095 0 / 19 / 55 
as treated  
  Clinically improved on the NEI VFQ-25 7654 6692 0.58 0.50 11645 5 / 43 / 74 
  Endothelial cell loss of maximally 20% 7654 6692 0.39 0.27 7718 13 / 72 / 92 
DALK = deep anterior lamellar keratoplasty; NEI VFQ-25 = 25-item National Eye Institute Visual Functioning Questionnaire; 
PK = penetrating keratoplasty.
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However, what society is willing to pay for an additional improved patient has not yet 
been evaluated, and no studies are found that evaluated cost effectiveness using the 
NEI VFQ-25 or endothelial cell loss as an outcome measure. Therefore, it is difficult to 
interpret these results. However, compared with the mean total costs per patient, which 
were €7607 (US$10 498) and €6552 (US$9042) in the DALK group and the PK group, 
respectively, the ICERs seem considerably high.
It is known that the cost effectiveness of health technologies may vary between coun-
tries caused by so-called transferability factors, such as methodologic characteristics 
(i.e., medical cost approach), health care system characteristics (i.e., characteristics of 
evaluated technology), and population characteristics (i.e., case mix).36,37 Because this 
study was conducted in The Netherlands, the results therefore may not be directly 
transferable to the United States. However, because the study data and methods are 
presented in a transparent and reproducible way, we believe that simple adaptations 
may suffice. For example, as in Table 4, volumes of resource use and prices are presented 
separately, readers are able to use different prices and recalculate costs. 
In our study, endothelial cell loss at 12 months after surgery was 24.1% in the DALK 
group and 28.1% in the PK group. The higher endothelial cell loss in PK-treated eyes is in 
accordance with previous studies.4,9,11,13,18,38 The endothelial cell loss in the DALK group 
is somewhat higher compared with cell loss in other studies ranging from 6% to 20% 
in the first year.4,26–28 However, in the DALK group, endothelial cell loss was higher at 6 
months compared with 12 months, indicating cell loss stabilization within 12 months. 
This is in  concordance with a study by Shimazaki and associates, who found a stabiliza-
tion of endothelial cell loss 6 months after a DALK procedure.9
A limitation of the study is the follow-up period, which was only 12 months. During 
the first year, the mean total costs per patient were €7607 (US$10 498) in the DALK 
group and €6552 (US$9042) in the PK group. Costs differences were related mainly to 
the transplantation procedure and the additional surgical procedures. The higher costs 
regarding the transplantation procedure can be explained by the technically challeng-
ing and time-consuming big-bubble technique that is used in the DALK group, which 
increases the time needed for surgery as compared with PK. It needs to be mentioned 
that the patients included in this study are among the first treated with DALK in the par-
ticipating hospitals and that the procedure has a definite learning curve. For example, 
3 of the 5 patients in the DALK group who were converted to PK were among the first 
5 patients included in the study. Clearly, this increased the surgery time, resulting in 
higher costs. In addition, this may have increased the time and costs of hospitalization in 
the DALK group. Furthermore, in the DALK group, more money was spent on additional 
surgical procedures. This is mainly caused by additional surgery as a result of conversion 
to PK and postoperative air injection in the anterior chamber.
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The differences in costs of follow-up visits between DALK and PK can be explained by 
the higher complication rate in the DALK group. Besides perforations of the Descemet 
membrane and conversion to PK, more suture reactions and elevated intraocular pres-
sure was found in the DALK group. Further details of the complication profile have been 
described elsewhere.35 Although costs within 1 year after surgery were higher in DALK 
patients, it could be argued that long-term costs are higher in PK patients because of the 
higher risk of graft failure and need for retransplantation. 
In DALK patients, the preservation of healthy endothelium reduces the incidence of 
endothelial rejection, which is one of the major reasons for graft failure. Several studies 
showed a graft failure of 10% to 38% at 5 years6,8,13,39–42 and 18% to 37% at 10 years6,13,43 
in PK patients. In DALK patients, a graft failure of 3% after 5 years has been reported.13 In 
a study by Borderie and associates, the predicted graft survival was 41% at 20 years and 
3% at 30 years for PK patients.13 For DALK patients, this was 63% and 11%, respectively. 
These results indicate that in the long term, graft survival is higher in DALK patients 
as compared with PK patients. Therefore, the need for retransplantation will be less in 
DALK patients as compared with PK patients, which will have a positive effect on the 
long-term cost  effectiveness of DALK.
In addition, the composite score on the NEI VFQ-25 shows a downward trend over time 
in the PK group between 6 and 12 months, whereas in the DALK group, an increasing 
trend is displayed (Figure 2). Although a longer follow-up period is needed to evaluate 
this further, this may indicate that DALK is more effective in the long term.
The results of this study show that DALK is more costly and more effective as com-
pared with PK. Results on theNEI VFQ-25 were in favor of DALK, and endothelial cell 
loss in DALK patients remained stable after 6 months after surgery, whereas cell loss 
in PK patients continued. Furthermore, it is shown that DALK procedures performed 
without perforation of the Descemet membrane were more effective. However, because 
it is unknown what society is willing to pay for an additional improved patient, the cost 
effectiveness of DALK within a limited follow-up period of 12 months is unclear. Because 
cost effectiveness of DALK may improve over time because of lower graft failure, studies 
with a longer follow-up period are necessary. Furthermore, further surgical improve-
ments to reduce the perforation rate will improve the cost effectiveness of DALK.
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In 1906, the first successful human penetrating keratoplasty (PK) was performed by Dr. 
Eduard Zirm.1 Worldwide, human corneas are the most commonly transplanted tissue 
and most successful tissue transplantation type. Until the last decade, PK has been 
the golden standard surgical technique for most corneal diseases. Several important 
innovative techniques and instruments have been introduced with a transformation to 
selective lamellar keratoplasty. 
Penetrating keratoplasty versus deep anterior lamellar keratoplasty 
In about 30% of keratoplasty cases, the indications are corneal pathologies with a 
normal endothelium. Among these, keratoconus is the most common indication.2  In 
the past, PK was considered the standard surgical keratoplasty technique. However, 
endothelial allograft rejection was one of the most important reasons for graft failure 
in these patients.3 
Deep anterior lamellar keratoplasty (DALK) aims to replace the recipient epithelium 
and corneal stroma, leaving Descemet’s membrane and the endothelium intact, thus 
eliminating endothelial allograft rejection. In a comparative study by Borderie et al, the 
median predicted graft survival was 49.0 years in the DALK group versus 17.3 years in 
the PK group.4 Therefore, the need for re-transplantation will be less in DALK patients as 
compared to PK patients. 
Since endothelial allograft rejection is eliminated in DALK patients, topical cortico-
steroid treatment can be discontinued earlier than in PK patients, thereby reducing the 
incidence of glaucoma and/or cataract.5 Another advantage of the DALK technique is 
the prevention of long-term endothelial cell loss. In this thesis, endothelial cell loss after 
DALK without perforation of Descemet’s membrane was 12.9% and 27.7% after PK with 
a follow-up of 12 months.6 During the 1 year follow-up of our study, endothelial cell loss 
did not show evident stabilization after DALK. However, several studies showed stabili-
zation of endothelial cell loss 6 months after a DALK procedure.5, 7 A longer follow-up is 
needed to evaluate this further. 
Furthermore, in our study we found a comparable visual outcome between the DALK 
and PK groups at 6 and 12 months follow-up.6 This finding indicates that DALK with 
Anwar’s big-bubble technique is able to achieve such a deep dissection up to the level 
of Descemet’s membrane that it does not lead to visually disturbing interface haze. 
Although another study did find a significantly better best-corrected visual acuity after 
DALK,8 the majority of studies have reported similar visual outcome values in DALK 
versus PK eyes.7 
Our cost-effectiveness analysis showed that DALK is both more expensive but also 
more effective than a PK.9 However, this study was done over a limited follow-up time 
of 12 months. To evaluate the cost-effectiveness more accurately and whether it will 
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improve over time (e.g. due to lower graft failure), studies with a longer follow-up are 
necessary. 
It is known that many countries suffer from a shortage in available and suitable donor 
corneas. Another important advantage of the DALK technique is that more donor cor-
neas will be available for transplantation, whereas for PK techniques they would have 
been discarded due to their low endothelial cell density. 
Despite these advantages, the number of anterior lamellar keratoplasty techniques 
performed in the United States remain low compared to PK techniques for keratoconus.2 
This can be explained by the technical challenges in and surgical learning curve in sepa-
rating the anterior stromal layer from Descemet’s membrane and endothelium. 
Furthermore, the main complication of the DALK technique is intraoperative perfora-
tion of Descemet’s membrane, which has been reported with a range of 4% to 39%.7 
There is substantial risk of required conversion to PK during a DALK procedure, so most 
corneal surgeons tend to order a donor cornea that is suitable for both DALK and PK, 
except for hospitals with an eye bank who can supply a back-up donor cornea with high 
endothelial quality (in case of perforation). 
More effective use of donor corneas in PK patients can be achieved by further surgi-
cal improvements in order to reduce risk of perforation (and thus conversion to PK), 
and by close collaboration between the surgical team and their eye bank, especially in 
countries with corneal graft shortages. 
Penetrating keratoplasty versus endothelial keratoplasty 
In the USA and Europe, endothelial keratoplasty (EK) techniques constitute about 45-
50% of all transplant procedures.2 In the early twentieth century, EK has replaced PK as 
the golden standard surgical treatment for endothelial cell dysfunction. 
Currently, Descemet’s stripping automated endothelial keratoplasty (DSAEK) is the 
most popular EK procedure. The major advantage of DSAEK is that no sutures are re-
quired to keep the donor tissue in place, thereby preventing high irregular astigmatism 
and suture-related events, resulting in faster visual rehabilitation and better wound 
stability.10 Furthermore, DSAEK is a ‘closed eye’ surgery, which also reduces the risk of 
expulsive hemorrhage. 
Several techniques have been described in order to harvest donor lenticules for EK. 
The manual lamellar dissection techniques was not very popular due to the amount of 
technical challenges.11, 12 Subsequently, the use of an automated microkeratome and a 
Femtosecond laser were reported for preparation of the donor lenticule.13 
This thesis aims to demonstrates the feasibility of Femtosecond laser technology in 
order to prepare a standardized posterior lamellar lenticule for EK.14 The clinical out-
come of our randomized study showed lower postoperative astigmatism and absence 
of wound healing related problems in the group of patients after Femtosecond laser-
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assisted Descemet’s stripping endothelial keratoplasty (FS-DSEK).15 However, visual acu-
ity is lower as compared to the conventional PK, and the high percentage of endothelial 
cell loss.  
The results of our cost-effectiveness analysis between FS-DSEK, PK and DSAEK showed 
that FS-DSEK was not cost-effective compared to PK and DSAEK.16 DSAEK, on the other 
hand, was more costly but also more effective. With the increasing amount of cornea 
banks that are able to prepare lamellar transplant buttons for the various endothelial 
keratoplasty techniques, it may significantly lower the costs per patients, thereby im-
proving the cost-effectiveness of endothelial keratoplasty. 
In 2006, Melles described the technique of Descemet membrane endothelial kerato-
plasty (DMEK).17 The use of DMEK is currently still limited because of major challenges in 
donor preparation, difficulty to unfold the thin donor lenticule in the anterior chamber, 
and the high rebubbling rate.18 Several studies have shown faster and better visual 
rehabilitation after DMEK compared to DSAEK.18-20 Thickness of the donor lenticule is 
correlated with better visual acuity. The study of Neff et al showed that a thinner en-
dothelial graft (≤ 131 µm) is correlated with a significantly better postoperative visual 
acuity compared to a thicker endothelial graft (≥ 131 µm).21 Busin et al introduced the 
ultrathin (UT-) DSAEK  technique to prepare a thin donor lenticule (< 130 µm) with a 
standardized method.22 UT-DSAEK visual outcomes were comparable with reported 
DMEK studies and with less surgical challenges than DMEK.18, 23 A study by Dickman 
et al. found a correlation between a thicker donor graft and greater asymmetry of the 
posterior corneal surface, which associated with higher posterior corneal higher-order 
aberrations (HOAs).24 This means that thinner grafts result in significantly less posterior 
corneal (HOAs), probably resulting in higher visual acuity.25 Another benefit of a thinner 
donor graft is reduced allograft rejection compared to DSAEK or PK.26 
Further randomized clinical research is needed to compare the clinical results of dif-
ferent types of EK (DSAEK, UT-DSAEK and DMEK), and longer-term follow-up is required 
to analyze the graft survival. 
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Knowledge valorization refers to implementation of scientific knowledge for social or 
economic use or by making knowledge for new products, services, system and research.
For many years, full thickness penetrating keratoplasty (PK) was the gold standard treat-
ment for various corneal diseases. In PK, the recipient full-thickness corneal tissue is re-
placed with full-thickness donor corneal tissue. The goals of PK were visual rehabilitation, 
tectonic support, reduction of pain, prevention of infection and cosmetic restoration. 
The leading indications were keratoconus, pseudophakic bullous keratopathy, Fuchs’ 
endothelial dystrophy and regrafts. Other less common indications were post-infectious 
scarring, diverse corneal dystrophies, perforating corneal injury or chemical burns. 1
During the years 1998-2001 (prior to starting this thesis research) the percentage of 
donated eye tissue in the Netherlands issued for corneal grafting decreased from 50.8% 
(1998) to 35.2% (2001). In 2001 the Cornea Bank N.O.R.I. Amsterdam processed 2955 
donor eyes of which 1040 were actually grafted. The major reasons for the discard rate 
of 64.8% of donated eye tissue were abnormalities of the anterior corneal stroma and a 
decreased vitality of the corneal endothelium. The shortage of donor tissue had resulted 
in an average waiting time for corneal transplantation of 6 months. 
Lamellar corneal transplantation techniques that only transplant the anterior side of 
the cornea (deep anterior lamellar keratoplasty, DALK) or the posterior side (endothelial 
keratoplasty, EK) may use previously discarded tissue by transplantation of only the 
healthy part of the donated corneal tissue. The use of DALK and EK may lead to a more 
efficient use of donor material and could theoretically decrease the discard rate of donor 
tissue and shorten the waiting time. In the current thesis, we studied the clinical out-
comes of innovative lamellar corneal transplantation surgery versus PK in a randomized 
multicenter clinical trial. Further, economic evaluation had been performed between 
lamellar keratoplasty  (DALK and EK) versus PK. 
In this chapter of valorization, we discuss the practical implications of the presented 
studies and the  impact at the social and economic level. 
In about 30% of keratoplasty cases, the indications are corneal pathologies with a 
normal endothelium. The most common indication is keratoconus. Endothelial allograft 
rejection was one of the most important reasons for graft failure in these patients. The 
main clinical aim to develop DALK was to preserve the endothelial layer, and to leave 
Descemet’s membrane and the endothelium intact, thus eliminating endothelial al-
lograft rejection. In the study of Borderie et al. the median predicted graft survival was 
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49.0 years in the DALK group and 17.3 years in the PK group.2 Therefore, the need for 
re-transplantation will be less in DALK patients as compared to PK patients. 
In this thesis  the mean age of DALK and PK group is 43 years, and the most common 
indication for DALK is keratoconus.  In these young patients visual impairment has a 
impact on their social and financial life since they are not able to perform the normal 
daily working activities. Our cost-effectiveness analysis showed that during the first year, 
the mean total costs per patient were €7607 in the DALK group and €6552 in the PK 
group.3  Costs differences were related mainly to the transplantation procedure and the 
additional surgical procedures. The higher costs regarding the transplantation proce-
dure can be explained by the technically challenging and time-consuming big-bubble 
technique that is used in the DALK group, which increases the time needed for surgery 
as compared with PK. DALK is both more expensive but also more effective than a PK 
procedure. However, this study was done with a follow-up of 1 year, and it could be 
argued that long-term costs are higher in PK patients because of higher risk of graft 
failure and need for re-transplantation. 
The main complication of the DALK technique is intraoperative rupture of Descemet’s 
membrane, which required conversion to PK during the DALK procedure.  This means 
that most corneal surgeons will order a donor cornea that is suitable for both DALK 
and PK. So the concept of using a donor cornea with low endothelial cell density is not 
widely accepted.  More effective use of donor corneas in PK patients can be achieved by 
further surgical improvements in order to reduce  risk of perforation. 
In our study we showed that visual acuity was improved after DALK or PK procedure, 
but the costs were also very high. In cases of keratoconus, which is the most common 
indication for surgery , corneal crosslinking treatment had been described to stop 
the progression of the keratoconus. A randomized clinical trial with  3 years follow-up 
showed that corneal crosslinking was effective to stabilize the progression.4 In 2014, 
the Dutch Zorginstituut Nederland (ZiNL) decided that epi-off corneal treatment is in 
line with current standards of care and science and therefore is a treatment option for 
progressive keratoconus and should be reimbursed by all health insurances. 
In the Netherlands, the cost of corneal crosslinking is around €1500 which is much lower 
than the cost of corneal transplantation. Long term analysis is needed to determine 
whether corneal crosslinking will be capable to decrease the need for corneal transplan-
tation in keratoconus patients.  Further, it is important for ophthalmologist, optician or 
eye care professional to diagnose progressive keratoconus in an early stage and to refer 
patients timely for corneal crosslinking.
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For many years , PK has been the gold-standard technique for corneal transplantation 
resulting from endothelial disease or endothelial dysfunction. In recent years, in the USA 
and Europe, EK constitutes for about 45-50% of all transplant procedures. The major 
advantage of EK is that no sutures are required to keep the donor tissue in place, thereby 
preventing high irregular astigmatism and suture related events, resulting in faster 
visual rehabilitation and better wound stability.5 
In EK, different techniques have been developed for the preparation of the donor cor-
nea. Several techniques have been described in order to harvest donor lenticules for 
EK. The manual lamellar dissection techniques was not very popular due to the amount 
of technical challenges. Subsequently, the use of an automated microkeratome and a 
Femtosecond laser were reported for preparation of the donor lenticule.6  
In our study, we showed the feasibility of the Femtosecond laser to prepare a standard-
ized posterior lamellar lenticule for EK. The clinical outcome of our randomized study 
showed lower postoperative astigmatism and absence of wound healing related prob-
lems in the group of patients after Femtosecond laser-assisted Descemet’s stripping 
endothelial keratoplasty (FS-DSEK). 7 However, visual acuity is lower as compared to the 
conventional PK, and there was a high percentage of endothelial cell loss.  
The results of our cost-effectiveness analysis between FS-DSEK, PK and Descemet’s 
stripping automated endothelial keratoplasty (DSAEK) showed that FS-DSEK was not 
cost-effective compared to PK and DSAEK.8 DSAEK, on the other hand, was more costly 
but also more effective.  The costs within 1 year follow-up were higher in EK patients, but 
it could be argued that long-term costs are lower and long-term effects are higher as 
compared to PK, because of the effects of suture removal in the PK group and a reduced 
risk of complications in the EK groups, with fewer hospital visits and emergency surgical 
interventions to be expected. However, long-term follow-up is needed to evaluate this 
potentially positive effect on the long-term cost-effectiveness of EK.
Due to the lower visual outcomes and higher costs of FS-DSEK,  the Femtoscond laser 
technology is not widely use for the preparation of donor lenticules for EK. Currently, 
DSAEK is the most popular EK procedure and the donor lenticules were prepared with 
an automated microkeratome.  In the beginning the donor lenticules were prepared by 
the surgeon in the operating room during the surgery. Recently, cornea banks in the 
Netherlands are able to supply pre-cut donor cornea for DSAEK or Descemet’s mem-
brane endothelial keratoplasty (DMEK). This can significantly lower the mean costs per 
patients for the preparation of the lamellar disks. Further, it will avoid the risk of tissue 
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loss during the stromal separation step in the surgery room, and the time needed for 
surgery has also decreased by approximately fifty percent.  
With the automated microkeratome placed at the cornea bank it is now possible to use 
donor corneas with abnormalities of the anterior stroma and good corneal endothelium 
for EK procedures. This can lead to more donor corneas available for transplantation, a 
reduction of discard rate, and a shorter waiting list. 
Several studies have shown that thickness of the donor lenticule is correlated with bet-
ter visual acuity.9, 10 In the Netherlands, a randomized multicenter study is now evaluat-
ing the clinical outcomes between ultrathin (UT)-DSAEK and DSAEK. The preliminary 
results showed that the visual outcomes are significantly better in the UT-DSAEK group 
(personal communication with R.M.M.A. Nuijts, MD, PhD).  Further, several studies have 
shown faster and better visual rehabilitation after DMEK compared to DSAEK.11 As far as 
we know, there is no randomized clinical trial that has evaluated the clinical outcome 
of DMEK versus UT-DSAEK.  The DMEK procedure is at this moment not accepted as 
standard treatment by ZiNL because it is not yet in line with current standards of care 
and science. Further randomized clinical research is needed to compare DMEK with UT-
DSAEK, and long-term follow up is required to analyze graft survival. 
In summary, this thesis presents the clinical outcomes and cost effectiveness of lamellar 
keratoplasty with the golden standard treatment PK. DALK is a promising surgical tech-
nique, but further surgical improvements are needed to be widely accepted.  In cases of 
endothelial dysfunction, the EK procedure is now the first choice of surgical treatment. 
Nowadays, cornea banks in the Netherlands can provide pre-cut donor corneas and 
donor cornea with good corneal endothelium and abnormality of the anterior corneal 
stroma can now be used for EK procedure.  
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SUMMARY
In this thesis the clinical outcome of femtosecond laser-assisted Descemet’s stripping 
endothelial keratoplasty (FS-DSEK) and deep anterior lamellar keratoplasty (DALK) ver-
sus penetrating keratoplasty (PK) is described and the application of the femtosecond 
laser in corneal transplantation surgery is evaluated.
Chapter 1 is a general introduction and describes the aim and outline of the thesis. 
Chapter 2 describes the smoothness of the stromal bed and the accuracy of the 
predicted depth after femtosecond laser preparation of posterior lamellar disc (PLD). 
Nineteen human donor eyes unsuitable for corneal transplantation were used for 
histologic evaluation. The femtosecond laser is able to prepare a deep horizontal cut 
in a standardized method with a relatively smooth surface, without extensive adjacent 
tissue damage. 
In Chapter 3 we evaluate the effect of the femtosecond laser on endothelial cell vi-
ability. There was no significant effect of laser frequency on endothelial cell loss. The 
dissection of a PLD from the anterior cornea using a blunt dissection technique does not 
result in significant endothelial cell loss. 
Chapter 4 describes a case report of the first patient with pseudophakic bullous 
keratoplasty treated by FS-DSEK. After 4 months, the PLD was clear and the induced 
astigmatism was 2.1 diopters (D), demonstrating a functional corneal endothelial layer. 
In Chapter 5 we describe the preliminary visual results and endothelial cell density 
of FS-DSEK in 20 eyes with endothelial cell dysfunction. In our study, at the 6-month 
follow-up, 50% of patients with a normal visual potential showed a significant improve-
ment of their best spectacle-corrected visual acuity (BSCVA). We also found a hyperopic 
shift, which can be explained by the meniscus shape of the PLD, which was comparable 
with previously reported results. 
Chapter 6 and Chapter 7 discuss the results of our randomized multicenter clinical 
trial comparing FS-DSEK and PK of patients with endothelial cell dysfunction. Chapter 6 
reports on the clinical outcomes and incidence of postoperative complications between 
FS-DSEK versus PK. Eighty eyes of 80 patients were treated. At the 1 year follow-up, the 
percentage of patients with astigmatism lower than 3 D was higher in the FS-DSEK group 
compared to the PK group. After 1 year, the mean BSCVA was better after PK compared 
to FS-DSEK, but BSCVA gain was not significantly different between the two groups. 
Endothelial cell loss is significantly higher in the FS-DSEK group (65%) compared to the 
PK group (23%), which may be explained by the several surgical steps in the FS-DSEK 
procedure. The most common postoperative complication in the FS-DSEK group was 
graft dislocation and in the PK group this was wound healing related problems. Chapter 
7 reports on the results of straylight and contrast sensitivity between FS-DSEK versus 
PK. We found a significant improvement of straylight and contrast sensitivity after both 
FS-DSEK and PK. 
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Chapter 8 evaluates the cost-effectiveness of PK, FS-DSEK and Descemet stripping 
automated endothelial keratoplasty (DSAEK). Data of 118 patients with corneal en-
dothelial cell dysfunction were analyzed. To evaluate cost-effectiveness, incremental 
cost-effectiveness ratios (ICERs) were calculated. The primary ICER was the incremental 
costs per clinically improved patient, defined as a patient with a combined effectiveness 
of both a clinically improved BSCVA (defined as an improvement of  ≥ 2 lines) and a 
clinically acceptable refractive astigmatism (defined as ≤ 3.0 D). In our results, FS-DSEK 
was less effective and more costly compared to both PK and DSAEK. On the other hand, 
DSAEK was more costly but also more effective compared to PK.  
Chapter 9 describes the results of a case series of 5 eyes undergoing femtosecond 
laser-assisted inverted mushroom keratoplasty. The femtosecond laser was used to cre-
ate a ‘top-hat’ configuration in the donor and recipient cornea. After 1 year, all corneal 
grafts were clear and showed an excellent adaptation of the lamellar donor and recipi-
ent wound surfaces. Fast wound healing was noted in 2 cases in which all sutures were 
removed at 19 and 21 weeks. 
Chapter 10 and Chapter 11 describe the results of our randomized multicenter 
clinical trial comparing DALK and PK in eyes with corneal stromal pathology without 
endothelial disease. Chapter 10 reports on endothelial cell loss and visual outcome 
after DALK versus PK. One year after DALK, we found a significantly lower endothelial 
cell loss in comparison to PK, whereas BSCVA was comparable between the two groups. 
Descemet’s membrane perforation remains a major challenge in DALK, necessitat-
ing further surgical improvements. In Chapter 11 we discuss the results of straylight 
and contrast sensitivity after DALK and PK. At the 1-year follow-up, straylight was not 
significantly different after DALK compared to PK. In addition, there was a significant 
improvement in straylight and contrast sensitivity 1 year after DALK and PK.
Chapter 12 evaluates the cost-effectiveness of DALK versus PK in our randomized 
multicenter clinical trial. The main outcome measures were incremental cost-effective-
ness ratios per clinically improved patient on the 25-item National Eye Institute Visual 
Functioning Questionnaire and per patient with endothelial cell loss of maximally 20% 
within the first year. In our study, we found that DALK is more costly and more effective 
as compared with PK. Results on the 25-item National Eye Institute Visual Functioning 
Questionnaire were in favor of DALK, and the endothelial cell loss in DALK patients 
remained stable after 6 months, whereas endothelial cell loss in PK patients continued. 
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SAMENVATTING
Dit proefschrift beschrijft de klinische resultaten van femtosecond laser Descemet’s 
stripping endothelial keratoplastiek (FS-DSEK) en diep anterieure lamellaire keratoplas-
tiek (DALK) versus perforerende keratoplastiek (PK) en evalueert de rol van de femtose-
cond laser bij corneatransplantaties. 
hoofdstuk 1 is een algemene introductie en beschrijft de doelstellingen van dit 
proefschrift. 
hoofdstuk 2 beschrijft de gladheid, nauwkeurigheid en de voorspellende diepte van 
het stromale bed van de posterieure lamel zoals geprepareerd met de femtosecond 
laser. Negentien humane donor ogen die ongeschikt waren voor transplantatie werden 
gebruikt voor histologische evaluatie. Met de femtosecond laser is het mogelijk op 
gestandaardiseerde wijze een diepe horizontale snijvlak te creëren met een relatief glad 
oppervlak en weinig weefsel schade. 
In hoofdstuk 3 wordt het effect van de femtosecond laser op endotheelcel kwaliteit 
geëvalueerd. Er was geen significant effect van de laser frequentie op endotheelcel 
verlies. Het los prepareren van de posterieure lamel met een canule gaf geen significant 
endotheelcel verlies. 
hoofdstuk 4 beschrijft de eerste casus van een patiënt met pseudofake bulleuze 
keratopathie die behandeld werd met FS-DSEK. Vier maanden postoperatief was de 
posterieure lamel helder en het geïnduceerde astigmatisme was 2.1 dioptrie (D), en was 
er een functionerende endotheelcel laag. 
In hoofdstuk 5 beschrijven we de voorlopige visuele resultaten en de endotheelcel 
dichtheid na FS-DSEK bij 20 ogen met een endotheel dysfunctie. Zes maanden postope-
ratief vertoonden 50% van de patiënten (zonder andere visusbeperkende factoren)  een 
verbetering van hun best gecorrigeerde visus (BSCVA). Postoperatief was er sprake van 
een hyperope verandering, verklaard door de meniscus-vorm van de posterieure lamel. 
hoofdstuk 6 en hoofdstuk 7 bespreken de resultaten van onze gerandomiseerde 
multicenter studie van FS-DSEK en PK bij patiënten met een endotheel dysfunctie. 
hoofdstuk 6 rapporteert de klinische resultaten en incidentie van postoperatieve 
complicaties na FS-DSEK en PK. Tachtig ogen van 80 patiënten werden behandeld. Een 
jaar postoperatief was het percentage patiënten met astigmatisme < 3 D hoger in de FS-
DSEK groep dan in de PK groep. De gemiddelde BSCVA was beter in de PK groep, maar de 
visuswinst was niet significant verschillend tussen beide groepen. Endotheelcel verlies 
was significant hoger in de FS-DSEK groep (65%) in vergelijking met de PK groep (23%). 
Dit verschil wordt mogelijk verklaard door de verschillende chirurgische stappen bij de 
FS-DSEK procedure. De meest voorkomende postoperatieve complicatie in de FS-DSEK 
groep was een afliggende donor lamel; in de PK groep waren dit wond gerelateerde pro-
blemen.  hoofdstuk 7 bespreekt de resultaten van strooilicht en contrastsensitiviteit na 
FS-DSEK versus PK. Wij vonden een significante verbetering van strooilicht en contrast 
sensitiviteit na zowel FS-DSEK als PK. 
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hoofdstuk 8 evalueert de kosteneffectiviteit van PK, FS-DSEK en Descemet’s strip-
ping automated endothelial keratoplastiek (DSAEK).  De data van 118 patiënten met 
endotheel dysfunctie werden geanalyseerd. Om de kosteneffectiviteit te evalueren, 
werden incrementele kosteneffectiviteitsratios (ICERs) berekend.  De primaire ICER 
was de incrementele kosten per klinische verbetering bij de patiënt; dit betekent een 
gecombineerde effectiviteit van klinische verbetering van BSCVA (verbetering van > 1 
Snellen visus regel) en acceptabele refractie astigmatisme (≤ 3.0 D). In onze resultaten 
was FS-DSEK minder effectief en meer kostbaar in vergelijking met PK en DSAEK. DSAEK 
is effectiever in vergelijking met PK, maar leidt ook tot hogere kosten. 
hoofdstuk 9 beschrijft de resultaten van 5 ogen die met femtosecond laser-assisted 
inverted mushroom keratoplastiek waren behandeld. Met behulp van de femtosecond 
laser werd een ‘top-hat’ configuratie gecreëerd  in de donor en recipiënt cornea. Een jaar 
postoperatief waren alle donor corneae helder, met een uitstekende adaptatie tussen 
de donor en recipiënt cornea.  Bij 2 ogen zagen we een snelle wondgenezing optreden 
waardoor alle hechtingen al na 19 en 21 weken verwijderd konden worden. 
hoofdstuk 10 en 11 bespreken de resultaten van een gerandomiseerde multicenter 
studie van DALK versus PK bij ogen met cornea pathologie zonder endotheel dysfunctie. 
hoofdstuk 10 rapporteert het endotheelcel verlies en de visuele uitkomsten na DALK 
versus PK. Een jaar na DALK, zagen we significant minder endotheelcelverlies na DALK in 
vergelijking met PK. De BSCVA was vergelijkbaar tussen de twee groepen. Perforatie van 
het Descemet membraan blijft een belangrijke uitdaging bij DALK en vergt nog verdere 
chirurgische verbeteringen. In hoofdstuk 11 werden de resultaten van strooilicht en 
contrastsensitiviteit na DALK en PK besproken. Bij de 1 jaar follow-up zagen we geen 
significant verschil in strooilicht tussen DALK en PK. In beide groepen zagen we een 
significante verbetering van strooilicht en contrast sensitiviteit na 1 jaar bij zowel DALK 
als PK. 
hoofdstuk 12 evalueert de kosteneffectiviteit van DALK versus PK in onze gerandomi-
seerde multicenter studie.  De belangrijkste uitkomst maten van ICER waren verbetering 
per klinische patiënt gemeten met behulp van de 25-item item National Eye Institute 
Visual Functioning Questionnaire en per patiënt met maximale endotheelcelverlies van 
20% in het eerste postoperatieve jaar.  In onze studie leverde DALK meer kosten op, maar 
was het wel effectiever dan PK. De scores van de 25-item item National Eye Institute 
Visual Functioning Questionnaire waren beter in de DALK groep en het endotheelcel 
verlies in de DALK groep bleef na 6 maanden stabiel, terwijl in de PK groep er nog sprake 
was van toenemend endotheelcel verlies. 
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